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ABSTRACT  
 
Alginate culture system offers an ideal 3-Dimensional microenvironment for the re-
differentiation of chondrocytes following its isolation from its environment and 2D 
culture expansion. It has also been shown that this material supports chondrogenesis for 
mesenchymal stromal cells in vitro. Bone marrow-derived mesenchymal stromal cells 
(MSCs) have been considered a potential cell source for cartilage repair. However, 
successful translation of such stem cell therapy into clinical trials using alginate as a 
carrier requires better understanding of the complex processes involved in the 
differentiation of MSCs. Changes in chondrogenic microenvironment may induce 
different outcomes during chondrogenesis, i.e. either stable chondrocyte-like phenotype 
or terminally differentiated hypertrophic chondrocytes, which may result in 
endochondral ossification formation following transplantation in vivo. Moreover there 
remains a question as to whether non-induced or lineage-committed MSCs should be 
applied for cartilage tissue engineering. Therefore the present thesis was conducted in 3 
main studies to investigate the use of alginate as a scaffold or cell carrier in 
chondrogenic differentiation of mesenchymal stromal cells and cartilage repair. 
In the first study, chondrogenic differentiated MSCs were characterized using 
morphological, biochemical and ultra-structural analyses. In the second study, 
expression of chondrogenic genes and adhesion molecules in alginate culture, pellet 
culture and 2D monolayer were compared using real-time RT-PCR. In the third study, 
alginate was transplanted with or without mesenchymal stromal cells in rabbit knee 
focal cartilage defects to determine whether chondrogenic MSCs, non-induced MSCs, 
or alginate alone will result in superior repair outcome in full thickness cartilage 
damage. 
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 The results of the first part of the study demonstrated superior chondrogenic 
differentiation in the alginate group, indicated by the higher cell viability and 
production of chondrogenic markers of sulphated glycosaminoglycan and collagen type 
II as compared to monolayer or pellet cultures. Ultrastructural studies further revealed 
detailed cell structures, cell-matrix interactions and cell viability in 3D structures during 
chondrogenic differentiation. In the second part of the study, chondrogenic and 
hypertophic gene analysis demonstrated the hypertrophic nature of chondrogenesis in 
2D monolayer and 3D pellet culture while non-hypertrophic features were observed in 
alginate. In the third study, the application of alginate in cartilage repair either as a 
carrier for undifferentiated MSCs or as a scaffold for chondrogenic differentiation of 
MSCs before being transplanted, improved the cartilage repair outcome in rabbit knees. 
However there were no differences observed in the outcome following transplantation 
of alginate alone in cartilage defects compared to the non-treated knee.  
In conclusion, the present thesis suggests that alginate may prove to be a potential 
biomaterial that provides a favourable environment for chondrogenic differentiation of 
MSCs in vitro and in vivo, thereby proving itself as a potential candidate scaffold/cell 
carrier for clinical application involving the repair of damaged cartilage. 
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  ABSTRAK 
Sistem kultur alginat menawarkan persekitaran mikro 3-Dimensi yang sesuai untuk 
pembezaan  kondrosit setelah melalui  perkembangan kultur 2D. Kaedah in terbukti 
menyokong proses kondrogenesis bagi sel-sel stromal mesenkimal secara in vitro. Sel-
sel mesenkimal stromal (MSC) yang diperoleh daripada tulang sum-sum merupakan sel 
punca yang berpotensi untuk pembaikan tisu rawan. Walau bagaimanapun, kejayaan 
ujian klinikal terapi sel punca di dalam persekitaran mikro alginate memerlukan 
pemahaman yang lebih baik kerana pembezaan MSC melibatkan proses yang kompleks. 
Perubahan dalam persekitaran mikro  kondrogenik boleh memberikan hasil yang 
berbeza semasa proses kondrogenesis. Ia boleh menghasilkan kondrosit yang 
mempunyai fenotip yang stabil ataupun kondrosit hipertrofi yang mengalami pembezan 
secara terminal di mana ia menyebabkan pembentukan osifikasi endokondral selepas 
transplantasi secara in vivo. Tambahan pula masih timbul persoalan sama ada ‘lineage-
commited’ MSCs boleh digunakan untuk kejuruteraan tisu tulang rawan. Oleh itu tesis 
ini mengandungi 3 kajian utama yang telah dijalankan untuk menyiasat penggunaan 
alginat sebagai konstruk 3-Dimensi yang sesuai dalam proses pembezaan kondrogenik 
sel-sel stromal mesenkimal dan pembaikan tisu rawan. 
Dalam kajian pertama, MSC yang melalui pembezaan secara kondrogenik telah 
diklasifikasikan  dengan menggunakan analisa morfologi , biokimia dan ultra- struktur. 
Dalam kajian kedua , ekspresi  gen kondrogenik dan molekul lekatan di  dalam kultur 
alginate telah dibandingkan dengan kultur pelet dan lapisan mono 2D menggunakan 
kaedah ‘real time RT- PCR’. Dalam kajian terakhir, alginat yang mengundungi sel dan 
tanpa sel, ditransplantasi ke dalam sendi lutut arnab yang mengalami kerosakkan. Ini 
adalah  untuk menentukan sama ada hanya MSC kondrogenik yang tidak terinduksi, 
atau hanya alginat yang akan mempengaruhi proses pembaikan kerosakkan tisu rawan. 
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 Keputusan kajian menunjukkan, kumpulan alginat menyokong proses pembezaan 
kondrogenik. Ini dibuktikan melalui proliferasi sel yang lebih tinggi, pengeluaran 
penanda kondrogenik daripada glikosaminoglikan sulfat dan kolagen jenis II dalam 
alginat jika dibangdingkan dengan lapisan mono atau kultur pelet. Kajian Ultrastruktur 
mendedahkan lagi struktur terperinci sel, interaksi sel -matriks dan proliferasi sel dalam 
struktur 3D semasa pembezaan kondrogenik. Dalam bahagian kedua kajian ini, Kultur 
lapisan mono 2D dan kultur pelet 3D yang melalui proses kondrogenesis menunjukkan 
ciri-ciri hipertrofik. Manakala ciri-ciri bukan hipertrofik diperhatikan dalam alginat 
yang melalui proses kondrogenesis. Dalam kajian terakhir, penggunaan alginat sebagai 
konstruk 3D yang menyokong  pembezaan kondrogenik daripada MSC sebelum 
ditransplantsi, menunjukkan hasil yang baik dalam pembaikan tulang rawan di dalam 
sendi lutut arnab. Walau bagaimanapun tiada perbezaan yang ketara dapat diperhatikan 
dalam transplantasi yang  hanya menggunakan  alginat jika dibandingkan dengan lutut 
yang tidak dirawat . 
Kesimpulannya, tesis ini menunjukkan alginat berpotensi untuk menjadi  satu biobahan 
yang mampu  menyediakan persekitaran yang kondusif bagi pembezaan kondrogenik 
daripada MSC secara in vitro dan in vivo. Dengan ini, terbukti bahawa alginate 
merupakan konstruk 3D yang menyokong perkembangan sel punca seperti MSCs dan 
sekaligus berpotensi dalam aplikasi klinikal yang melibatkan pembaikan tulang rawan 
yang rosak. 
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1 CHAPTER 1 
1.1 General Introduction  
Articular cartilage being the load-bearing tissue of the joint has limited repair and 
regeneration potential as the result of its poor tissue vascularity. Hence, once damaged, 
long-term disability can be expected in patients. For many years, this issue remains to 
be an unsolved clinical challenge in the field of orthopaedics. Traditional treatment 
modalities intended to regenerate cartilage, such as abrasionplasty, subchondral drilling 
and microfracture only provides short-term benefits at best (Hunziker E.B. et al. 2002; 
Gomoll A.H. et al. 2012). To overcome this, tissue engineering approaches using cells 
seeded in scaffolds have been introduced. This treatment option presents itself as a 
viable alternative to introduce techniques that promises better outcome. However, how 
much better is this method as compared to other more conventional techniques? In most 
studies, results of using these constructs to treat damaged cartilage has shown to be 
promising (Løken S. et al.  2008; Lin L.C. et al. 2012; Jang K.M. et al.  2013). In a 
number of systematic reviews, it has been shown that the use of cell therapy is 
somewhat superior to that of many known techniques (Naveen S. et al. 2012, Gopal K. 
et al. 2014). Generally, cell therapy for cartilage has been confined to the use of 
cultured articular chondrocytes, such as autologous chondrocyte implantation (ACI), 
which is an FDA approved technique. However, mesenchymal stem cells (MSCs),  has 
been considered to be an alternative cell source to  native chondrocytes because such 
cells may be made available from different tissues such as adipose and bone marrow. In 
addition to MSCs possessing potent anti-inflammatory and immunomodulatory effect, it 
has been postulated that good or excellent outcomes observations can be expected as the 
result of either direct cell-cell interaction or secretion of different factors (Caplan A.I. et 
al. 2006; Iyer S.S. et al. 2008; Oh J.Y. et al. 2008). 
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  Various in vivo experiments have described superior repair outcomes when using 
MSCs with supportive scaffolds in treating cartilage defects (Wakitani S. et al.  2002; 
Yan H. et al. 2007; Qi Y. et al. 2012; Zhao Q. et al. 2013). Naturally derived 
biomaterials such as agarose, hyaluronic acid, chitosan, collagen, gelatine, and alginate 
have been used in cartilage tissue engineering. The main advantages of using such 
scaffolds are their biodegradability and biocompatibility properties (Yoon D.M. et al.  
2006). Among these scaffolds, only hyaluronic acid and collagen have been used in 
clinical studies using MSCs (Table 1.1). Alginate is a well characterized biomaterial 
that has been largely described in literatures (Draget K.I. et al. 1997; Sun J. et al. 2013). 
Its use has included applications such as wound dressings (Clark M. et al. 2012) and 
drug delivery systems (Tønnesen H.H. et al.  2002). More recently, alginate has been 
used as a carrier for chondrocyte in clinical trials for treatment of cartilage defects 
(Selmi T. A. S. et al. 2008).  
Despite the variety of clinical application of alginate, it has not been used in clinical 
applications of cartilage repair using MSCs. The reasons for this appear to be 
undetermined since the biomechanical properties or the ability for the material to allow 
cell attachment is not the issues of this material. However, there are arguments that 
suggest that alginate may not possess the necessary biomechanical characteristics that 
can allow it to perform as good as native cartilage tissue. Hence, in many studies 
alginate is used mainly as a delivery vehicle rather than a scaffold for cartilage repair 
purposes (Diduch D.R., et al. 2000; Tay L.X., et al. 2012). Moreover the mechanical 
properties of alginate can be enhanced by increasing its concentration and/or gluronic 
acid contents in its molecular structure (Enobakhare B.O et al. 2006). Cell adhesion 
properties can also be improved using RGD peptide modification into the pourus 
alginate scaffolds(Re’em T. et al. 2010) or alginate gel-microsphers(Sun J. et al. 2013). 
However, it has become apparent that the use of alginate may result in differing 
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outcomes when used in experiments; resulting in either the formation of the preferred 
cartilage-like tissues or, the hypertrophic-like cartilage tissues that is less desirable. 
The review of present available literatures demonstrates that studies relating to the 
chondrogenic differentiation of MSCs in alginate has been reported extensively (Xu J.P. 
et al. 2008; Duggal S. et al. 2009; Herlofsen S.R. et al. 2011, Herlofsen S.R. et al. 
2013). It is interesting to note that the use of the same biomaterial as a 3D matrix for 
chondrogenic differentiation of MSCs produces varying degrees chondrogenic 
differentiation. One group of researchers described the chondrogenic differentiated 
MSCs in alginate as an articular cartilage model (Yang I.H. et al.  2004; 
Andriamanalijaona R. et al. 2008), while others have reported that when cultured in 
vitro, the expression of hypertrophic markers can be expected (Ma H.L. et al.  2003; 
Steinert A. et al.  2003; Ichinose S. et al. 2005; Xu J. et al. 2008; Bian L. et al. 2011).  
It is suggested that the source of cell itself, such as bone marrow derived MSCs may 
have a role in the observed hypertrophic state although further investigation relating to 
this needs to be substantiated (Brian Johnstone et al. 2013). In other studies, it has also 
been postulated that the surrounding microenvironment may be the determining factor 
for the different fates observed within the same cell source. It is suggested that the 
reason for this may be due to the epigenetic effect being exerted during the 
chondrogenic differentiation process. This process appears to be similar to that observed 
during the normal development of cartilage. Epigenetics mechanisms are stable changes 
in gene expression, in which histone modification and DNA methylation influence the 
chromatin structure (Furumatsu T. et al. 2010). These changes although heritable do not 
alter the genetic messages (Jaenish R.et al.2003) 
During the limb budding stages at the embryonic development of vertebrate, the initial 
population of MSCs undergo chondrogenesis resulting in two distinct cell fates. One 
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group of cells is directed to form articular cartilage at the joint surfaces, arrest maturity 
before terminal differentiation to  a hypertrophic chondrocyte and maintain their 
chondrogenic phenotype throughout life unless in pathological conditions such as 
osteoarthritis (OA)  (Drissi H. et al. 2005, Goldring M.B., et al., 2007).   The second 
group of cells destined to form the shaft of the limb, chondrogenic cells undergo 
maturation, hypertrophy, apoptosis, vascular invasion and finally replaced by bone. This 
processes appears to undermine the mechanisms for long bone growth in epiphyseal 
growth plate (Drissi H. et al. 2005; Pacifici M. et al. 2005). 
In vitro chondrogenic differentiation models usually apply high density of cells in the 
form of pellet or aggregates or a combination of cells and biomaterials to provide a 3D 
structure for maximum cell-cell and cell-matrix interactions (Penick K.J. et al. 2005). In 
addition, stimulating factors such as transforming growth factor-β (TGFβ), Insulin like 
growth factors and bone morphogenic proteins (BMPs) are needed to induce 
chondrogenesis (Seo S. et al. 2011). However for its application in articular cartilage 
tissue engineering, the differentiated cells should produce tissues that mimics articular 
cartilage model and arrest maturity before terminal hypertrophic differentiation occurs. 
This is done in order to provide a natural glistening and smooth surface needed on 
cartilage (Rubin R. et al.  2011) for normal joint movement after transplantation in 
defective area.  
In this study in order to further explore the chondrogenic differentiation potential of  
MSCs in alginate beads in vitro, alginate is compared to 2D monolayer and the most 
commonly used 3D chondrogenic  model i.e., pellet culture, which possess a 
hypertrophic nature for chondrogenic differentiation (Yang I.H. et al. 2004; Liu T.M. et 
al.  2007; Uesatoll R. et al.  2008; Pelttari K. et al. 2010).  In order to study the cartilage 
repair, MSCs or chondrogenic MSCs (CMSC) loaded in alginate or alginate beads 
without cells were then transplanted in the defective area of rabbit knee cartilage.  
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1.2 Rationale for conducting this study 
Chondrocytes in articular cartilage maintain their chondrogenic morphology and 
physiology which, unlike chondrocytes at the epiphyseal plate do not undergo 
hypertrophy at early maturation. In pathological conditions such as osteoarthritis, 
changes are observed and ultimately results in poor joint function. As such, the use of 
engineered cartilage that results in these unwanted outcomes would be deemed 
inappropriate for use to repair damaged cartilage. To overcome this problem, many 
studies have looked into improving the biomaterials that avoids such outcomes.  
 Alginate, although have been selected as a potential material, have not been researched 
into great depth specifically in the areas of cartilage repair or regeneration in clinical 
applications. In previous studies, there have been controversies between those who 
support and refute its usefulness for this application. Among which, several researchers 
have indicated that hypertrophic markers during chondrogenic differentiation are 
observed and therefore may be detrimental to cartilage repair outcomes, while others 
have demonstrated otherwise. Considering that there is likelihood that alginate, being a 
biomaterial that has been shown to be useful for chondrogenesis previously, and that it 
serves as a potential carrier or scaffold for tissue engineering; it is only appropriate that 
a complete study looking into its potential be undertaken. Thus, the present thesis 
encompasses studies that looks into the potential of alginate as a promoter of 
chondrogenesis in primary mesenchymal stromal cells, and as such will express the 
appropriate functions and phenotypic expressions that would eventually be useful for 
repairing damaged cartilage.  
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1.3 Review of the literature 
1.3.1 Alginate  
Alginate has been used for more than one century in the food industry, textile printing, 
pharmaceutical and several medical uses including immobilized biocatalyst (McHugh et 
al. 2003). Alginate is a natural and un-branched polysaccharide commercially derived 
from brown alga or biologically synthesized from bacteria (Sabra W. et al. 2001; Hay 
I.D. et al. 2010). In the cell wall of brown sea weed, alginate may be present as a 
sodium, calcium or magnesium salts of alginic acid, since the calcium and magnesium 
salts are insoluble in water only sodium alginate is the goal of extraction (McHugh et al. 
2003).   
Alginate molecule is made of  co-polymer components of  mannuronate-guluronate 
(MG) containing (1,4)-linked β- D-mannuronate (M) and α -L-guluronate (G) (Fig. 1-1) 
The G content is varied between 40% to 70% and the sequence of monomers are also 
different in different industrial products (Andersen T. et al. 2012). Alginate can be 
manufactured with variable content of G and M blocks. G blocks are the main part for 
crosslinking, higher G content results a stronger gel (McHugh et al. 2003). 
Concentration of alginate itself and ionic cross linkers were also contributed to the gel 
strength (Martinsen A. et al. 1989; LeRoux M.A. et al.  2000; Enobakhare B.O. et al. 
2006). 
                               
Figure  1-1 chemical structure of alginate containing G and M blocks. 
 Tokarev A. et al. (2012)    
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Different applications of alginate are based on their heterogeneous chemical properties.  
One of these properties is forming gel due to their ionic crosslinks (McHugh et al. 
2003). Alginate can be cross-linked through ionic cross-linkers such as Ca
2+
, Ba
2+
, 
Sr
2+
,Al
3+
,Zn
2+
,  Fe
+3
  (Machida-Sano I. et al.  2012; Olukman M. et al. 2012). Among 
these ions, calcium is a more popular cross linker for cell delivery purpose because of 
its non-toxic nature (Nussinovitch A. et al. 2010).  
Cross-linking can take place with external exposure by dripping into a calcium chloride 
solution or internal release of calcium in alginate. When Na- alginate is dropped into a 
calcium solution, calcium ions bind to poly G segments (G-blocks) in different alginate 
chains and produce more cross-links (Fig. 1-2). Covalently cross linking of 
metacrylated alginate is formed using carbdamiide chemistry in the presence of a photo 
initiator and UV light (Chou A.I. et al. 2009; Jeon O. et al. 2009). Using this method, 
bioactive peptides such as RGD (arginine- glycine- asparagine) and HBP (Heparin -
binding peptide) covalently attach to alginate to facilitate cell attachment through 
integrins or non-integrin adhesions (Sapir Y. et al. 2011).  
 
                   
Figure  1-2 Ionic cross-linking in alginate 
 (Lee K.Y. et al.  2007)  
Alginate has been used in a variety of physical forms in biomedical applications 
including, gel, fibres, beads, and microcapsules (Thu B. et al. 1996; Trouche E. et al. 
2008; Tabata Y. et al. 2014) in which the resulted ionically cross-linked alginate 
microbeads are wrapped in another layer of poly (L-lysine) to reduce permeability and 
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increase stability.  Such microcapsules were used for immunoisolation of transplanted 
tissues such as pancreases (De Vos P. et al. 2006). Porous alginate/foam/ sponge 
(AlgiMatrix®) more commonly applies for studying of soft tissues such as liver cells 
(Glicklis R. et al. 2000; Glicklis R. et al. 2004; Ramasamy T.S. et al. 2013; Capone 
S.H. et al. 2013) give them a suitable environment to have cell-cell interactions and 
form aggregates or spheroids in a predefined open space, which facilitate exchange of 
nutrient and gases and allow vascularization in vivo. 
In vivo degradation of alginate can occur to the process of ion exchanges of calcium 
with sodium. In addition, reactive oxygen species (ROS) can also affect alginate 
degradation during sterilization with gamma irradiation (Andersen T. et al. 2012). 
 
1.3.2 Alginate in clinical application  
  Alginate is approved by the US Food and Drug Administration (FDA) for use in 
humans as a wound dresser and in the food industry. However the usage of alginate in 
biomedical/pharmaceutical including tissue engineering applications must first be 
specifically approved by a national governing body such as the FDA (Andersen  T. et 
al.  2012). For this purpose the product should be tested in pre-clinical trials including 
in vitro and in vivo experiments to establish the characteristics and safety of the 
biomaterial, which will include biocompatibility and biosafety of the treatment (Lee 
M.H., et al. 2009). The clinical trials initially have three Phases (0, I, II) to evaluate 
pharmacodynamics, safety, and pharmacokinetics within smaller groups of patients and 
phase III including a larger population of people involved in randomized trial to verify 
effectiveness  (Andersen  T. et al.  2012). Even after a product is marketed, FDA 
continues its supervision in different ways, such as inspections, post approval( Phase4) 
studies, and  surveillance of the side effects reported to FDA (Lee  M.H., et al. 2013). 
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As mentioned earlier, the issues shrouding the use of alginate in clinical applications 
remains unclear however, it is clear that further studies would be needed in order to 
satisfy the needs of regulatory bodies such as FDA before alginate can be used 
clinically. 
Having said this, alginate has been used in several clinical trials such as the 
encapsulation of pancreatic islets for treatment of type I diabetes patients. Others have 
also included trials such as a bone substitute with combination of collagen and 
demineralized bone matrix to treat spine fusion and as a biodegradable bone void filler. 
Its combination with propylene glycol and amelogenin (enamel matrix protein) is used 
to stabilize teeth and to induce tissue regeneration in periodontal diseases. It also has 
been used as a suture sealant during lung resection in cancer treatment. Injection of 
alginate chondrocytes was carried out in the submucosa of bladder in paediatric patients 
at the vesicouretric junction to prevent ureteral reflux (Leonard M. P. 2002; Andersen T. 
et al. 2012, U.S. National Institutes of Health 2013). In recently published clinical trials, 
sodium alginate have been orally prescribed to treat patients with non-erosive reflux 
disease (Chiu C.T. et al. 2013), and finally a commercial form of alginate-agarose 
combination (CARTIPATCH®) has been used as a carrier for chondrocytes in a clinical 
trial to treat osteochondral/chondral lesions of the knee (Selmi T.A.S. et al.  2008).  
 
1.4 Articular cartilage injury  
Damage to the cartilage tissue as the result of trauma or disease conditions are 
becoming increasingly common. The poor vascular property of cartilage tissue makes 
healing extremely difficult especially in the presence of full thickness articular cartilage 
defects. Different surgical treatments have been developed to deal with cartilage poor 
repair quality; some of these methods are based on marrow stimulating techniques, such 
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as subchondral drilling, abrasion, or microfractures. Other techniques such as 
ostochondral graft, mosaicplasty, periosteal and perichondrial grafts as replacement 
techniques have been used more commonly (Memon A.R. et al.  2012). A technique 
such as  osteotomy fixes the mal-alignment of the joint in order to remove the extra load 
from the defected area are even added to improve clinical outcomes (Nelson L. et al.  
2010). However the long term results of different surgical treatments for cartilage injury 
are disappointing and if they fail, the salvage and invasive methods employed such as 
arthrodesis or arthroplasty provide less acceptable outcomes for patients 
(Panagiotopoulos E. et al. 2006; Haslam P. et al. 2007). Therefore cell-therapy as 
another alternative treatment of cartilage injury has been applied which promises 
superior outcomes to that of these methods. 
 
1.4.1 Cell Therapy  
Cellular therapy has been considered a successful treatment modality for the repair of 
damaged articular cartilage, producing superior tissue repair quality as compared with 
the standard surgical approach (Brittberg M. 2010).  The first clinical trial reporting the 
efficacy of autologous chondrocyte implantation/transplantation (ACT/ACI), the 
conventional form of cellular therapy, was published in 1994 (Brittberg M. et al. 1994) 
after its successful trials in animal studies in the preceding years (Grande D.A. et al. 
1989; Wakitani S. et al. 1989).  
 ACI has been studied in many clinical trials with good outcomes in the majority of 
cases (Brittberg M. et al. 1994; Peterson L. et al. 2000; Bartlett W. et al. 2005; 
Manfedini M. et al. 2007). For example, in one study (Cole B.J et al. 2012) 85% of 
patients with osteochondritis dissecans, who already had experienced other methods 
unsuccessfully, had functional improvement and reduction of pain after ACI. However  
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first and second generation of ACI that involves the use of periosteal flap or collagen 
membrane, are technically difficult as many surgeons have found that suturing the flaps 
to the surrounding cartilage and in some areas such as osteochondral junctions or 
irregular defects proves to be a difficult task. Moreover the cell distribution in these 
methods is not uniform (Goyal D. et al. 2013). In order to overcome these problem, 
third generation of ACI using seeded chondrocyte on an extracellular matrix or MACI 
(Matrix associated autologous chondrocyte implantation/membrane seeded 
chondrocytes (Goyal D. et al. 2013) have been introduced.  
Despite a successful historical performance for more than 18 years, the use of ACI has 
not been without limitations. Its recognized shortcomings include donor-site morbidity, 
limited supply of chondrocytes, cellular dedifferentiation into fibroblast-like phenotype 
when cultivated in vitro, and inability to maintain good tissue repair in the long term 
(Brittberg M. 1999; Hunziker E.B. et al. 2002). It has been speculated that the use of an 
alternative cell source such as mesenchymal stem cells (MSCs) might overcome some 
of these issues. 
 MSCs were first used for cartilage repair in humans as an endogenous cell therapy 
(Pridie K.H.  1959; Kim S.H. et al. 2012) for the treatment of cartilage damage in 
conjunction with other surgical techniques which recruit MSCs from bone marrow; 
techniques such as microfracture, and most recently  a combination of microfracture and 
scaffold. However inadequate number of MSCs retrieved from bone marrow for the 
repaired site in such techniques reduces their efficacy and as a result the repaired tissue 
represents a fibrocartilage with inferior biomechanical properties as compared to 
hyaline cartilage (Nishimori M. et al. 2006). Therefore exogenous source of MSCs has 
been considered as mesenchymal stem cells may be harvested from many potential 
donor sites including bone marrow, adipose tissue (Im G-II et al. 2005; Kim D.H. et al. 
2013), trabecular bone, periosteum, synovium and dental pulp (Pelttari K. et al. 2008; 
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Mobasheri A. et al. 2009). In addition, with a high proliferation capacity, and owing to 
their multipotency, these cells can conveniently be manipulated in vitro to differentiate 
into chondrocytes for subsequent use in cartilage regeneration (Darwin J. et al. 1998; 
Caplan 2007; Karp J.M. et al. 2009). 
 There have been many previous reports involving in vivo experiments describing good 
repair outcomes after transplantation of MSCs in cartilage defects. Wakitani et al. in 
1994 were among the first research groups to report the successful transplantation of 
bone marrow–derived MSCs in osteochondral defects in rabbit models. Other 
researchers have also studied the application of allogeneic or autologous bone marrow–
derived MSCs using different scaffolds with or without the addition of growth factors to 
treat cartilage defects in various animal models (Gao J. et al. 2002; Murphy J.M. et al. 
2003) (Fig. 1-3).  
                     
Figure  1-3 Cartilage tissue engineering, using cells, scaffold and growth factor 
 
1.4.2 Scaffolds in cartilage tissue engineering 
Different strategies being used to engineer cartilage in addition to application of proper 
cell source and growth factors strongly depends on the selection of the scaffolds. In 
cartilage tissue engineering scaffolds not only provide a convenient method for 
delivering cells into focal defect sites, but also provide structural support to the 
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construct and induce cartilage matrix formation within the defective sites (Vinatier C. et 
al. 2009; Zippel N. et al. 2010). Scaffolds can be produced from different type of 
materials including polymers (Yoon D.M. et al. 2006) (Fig. 1-4). 
Naturally derived polymers are classified into two groups, polysaccharides and 
polypeptides (Ma P. X. 2004; Yoon D.M.  2006). Different naturally derived polymers 
have been applied in cartilage tissue engineering including: Agarose (Yin Z. et al. 2014) 
alginate (Herlofsen S.R. et al. 2011), hyaluronic acid (Solchaga L.A. et al. 2005), 
chitosan (Ragetly G.R. et al. 2010; Suh J.K. et al. 2000), collagen (Deponti D. et al. 
2013), chondroitin sulphate (Guo Y. et al. 2012), Cellulose (Pulkkinen H. et al. 2006)  
Gelatin (Schagemann J.C.,et al. 2009), fibrin (Eyrich D. 2006), and silk (Seda Tigli R. 
et al. 2009). 
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Figure  1-4 Biomaterials for tissue engineering 
Polymers being used in tissue engineering in form of hydrogels or porous solid –state scaffolds . Inorganic materials in form of Porous bioactive glasses or calcium 
phosphate. Alginate as a naturally derived polymer is used as a hydrogel or solid- state porous scaffold in tissue engineering. Adapted from Ma P.X. 2004  
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Among the described naturally derived polymers, only hyaluronic acid and collagen are 
being used as a cell vehicle or scaffold in cartilage regeneration clinical trials using 
MSCs (Table 1-1). 
Table  1-1 Commercial scaffolds using in clinical trials for cartilage repair 
Scaffold Natural Synthetic Cell 
Protein Polysaccharide 
MACI
®
 
 
Collagen I & 
III membrane 
- - Chondrocyte 
Maix
®
 
 
Collagen I & 
III membrane 
- - Chondrocyte 
Chondro-gide
®
 
 
Collagen I & 
III membrane 
- - Chondrocyte 
Atelocollagen
®
 
 
Collagen I-gel - - Chondrocyte, 
MSCs 
Hyalograft
®
 - Hyaluronic acid - Chondrocyte 
HYAFF11
® 
 
- Hyaluronic acid - Chondrocyte, 
MSCs 
Bio-Seed-C
® 
 
- - PGA-PLA-
polydioxan
one 
Seeded 
chondrocytes 
within a fibrin 
gel 
CARTIPATCH
®
 
 
- Alginate-Agarose - Chondrocyte 
Adapted from: Selmi T. A. S.  2008; Vinatier C. 2009; Iwasa J. 2009 
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There are strict criteria to be met for a biological product to be approved with FDA for 
clinical application (US Food and Drug Administration 2011, US Food and Drug 
Administration 2014).  Tissue engineering products are not described exclusively by 
components alone since cell–scaffold interactions also influence the characteristics of 
the final product. In evaluating cell–scaffold products, individual components before the 
assembly as well as the whole product after assembly should be evaluated with a variety 
of tests. Figure 1-5 summarizes the main safety and characterization of two main 
components of cell and scaffold that should be considered for tissue engineering.  
 
 
                                                                          
 
 
 
                              
 
 
 
 
 
 
 
 
Figure  1-5 Safety and effectiveness measures of a cell–scaffold combination to be used in a clinical trials  
 GMP, good manufacturing practice; MCB, master cell bank; QSR, quality systems regulation; 
WCB, working cell bank (Lee M.H., 2009). 
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1.4.3 Regulation of chondrogenic differentiation 
MSCs can be induced along a chondrogenic lineage using biochemical and biophysical 
factors. (Bahuleyan B. et al. 2009). It has been demonstrated that mechanical loading 
exerts an important effect on the chondrogenic differentiation of MSCs during the 
development of the musculoskeletal system as well as during cartilage repair using 
transplanted MSCs as shown in several animal studies (Bahuleyan B., et al. 2009, 
O’Conor C.J., et al. 2013) or in vitro chondrogenic differentiation (Henrionnet et al. 
2012)  
Chondrogenic differentiation is initiated in the embryo with aggregation of 
mesenchymal stem cells in the incipient limb site in a process called condensation. Cell-
cell communications seems to play an important role at this stage as it was shown by the 
expression of adhesion molecules of N-cadherin and N-CAM1 and gap junctions; i.e. 
during the prechondrogenic phase (Widelitz R.B et al. 1993, Delise A.M., et al.2002). 
Multiple growth factors and morphogens such as TGFβ and FGF regulate the initiation 
and maintenance of chondrogenesis. Having bound to their serine/threonine kinase 
receptors, TGFβs stimulate downstream signalling pathways through SMAD proteins or 
MAPK signal transducers (Wang W et al. 2014). TGFβs ligand- receptors stimulate 
phosphorylation of members of R-Smad (receptor activator Smad) including Smad2 and 
Smad3, to form a complex with Smad4 and transfer to the nucleus where it binds to the 
promoters and regulates the expression of chondrogenic genes (Ross S. et al. 2008).  
From studies determining the intracellular signalling chondrogenic pathways, it has 
been deemed that the transcription of Sox9 regulates the chondrogneic differentiation 
processes (Kawakami Y. et al.  2006). Following the condensation of differentiated and 
matured chondrogenic-differentiated MSCs, the regulatory effect of Sox9 is subjected to 
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other subgroups of Sox proteins, i.e.Sox5 and Sox6. (Ikeda T. et al. 2005; Hidaka C. et 
al. 2008). 
The importance of Sox9 during chondrogenesis was reported in different studies. Its 
physiological role has been demonstrated in specific genetic disease such as 
campomelic dysplasia. In this disease, the heterozygous mutations in the Sox9 gene 
caused an incomplete development of the skeleton (Ikeda T. et al. 2005). In addition, 
retroviral transfection of Sox9 on dedifferentiated chondrocytes increased the 
production of chondrogenic matrix such as Collagen type II and GAG, thus 
demonstrating the importance of the Sox9 gene (Hardingham T.E. et al. 2006).  
It needs to be highlighted here that extra cellular matrix (ECM) components play an 
important regulatory role during chondrogenesis. Certain proteins such as endoglin and 
betaglycan (βglycan) that bind to growth factors such as TGFβs and present them to 
their associated receptors on the cell surface enhances the chondrogensis process 
(DeLise A.M. et al. 2000).  ECM has dynamic and functional roles in transmitting 
signals from surrounding environment to the cell cytoskeleton (outside-in) or vice versa 
to disseminate signals (inside-out) through integrins (Harburger D.S. et al. 2009).  
MSCs in condensation phase produce ECM that mainly contain collagen type I, 
fibronectin, and tenascin. During chondrogenic differentiation, the major proteins 
produced by ECM are collagen type II and proteoglycans such as aggrecan (DeLise 
A.M. et al. 2000).  
During limb bud chondrogenesis in embryo, MSCs undergo different cell fates; they 
either differentiate to articular cartilage or to the shaft of the limb. The maturation 
process in the first group of cell undergoes abrupt arrest, and produce cartilaginous 
ECM contains collagen type II, IX, XI, VI, and aggrecan. It is only in pathological 
situations such as OA, that articular chondrocytes express hypertrophic factors as the 
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result of the disruption in the maturation process (Fig. 1-5). MSCs that are differentiated 
into cartilage producing cells, that produces the rest of the limb including the growth 
plate, resume proliferation and continues to produce matrix components including Col 
X, alkaline phosphatase, and express receptors for Ihh, PHrP, BMP-6, matrix 
metalloproteinase 1, 3, 9, and 13. Terminally matured chondrocytes then finally 
undergo apoptosis (Drissi H. et al. 2005; Hidaka C. et al. 2008). TGFβ, PTHrP Ihh/Shh 
inhibits hypertrophic maturation of chondrocytes through their downstream signalling 
pathways (Derynck R. et al. 2008).  
 
Figure  1-6 Permanent cartilage vs. hypertrophic cartilage pathways 
During limb formation MSCs undergo different fate during chondrogenesis i.e.: Growth plate 
chondrocyte or articular chondrocyte (Drissi H. et al. 2005). 
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1.5 Objectives of this thesis 
General objective: To investigate the use of alginate in chondrogenic differentiation of 
mesenchymal stromal cells and its usefulness in cartilage repair. 
 
 Specific objectives:  
• To compare the chondrogenic differentiation potential of MSCs in alginate 
beads, pellet, and monolayer cultures using chondrogenic medium. 
• To characterize chondrogenic differentiated MSCs (CMSC) by identifying the 
morphological, biochemical, gene analysis, cell viability/proliferation changes. 
• To study the gene expression levels of adhesion molecules during the 
chondrogenic differentiation process of the human MSCs. 
• To study the repair outcomes of transplanting chondrogenic and undifferentiated 
MSC on focal chondral defects of rabbit knees.  
• To determine the efficacy of alginate without cells in the repair of damaged 
cartilage, using rabbit knee model. 
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1.6 Hypotheses  
Hypothesis 1: MSCs embedded in alginate beads supported by chondrogenic medium 
will produce and sustain chondrogenic phenotypic expression similar to cells derived 
from articular cartilage. 
Hypothesis 2: Cell adhesion molecules of NCAM and N-cadherin will not be expressed 
in a differentiated chondrogenic alginate model. 
Hypothesis 3: The alginate constructs with condrogenic differentiated MSCs augments 
the repair outcomes when applied to damaged articular cartilage.  
Hypothesis 4: Alginate may be sufficient in promoting cartilage tissue repair without 
the use of MSCs.  
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2 CHAPTER 2: Method development 
 
2.1 Bone marrow isolation  
2.1.1 Rabbit 
Animals (3-5 months old, 2.5–3.3 kg) were sacrificed in accordance with the guidelines 
of the Animal Care and Use Committee and, institutional review board of University of 
Malaya (Reference number: OS/10/11/2008/0611/HD (R)) using a high dose of 
Nembutal intravenously. The long bones of the animal (Tibia, Femora, and Humorous) 
were collected under sterile conditions. The samples were kept on iced cooled 1XPBS 
(PH 7.2) supplemented with 4% antibiotic/antimycotics (Invitrogen). In a laminar flow 
hood, the bones were crushed using a bone cutter leaving the bone marrow to be 
collected, diluted, and mixed with the same volume of 1XPBS supplemented with 1% 
penicillin/streptomycin (Invitrogen, Carlsbad, CA) by pipetting. Four ml of the diluted 
bone marrow was layered on 3ml of Ficoll Paque (Amersham Biosciences, Uppsala, 
Sweden) in a 15ml centrifuge tube and centrifuged in 2200 rpm for 25 minutes. 
The mononuclear layer (Fig. 2-1A) was collected using a pipette, washed in 1XPBS 
containing 1% Penicillin/Streptomycin and centrifuged at 1100 rpm for 5 minutes    
(Fig. 2-1B). The pellet was then re-suspended in the growth medium (DMEM-LG 
supplemented with 10% FBS and 1% Penicillin/Streptomycin) and cultured in 75ml 
culture flasks (Nunc, Rockside, Denmark) in a humidified incubator (37
 o
C, 5% CO2). 
 
2.1.2  Human 
Human bone marrow samples were obtained from adult healthy individuals (male, 
age=21+2.6 years) whom were undergoing fracture fixation involving the long bones. 
Approval to collect human samples was with ethics approval from University of Malaya 
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Medical Centre Ethics Committee (reference No. 472.95). Bone marrow samples were 
collected in a sterile 3ml BD Vacutainer blood   tubes (K2 EDTA, BD franklin Lakes 
NJ USA) by dedicated orthopaedic surgeons and was kept at 4
o
C until isolation was 
performed. 
The bone marrow samples were diluted with an equal volume of 1XPBS containing 
1% antibiotic/antimyotics and mixed thoroughly. The mononuclear layer was isolated 
with the same method as described above.  
    
Figure  2-1 Bone marrow mononuclear cells  
A. Mononuclear layer (arrow).  
B. Mononuclear cells after washing with PBS.  
C. Mononuclear cells under light microscopy 10X.  
D. (Day 3) P0 fibroblastic shape HMSCs attached to the culture flask (arrow), phase contrast 
microscopy10X. 
 
 
2.1.3 Cell culture and expansion  
The isolated mononuclear cells were cultured in a 75ml culture flask and supplemented 
with growth medium (DMEM-LG supplemented with 10% FBS and 1% 
penicillin/streptomycin) which was replaced every three days. With the first change in 
medium, the non-adherent cells were washed out. The adherent cells (Fig. 2-1D) were 
expanded and passaged until passage 3 (P3) before being characterized. 
 
A B C D 
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2.1.4  Passaging MSCs 
 Cells were cultured until they reached 70-80 % confluency (Fig.  2-3B). Before adding 
3ml of TrypLE
TM (
Invitrogen), the remaining FBS was removed from the culture by 
discarding the medium and washing with 1XPBS containing 1% antibiotic/antimycotic, 
so that it would not inhibit the enzyme during tripsinization.  After 3 minutes incubation 
with TrypLE at 37
 o
C, the cells were monitored under a phase contrast microscope to 
verify detachment of the cells (about 90%), before adding 4-6ml DMEM containing 
10% FBS to the culture to neutralize the active enzyme in TrypLE. The remaining cells 
were then detached completely from the surface using a cell scrapper and centrifuged in 
15ml propylene tubes at 1100 rpm for 5 minutes. The pellet was re-suspended in 1ml of 
medium. Cell count was conducted using a haemocytometer and the cells were sub 
cultured in 75ml culture flasks with a density of 3000-5000 cells per cm
2
. The medium 
was changed every 3 days.  
 
2.1.5  Cell counting and viability assessment 
 The viability of cells was determined by TrypanBlue exclusion dye method. While live 
cells do not absorb the dye (Fig. 2-2A), it penetrates the cell membrane of dead cells 
staining them blue (Fig. 2-2B and C). 10 µl of the cell suspension was mixed with 10µl 
of Trypan Blue (Sigma) and mixed by pipetting. 10µl of the mixture of the cell/dye was 
placed in each chamber of a haemocytometer which had already been cleaned with 
ethanol and wiped with a lent-free tissue. The cells were counted in 5 squares of each 
chambers (the corners and the central squares, total 10 squares from up and down 
chambers) (Fig. 2-2) and calculated using the formula: N= X/S*10
4
*D in which,   N= 
Total number of cells, X= Number of counted cells, S= Number of the squares, D= 
Dilution factor.  To avoid overlapping of the cell count in the small squares, cells were 
only counted on the left and bottom borders (Fig. 2-2).  
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Figure  2-2 Cell viability TrypanBlue exclusion   
A. Live cells do not pick up the TrypanBlue stain, and look glistening under microscope 4X. 
B. Dead cells stained blue with trypanBlue staining 4X. 
C. Higher magnification of dead cells stained with TrypanBlue, 40X arrow= Nucleus, 
p=Phyllopodia.  
 
2.1.6  Cryopreservation  
In order to preserve the cells for long time, the cells were tripsinized in sub-confluency 
and washed with 1XPBS containing 1% Penicillin/Streptomycin (Gibco) by 
centrifugation 1100 rpm for 5 minutes. A mixture of 10% DMSO (Sigma) in FBS 
(Gibco) was prepared and added to the cells after discarding the supernatant thoroughly. 
The cells  were mixed with the cryo-medium by gentle pipetting and transferred to 1ml 
cryo-tubes (TPP-Germany), within  a cryo freezing container (Nalgene®, Mr Frosty) 
and were placed at -80
o
C overnight before being transferred into liquid nitrogen 
tanks  (-  196
 o
C) (Freshney R.I., 2005). 
 
2.2 MSC Characterization 
The plastic adherent mesenchymal stromal cells (MSCs) (Horwitz E.M. et al. 2005) 
were further characterized based on the minimal criteria to define MSCs by the 
International Society for Cellular Therapy (Dominici M. et al. 2006). General 
morphology was studied using phase contrast microscopy (Fig. 2-3). 
A B C 
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Figure  2-3 Plastic adherent and fibroblastic shape of MSCs, phase contrast microscopy 
A. Cell protrusions (arrow) adhere on plastic surface as early as 2 hours after seeding. Rabbit MSC, 
P3 40X.  
B. Rabbit MSCs at P1, 70-80 % confluency 4X. 
C. Human MSCs at P3 4X. 
 
The presence or absence of  CD markers: CD29,CD44, and CD45 were studied in  both 
human and rabbit MSCs using immunocytochemistry , and a panel of antibodies for CD 
markers: CD105,CD90,CD73,CD44,CD45, and CD34 were  studied  in human MSCs 
using  flow cytometry:    
 
2.2.1 Immunocytochemistry 
Expression of CD markers in human and rabbit stem cells were studied using 
immunocytochemistry for CD29 anti-Human [P4G11] Abcam, mouse mAb to integrin 
beta1 (Abcam, Cambrige, UK) dilution 1/50, CD44 (Rat mAb (A020, 
CALBIOCHEM©, Merck, Germany) anti rabbit dilution 1/400, and CD45 (mAb, 
mouse anti Rabbit, AbD Serotec, Oxford) dilution of 1/100 as a negative marker      
(Fig. 2-4).    
MSCs in P3 were cultured on chamber slides, at cell densities of 3000-5000 cells per 
cm
2
. In subconfluency or when confluency is achieved, the cells were washed with 
phosphate buffer saline (PBS), fixed in 10% formalin for 20 minutes, and stained 
according to the manufacturer’s instructions provided in the DAKO kit:  Cells were 
A B C 
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treated for 5 minutes with peroxidase block (0.03%  hydrogen peroxide containing 
sodium azide) and rinsed with Tris-Buffered Saline (TBS) pH 7.6 or distilled water. 
Primary antibodies were applied to the test wells for 30 minutes. In the control wells, 
the cells were covered with TBS as a negative control for 30 minutes. The cells were 
then rinsed with TBS before peroxidase conjugated secondary antibody (peroxidase 
labelled polymer: goat anti-mouse immunoglobulins) was applied to the test as well as 
the control wells for another 30 minutes. After washing with TBS, the cells were stained 
with the Substrate-Chromogen (containing hydrogen peroxide and a preservative) plus 
DAB solution       (3, 3’ diaminobenzidine chromogen solution) for 5-10 minites. Cells 
were then washed by distilled water and counter stained with haematoxylin for 2 
minutes and the nucleus staining was enhanced in bluing agent (10 dips). The slides 
were then dehydrated in an ascending series of ethanol, cleared in xylene, and mounted 
with DPX.  
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Figure  2-4 Immunocytochemistry for CD markers 
MSCs in human and rabbit showed positive for CD44 and CD29 and negative for CD45. Upper panel 
human MSCs, Lower panel rabbit MSCs. 
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2.2.2 Flow Cytometry  
Expression or the lack of expression of a panel of antibodies was studied in human 
MSCs using flowcytometry analysis: CD105 (Endoglin), CD73, CD45 (leukocyte 
common antigen), CD44 (Hyaluronic acid receptor), CD34 (haematopoietic progenitor 
cell marker), and CD90. Each antibody (Mouse anti-Human) was conjugated with a 
special fluorochrom: Percp-Cy 5.5 CD105, APC CD44, FITC CD73, PE-CyTM7 CD90, 
PE CD34, and APC-H7 CD45. 
BD
TM
 CompBead plus (7.5um) particle set was used as a negative control for the 
sample. The beads were prepared according to the manufacturer protocol: The BDTM 
CompBead plus was vortexed before use. For each fluorochrom conjugated antibody 
use in the experiment a 12x75 mm sample tube (Falcon) was labelled. 100ul of PBS as 
staining buffer was added to each tube. One full drop (60ul) of each BD CompBead was 
added to each tube and vortexed. The samples were incubated in dark chamber at room 
temperature for 15-30 minutes. Using BD
TM
 CompBead plus Negative Control (BSA) 
beads, the voltage of the flow cytometer instrument was set for MSCs experiment. 2ml 
PBS was then added to each tube and pellet by centrifugation at 200xg for 10 minutes. 
The supernatant was aspirated and discarded thoroughly using a fine-tip pipette. 
Another 0.5ml of PBS was added to each tube and mixed using a vortex. Each tube was 
run separately on the flow cytometer. Each single bead population gated on FSC 
(forward-light scatter) and SSC (side-light scatter) characteristics.  
 
 Sample preparation for flow cytometry: MSCs were tripsinized at P3. The Cells 
(500x10
3
) were suspended in 100µl PBS. Each mAbs antibody stock was diluted to an 
optimum concentration for 10
6
 cells and the antibodies were added accordingly:     
CD73 FITC 5µl, CD34 PE 10µl, CD105 PCP 5.5µl, CD44 APC 10µl, CD 45 APC 5µl, 
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and CD90 PECY 5µl. the samples were kept for 15 minutes in dark, incubated on ice 
before 2ml PBS was added and centrifuged 200g for 10 minutes. The supernatant was 
discarded and 500µl of PBS was added and vortexed. Samples were kept in dark and on 
ice before flow cytometry analysis. Gating was performed using forward and side 
scatter to exclude cellular aggregates and debris. At least 10000 events per sample were 
analysed by the BD FACSDiva software (BD Biosciences). 
  
                  
 
A 
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Figure  2-5 Co-expression of CD markers in HMSCs using flow cytometry 
A. Un- stained sample negative control dot-plots. 
B. HMSCs were stained with antibodies against the indicated antigens labelled on each axis. 
Representative dot plots were derived from gated events and displayed as combination of 
forward and side light scatters (FSC and SSC) on a log scale. FSC correlates with particle size 
while SSC indicates granularity or internal morphology of cells or particles. Cells/events in Q2 
are positive and in Q3 are negative for both axes. Q1 is positive for Y and negative for X, Q4 is 
positive for X and negative for Y (Appendix I). 
  
Table  2-1 Percentage co-expression of CD markers in HMSCs 
                         Antigens                                     CD markers (%) 
                  CD73+ and CD34-               94.3 
                   CD73+and CD44+             99.8 
                   CD73+ and CD90+            100 
                   CD105+and CD34-          98.2 
                   CD44+and CD34-             99.9 
                   CD90+and CD34-             98.7   
         CD34- and CD 45-                   97 
B 
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2.2.3 Tri-lineage differentiation 
Multi lineage differentiation of mesenchymal stem cells (MSCs) were investigated in 
rabbit and human stem cells, by inducing osteogenic, adipogenic and chondrogenic 
lineages as follow:  
 
2.2.3.1  Osteogenesis 
MSCs were cultured in chamber slides (3000-5000 cells/cm
2
). Upon confluency, the 
culture was supplemented with osteogenic medium (Gibco) up to 21 days. The medium 
was changed every three days, and cell morphology was assessed using phase contrast 
microscopy at three-day intervals. To verify the calcium deposition after 21 days, the 
cells were stained with Alizarin Red S (Sigma). To demonstrate this, the medium was 
removed and the cells were washed with 1XPBS, and fixed with formalin 10% for 20 
minutes. The fixative was removed and the cells were stained with 2% AlizarinRed 
solution (Appendix B-e) for 10 minutes. The dye was then removed from the culture 
and the cells were washed with 1XPBS once or twice. Images were captured at this 
stage using a phase contrast microscopy. Alternatively after proceeding with 
dehydration in ascending graded series of ethanol, clearing with Xylene and mounting 
with DPX (Fig. 2-8) images were captured through a light microscope. 
 
 2.2.3.2  Adipogenesis 
MSCs were cultured in chamber slides and the cells were supplemented with growth 
medium until reaching confluency. The cells were then supplemented with defined 
medium (Gibco adipogenic medium) until day 21. The medium was change every 3 
days. On day 21 the cells were washed with PBS and fixed with 10% formalin for      
10-20 minutes followed by rinsing with distilled water twice.  The cells were then 
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incubated in 60% isopropanol for 5 minutes at room temperature and stained with      
Oil Red working solution (Appendix B-f) for 10 minutes. The dye was removed and the 
cells were washed four times with ddH2O. Images were taken at this stage through light 
microscopy while the cells were covered with distilled water (Fig. 2-8).  
 
2.2.3.3  Chondrogenesis  
In order to test the quality of defined medium for chondrogenic differentiation of MSCs 
it compared with standard medium (STEMPRO® Chondrogenesis Differentiation Kit, 
Gibco-Invitrogen) with two types of cell aggregates micromass and pellet cultures, in 
two groups of induced (chondrogenic medium) and non-induced (growth medium). 
Production of cartilaginous extracellular matrix or   proteoglycans verified using 
Safranin O Fast green and Alcian Blue staining (Appendix B).   
 
Chondrogenic medium (defined medium): Chondrogenic medium was prepared 
according to Gregory  C. A. & Prockop  D. J. (2007).  It included DMEM high glucose 
(4.5mg/ml D-Glucose) with sodium pyruvate  (110µg/ml) (invitrogen), ITS-A  50 
mg/ml (1X) (invitrogen), L Ascorbate 2 phosphate (50µg/ml) Sigma, TGFβ3 10ng/ml 
(Invitrogen), Dexamethason 100nM (1x10
-7
M; Sigma), Penicillin/Streptomycin 
100µg/ml (Invitrogen), L Proline 40µg/ml (Sigma). 
 
 Micromass culture:    MSCs at P3 were seeded in 5µl drops in a cell concentration of 
2 million cell per ml in a 24 well culture dish (2 micromasses per well), and incubated 
in 37
o
C and 5% Co2 for 2 hours, before adding media. The wells divided in different 
groups of control or test. The control group was cultured using growth medium, while 
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the test groups were supplemented either by commercial chondrogenic medium (Gibco-
Invitrogen) or by defined medium (6 well per group). The media were changed every 3 
days. After 14 days the micromasses stained with Safranin O and Alcian Blue          
(Fig. 2-6). 
  
    
    
Figure  2-6 Chondrogenic differentiation of human MSCs in Micromass culture 
A. Day 6 cultured in standard medium, phase contrast microscopy 4X. 
B. Day 6 cultured in defined medium, phase contrast microscopy 4X. 
C. Day 14 cultured in standard medium stained with Alcian Blue10X. 
D. Day 14 cultured in defined chondrogenic medium stained with Alcian Blue 10X. 
E. Day 14 cultured in defined medium, Alcian Blue staining 10X. 
F. Day 14 negative control cultured in growth medium stained with Alcian Blue 4X. 
G. Day 14 cultured in defined chondrogenic medium Safranin O staining 10X. 
H. Day 14 negative control cultured in growth medium stained with Safranin O 4X. 
 
 
  
Pellet culture: The chondrogenic medium was then tested with pellet culture of human 
and rabbit MSCs for chondrogenesis. 250x10
3
cell harvested at p3 and centrifuged at 
1100 rpm for 5 minutes, the supernatant discarded and the pellet supplemented with 2ml 
of chondrogenic medium for one month. Medium was changed every 3days. The pellet 
were then fixed with10% formalin and processed for routine histology. Paraffin sections 
were stained with Safranin O Fast green (Appendix B). The staining outcome           
A B 
C D 
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(Fig. 2-6 & 2-8) compared with positive control samples of human and rabbit cartilages 
stained with Safranin O Fast green and Alcian Blue (Fig. 2-7).     
 
    
 
Figure  2-7 Safranin O Fast Green and Alcian Blue staining of human and rabbit Cartilage  
A & B. Safranin O Fast Green. Cartilage stains deep red in zones rich in GAG content, bone and other 
low/no GAG content of cartilage stains green A. Rabbit cartilage 10X, B. Human cartilage 20X. 
 C & D Alcian Blue staining, cartilage stains blue in zones rich in GAG content. C. Human cartilage 20X, 
D. Rabbit cartilage 20X 
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Figure  2-8 Tri-lineage differentiation of human and rabbit MSCs 
Mineral deposition in osteogenic cultured stem cells. Human 10X and rabbit 20X.  Alizarin Red staining 
differentiated human MSCs to pre-adipocytes. Oil Red staining, counter stained with Haematoxylin 40X. 
Rabbit 20X. Chondrogenic differentiation of human 10X, and rabbit MSCs 20X Safranin O Fast Green. 
 
A B C D 
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2.3   Proliferation assay  
Cell proliferation rate was assessed using AlamarBlue® colorimetric assay (Invitrogen) 
according to the manufacturer protocol. 10% AlamarBlue were prepared in medium and 
added to the cells culture, after 3 hours of incubation (37°C, 5% CO2), 100µl of the 
medium from each sample and from the 10% AlamarBlue solution as negative control 
were transferred into a 96 well culture plate (Costar, Corning, NY, USA) (3 replicates ). 
The absorptions of 570nm and 600nm were recorded using Epoch microplate 
spectrophotometer and Gene 5 data analysis software (Epoch Bio-Tek). The percentage 
absorption of AlamarBlue was calculated according to the formula from 
www.Invitrogen.com (Appendix D). 
Standard curve: Cells were harvested at P3 and cultured with different cell 
concentrations at 3 replicates in six well plates for producing a standard curve. On day 3 
medium was removed from the cells and replaced by a medium containing 10% 
AlmarBlue. The absorption of 570 and 600nm were measured by a micro plate reader 
and a linear line was plotted after data were analyzed by respected formula 
(Appendix  D). 
 
2.4 Gene expression analysis  
2.4.1 Primers 
 Human gene sequences for Collagen type II, aggrecan, Sox9, Collagen type I were 
obtained from NCBI gene bank. The primers designed using Primer 3 and NCBI 
software. The selected primers were analysed with the NetPrimer software for 
secondary structures such as Hairpin, Dimers, Cross-dimers, and Palindromes repeat 
and run in primer pairs. The chosen primers were checked for speciality with NCBI 
Nucleotide blast tool:  http://blast.ncbi.nlm.nih.gov/ 
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2.4.2  RNA isolation  
Cells were tripsinized from monolayer, cell count and viability test with TrypanBlue 
were performed. The cells then washed with iced cooled PBS and centrifuged at      
1100 rpm for 5 minutes and kept in -80°C until further processing. RNA was isolated 
from cells using SV total RNA isolation system, Promega (USA) according to the 
manufacturer instructions.  
All Pipettors and surfaces were wiped with RNase away spray before use to create a 
ribonuclease free environment in order to reduce the risk of RNA degradation. Quality 
and purity of RNA was measured using a NanoDrop 2000 (ThermoScientific, UK) 
spectrophotometer. The UV absorbance of 280nm for DNA, 260nm for RNA and     
230nm for background carryovers (salts, proteins) were measured. The ideal values 
were placed 1.8-2 for the ratios of 280/260 and 260/230. Lower values show the lower 
purity of 280/260 and carry over for 260/230 .The integrity of RNA were determined 
using gel electrophoresis for 28s and 18s ribosomal RNA. The ratio of 2/1 for 28s/18s 
and the sharpness of the bands (without smears) were considered intact RNA (Fig. 2-9).  
The RNA was kept in -80°C until further processing to cDNA.    
 
  2.4.2.1   RNA quality gel electrophoresis  
Before gene expression analysis, integrity of extracted RNA from different 
experimental groups was evaluated using gel electrophoresis: High integrity and purity 
RNA was selected to be converted to cDNA, based on gel electrophoresis and 
spectrophotometer results.         
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200-500ng RNA was loaded in each gel wells along with loading buffer (Biotium gel 
Red 6X). The gel was visualized in a transiluminator (Alpha Innotech FluorChem® 
FC2 Imager). 
The MW of human 18S rRNA is 1868 and 28S rRNA 5025. In 1% gel electrophoresis 
sharp bands of RNA 28S place at about 5kb and 18S at 2kb. With an approximation of 
2:1 ratio, the findings indicates that the RNA is intact, the faded and smear bands 
indicate the degraded RNA (arrow).  
 
                                   
Figure  2-9 RNA quality using gel electrophoresis 
A. Gel electrophoresis shows 28S at the level of 4981 bp and 18S bands at the level of 1908 
band of ladder.  L. RNA marker Promega USA.  
B. Comparing a degrading and intact RNA, arrow indicates the fading 28S ribosomal rRNA 
undergoing degradation.  
 
  
  2.4.2.2   Primer validation and annealing temperature  
Normal human chondrocytes (CloneticsTM (NHAC-kn) Lonza, Walkersville. Inc. U.S.) 
embedded in alginate beads for 21 days (to re-differentiate the  dedifferentiated 
chondrocytes after expansion in monolayer) was used  as positive control to test 
chondrogenic markers of Collagen II, Sox9, and aggrecan. RNA for testing 
housekeeping genes extracted from MSCs in monolayer and for hypertrophic genes of 
RunX2 and collagen X from MSCs cultured in osteogenic medium on day 12.  
 
    Size bp 
 
       
      4,981 
 
      1,908 
 
Intact 
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  2.4.2.3     Gradient PCR  
In a gradient series of temperatures, the temperature which was common between 
primers with the lowest Cq values obtained with RT-PCR or the single and brightest 
band produced with gel electrophoresis (Fig. 2-10) was chosen as the annealing 
temperature.  
 
  2.4.2.4   Gel electrophoresis for primer assessment  
2% agarose in 1XTAE buffer, heated in microwave. The gel was cooled to about 60
°
C 
before a 1X of fluorescent dye (Gel Red, Biotium, USA) was added and cast in a mould. 
A proper comb was inserted to make wells and removed after gel was solidified. The gel 
was placed in an electrophoresis tank filled with proper amount of 1XTAE buffer (the 
wells located in the negative side of the tank).  cDNA was mixed with 5X loading 
buffer (Bioline), to make a 1X mixture (4µl cDNA plus 1µl loading buffer) for each 
well. The first well was loaded with DNA marker. The gel was run at 90 volt for 45 
minutes.  
 
          
 
Figure  2-10  Gradient PCR of primers in gel electrophoresis 
Gel electrophoresis of 3 primers show the shared annealing temperature (arrows) of 58.6 on gel 
electrophoresis. M. DNA marker (HyperLadderTM IV, BIOLINE) 
 
M M M 
ᵒC   55.6, 56.8,  58.6,  60.7, 62.5, 64 
 39 
 
2.4.3  cDNA synthesis 
 In each reaction 100ng RNA were converted to first strand cDNA in 20µl final volume 
using iScriptTM Reversed Transcription Supermix for RT-qPCR (BioRad) according to 
the manufactures’ protocol.   
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3 CHAPTER 3 
Study 1: Chondrogenic differentiation and characteristics of human 
bone marrow-derived stromal cells in alginate beads, pellet culture and 
monolayer 
 
3.1  Study design 
In this part of the study, chondrogenic MSCs (CMSC) were characterized after human 
bone marrow mesenchymal stromal cells were isolated and initially characterized based 
on  “the minimal criteria for defining multipotent mesenchymal stromal cells” (Dominici 
M. et al. 2006) including fibroblastic morphology, cell adherent to  plastic surface, tri-
lineage differentiation, and expression  or lack of expression specific CD markers. The 
cells were then cultured in 2D monolayer, and 3D (alginate bead, and pellet cultures) in 
two groups: chondrogenic differentiated MSCs (CMSC) and undifferentiated MSCs. 
CMSCs were characterized based on morphological parameters (Histology and electron 
microscopy), proliferation and viability tests and biochemical analysis 
(Glycosaminoglycan content or GAG) and compared with the non-chondrogenic 
(control) group. 
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Figure  3-1 Flowchart shows the study design for chapter 3. 
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3.2  Introduction  
 Articular cartilage is a unique tissue with a sparse number of chondrocytes  responsible 
for production and maintenance of an extracellular matrix rich in proteoglycans 
(consisting of a protein core  bonded to glycosaminoglycan groups or GAG) and 
collagen fibrils (mainly type II) ( Kheir E. et al. 2009). For characterization of an 
engineered construct it is mandatory to study the main component of articular cartilage 
such as collagen type II and GAG. GAG are carbohydrate polymers that form building 
blocks of large aggregating proteoglycans, (Lodish et al. 2004) and play an important 
role in the extracellular matrix (ECM) of cartilage. GAG provides the mechanical 
support for articular cartilage (LeRoux M.A. et al.  2000), and is commonly used as a 
marker of functionality for damaged or repaired cartilage. This measure is commonly 
used in cartilage repair outcome studies (Fan H. et al.  2006, Sharma A. et al. 2007, 
Vinardell T. et al. 2009, Bekkers J.E.J. et al. 2013)    or to evaluate the effectiveness of 
constructs to be applied for cartilage tissue engineering  (Enobakhare B.O. et al.  1996; 
Murdoch A.D. et al.  2007; Chan C.H. et al.  2008; Diekman B.O. et al. 2010).  
In cartilage, chondrocyte is the only responsible cell type for tissue homeostasis or 
synthesis and degradation of extra cellular matrix (ECM) (Pearle A.D. et al. 2005), 
therefore a profound understanding of the morphology and physiology of the engineered 
chondrocyte-like cell is required in order to determine the likelihood of cartilage 
regeneration outcomes. Although alginate culture system has been shown to provide the 
ideal microenvironment for evaluating chondrogenesis of mesenchymal stromal cells 
(MSCs) in vitro, the detailed ultrastructural description relating to cellular / matrix 
interactions of chondrogenic-differentiated MSCs cultivated in alginate has not been 
studied extensively (Yang I.H. et al.  2004; Ichinose S. et al.  2005; Xu J. et al.  2008; 
Duggal S. et al.  2009; Diekman B.O. et al. 2010). Whilst we understand that there are 
several other issues of alginate and use of MSCs, such as cell-matrix interaction and co-
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dimer polymerization issues have not been determined as well, the present study is 
focused on the ultrastructure aspect of alginate specifically. 
In  this study following  morphological studies using light microscopy and  quantitative  
expression of GAG, ultra structure of non-differentiated and chondrogenic differentiated 
MSCs was studied using scanning and transmission  electron microscopies             
(SEM and TEM). 
 
3.3  Materials and Methods   
 Three biological samples of cell or constructs (alginate loaded with cells; N=3) were 
cultured in chondrogenic medium or growth medium (control group) (DMEM-HG 
supplemented with 10% FBS and 1% penicillin/streptomycin) in six replicates. 
Outcome measures used for the end of this part of the study includes testing the viability 
and proliferation of the cells using AlamarBlue, GAG analysis using Blyscan kit, 
morphological studies using specific staining of Safranin O Fast Green, and 
immunohistochemistry for collagen II, collagen I and aggrecan. In addition, Alizarin 
Red staining was performed to rule out any deposition of mineral at the end of 
chondrogenesis in 3D cultures. Studies on the cell surface was further conducted using 
scanning electron microscopy (SEM) in the alginate group following chondrogenic 
differentiation and was  compared to MSCs. Transmission electron microscopy (TEM)  
was performed on 3D cultures of pellet and alginate beads to study the ultrastructural 
changes during chondrogenic differentiation. 
   
3.3.1 Pellet culture  
MSCs were harvested at P3, with 250X10
3
 cells were centrifuged in a 15ml 
polypropylene tube at 1100 rpm for 5 minutes. The supernatant was then discarded. The 
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cell pellets were cultured either with 2ml of chondrogenic or growth medium as control.  
The pellets were then detached from the tube by flicking the tube, the tubes were then 
kept in a 5% CO2, and 37°C humidified incubator with loosed cap in order to permit gas 
exchange. Medium was changed every 3 days.  GAG content of medium was measured 
by every medium change, i.e.: day 3, day 6, day 9, day12, day 15, day 18 and day 21. 
Other groups of pellet were cultured for morphological studies using histology.  At least 
3 samples in each group. On day3, day12, and  day21 pellet culture samples were  fixed 
in 10% formalin and processed for  histological studies staining with Safranin O Fast 
Green (Appendix B) or  immunohistochemistry (according to DAKO kit instructions).  
 
3.3.2 Cell-alginate constructs   
 1.2% alginate prepared from low viscosity sodium alginate powder (Sigma-Aldrich) in 
0.9% sodium chloride (NaCl) and filtered sterile by a 0.2µm filter. MSCs at P3 were 
harvested and a concentration of 4X10
6 
per ml (~80000 per bead) in alginate bead 
(Erickson G.R. et al. 2002, Mehlhorn A.T. et al. 2006) was obtained before dropping 
the cell laden alginate into sterile, calcium chloride solution (CaCl2) using a pipette. 
Alginate bead constructs cross linked in this solution for 10 minutes in 37°C incubator 
and then were rinsed in 0.9% normal saline 2-3 times, three beads per well transferred to 
the culture dishes (ultra-low attachment 12 well plates, Corning), and supplemented 
with 2ml chondrogenic or growth media. The medium changed every 3 days.  
 
3.3.3 Glycosaminogylcan contents   
  GAG content of the medium in different chondrogenic as well as control groups were 
analysed on days 3, 6, 9, 12, 15, 18,and 21 (n=6) using Blyscan assay kit (Biocolor, 
Northern Ireland). The protocol was optimized for this experiment using 500µl of 
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medium and it was mixed with 1ml of dye on a shaker for 30 minutes at room 
temperature. The samples then centrifuged at 12000 rpm for 10 minutes the supernatant 
was discarded and 500µl of dissociation buffer was added to dissolve the pellet using a 
vortex. The absorption of 656nm was recorded using a micro plate reader (Epoch 
microplate spectrophotometer). The concentration of each sample was calculated using 
a plot made of different concentrations of standards (Chondroitin-6-sulphate, shark 
cartilage). If the GAG content exceeded the highest amount of the standard, then the 
sample is diluted and the experiment repeated. After subtraction of background GAG, it 
normalized with the cell number in each sample (GAG/Cell). The data presented as an 
average of three time points of 3, 12 and 21 days. Data for day 12 and 21 were 
cumulative data of earlier time points. 
 
Background GAG: The final data were normalized with subtraction of background 
GAG from the GAG values of experimental groups. In two groups of monolayer and 
pellet culture, the final GAG calculated after subtraction of GAG from growth medium 
supplemented with 10% FBS and chondrogenic medium alone respectively. Final 
concentration of GAG in alginate group was obtained by subtracting the GAG from the 
incubation of cell-free alginate beads in chondrogenic or growth medium at respective 
time points similar to the experimental groups.   
 
3.3.4 Cell Proliferation 
 Cell proliferation was assessed using AlamarBlue colorimetric assay (invitrogen) 
according to the manufacturer protocol. AlamarBlue (10%) was added to the medium of 
cells/constructs of both groups of chondrogenic and control on day 0, day 3, day 12, and 
day 21 and incubated in 37°C and 5% CO2 incubator. After 3 hours the absorptions of 
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570nm and 600nm were recorded using Epoch microplate spectrophotometer and Gene5 
data analysis software (Epoch Bio-Tek). 
 
3.3.5 Live/Dead viability test 
LIVE/DEAD®   Viability/Cytotoxicity Assay (Invitrogen –Molecular Probes, Eugene, 
OR) was performed according to the manufacturer’s instructions. The principal of the 
test is based on intracellular esterase activity of live cells and their plasma membrane 
integrity, using two fluorescent dyes of Calcein and Ethidium homodimer-1(EthD-1) 
that produce green and red dyes respectively. Calcein AM primarily is a non-fluorescent 
dye, once entering live cells it converts to fluorescent Calcein and retained in the cell. 
While Ethidium homodimer-1  only  enter cells with damaged membrane, binds to 
nucleic acids and produces a bright red fluorescent dye in dead cells.  
 On day 3 and day 21, cell-alginate beads constructs were washed with PBS and stained 
with working solutions of 2µM Calein AM and 4 µM EthD-1 at room temperature for 
15-30 minutes and viewed with a fluorescent microscope (Nikon Eclipse Ti-U). 
 
3.3.6 Histology and Immunohistochemistry   
Samples were fixed with 10% formalin for 1 hour, and processed for routine histology. 
5µm of paraffin sections were stained with Safranin O Fast Green, (Appendix B-d), and 
immunohistochemistry of collagen type II with primary antibodies (Mouse mAb (II-
4C11) anti rabbit (CALBIOCHEM©, Merck, Germany), dilution of 1/100. Mouse 
monoclonal [6-B-4] to human aggrecan Abcam (Abcam Plc, Cambrige, UK), dilution of 
1/50 and mouse monoclonal (clone I-8H5) anti-collagen type I (CALBIOCHEM©, 
Merck, Germany) dilution of 1/100 (Using DAKO kit (DakoCytomation, Glostrup, 
Denmark) according to the manufactures protocol. 
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3-Dimentional cultures of chondrogenic alginate and pellet culture were also stained 
with Alizarin Red S (Sigma-Aldrich) staining (Appendix B-e) to verify any mineral 
deposition during chondrogenesis.  
 
3.3.7 Ultrastructural studies  
Detailed structures of cell surface, extracellular matrix and cytoplasm were studied in 
undifferentiated MSCs and chondrogenic differentiated CMSCs using scanning and 
transmission electron microscopy.  
 
3.3.7.1  Scanning electron microscopy (SEM)  
Cell surface and   matrix deposition in chondrogenic MSCs loaded in alginate bead vs. 
non chondrogenic MSCs was studied using SEM.  
Sample preparation: MSCs were tripsinized at P3 and centrifuged at 1100 rpm for 5 
minutes. After discarding the supernatant the resulted pellet of MSCs (day 0) along with 
CMSC in alginate beads on day 21 rinsed with 1XPBS  and fixed with 4% 
glutaraldehyde in cacodylate buffer for 48 hours 4
o
C.  Samples were then washed in the 
cacodylate buffer twice for 10 minutes and post fixed in the osmium tetroxide 1% for 
1hour at 4
o
C. The samples were washed in the same buffer three times each for 10 
minutes and stored  in the buffer overnight at 4
o
C before washing with distilled water 
for 3 times. A series of dehydration process was employed: dehydration in ascending 
series of ethanol, alcohol 30,  50, 70, 80, 90, 95, and 3 changes in 100 each for 10 
minutes, followed by a mixture of ethanol-acetone in these ratios: 3:1,  2: 2,  1: 3 each 
for 15 minute, and then to 3 changes of  pure acetone  each one for 20 minutes. At this 
stage, samples were transferred to the CPD machine (Bal-Tec CPD030 (Critical Point 
Dryer), immersed in the pure acetone.  
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CPD machine is supplied with CO2. When the temperature goes down to 9-10°C, the 
liquid CO2 flushes the samples and replaces acetone which is drained from the machine. 
While the acetone is completely replaced by CO2, the temperature goes up to 31-32°C 
and CO2 at this temperature turns into gas and escapes from the samples leaves the 
samples totally dried. 
 The samples  were then mounted on stubs using double sided tape and coated with gold 
in a sputter coater machine (Hitachi E-1010 Ion Sputter) for 120 seconds, and viewed 
with the SEM (Hitachi Scanning Electron Microscope S-3400N). 
 
3.3.7.2 Transmission electron microscopy (TEM)  
Ultrastructural details of cells and cell matrix interactions during chondrogenic 
differentiation of MSCs in alginate beads compared with pellet culture and MSC on  
day 0 using TEM. 
Sample processing: A. Fixation: Samples were fixed with 4% Glutaraldehyde in 
cacodylate buffer for 24 hours at 4
o
C  and washed with cacodylate buffer 0.1 M,        pH 
7.4 (Merck AG, Darmstadt, Germany) 3 times before post-fixation in buffered osmium 
tetra Oxide 1% (Appendix C) for 2 hours at 4ᵒC. The samples were washed with 
cacodylate buffer 2-3times and kept overnight at 4ᵒC. 
B. En-block staining: Samples were washed with ddw water 2-3 times and stained with 
Uranyl acetate (Agar scientific Ltd. R1043, Essex England) 4% in ddw for 10 minutes 
and washed with ddw 2-3 times.  
C. Dehydration and embedding:  Dehydration of samples were performed in ascending 
series of ethanol 35, 50, each 10 minutes followed by 95 and 100 (3times) each for 15 
minutes. Propylenoxid (BDH, VWR International Ltd, Poole, UK) two changes each for 
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15 minutes. transferred  to mixtures of 50% Propylen oxide in Epon (a mixture of 
Propylen Oxide/Epon 1:1 for) for  1 hour,  and 33% (a mixture of Propylen Oxid/Epon 
1: 3) for 2 hours. The samples were transferred to the pure Epon (Agar 100 resin kit, 
Agar scientific Ltd. R1043, Essex England) overnight on a rotary mixer (Ted Pella, 
Redding, CA, USA) at room temperature.  
 Fresh Epon was put in the labelled embedding moulds. The samples were adjusted in 
the right position using a fine forceps. The moulds containing the samples were kept at 
37
o
C for 5 hours and transferred to 60
o
C overnight to polymerize.  
D. Ultra Microtome: In order to cut the samples embedded in resin with 
ultramicrotomy, glass knives were prepared using glass strips in a Leica knife maker 
and samples were trimmed manually under a dissection microscope with a razor blade. 
E. Semi thin sectioning: 1µm semi thin sections were obtained using a Leica 
ultramicrotome (Reicher Ultracuts, Leica Microscystem, and Vienna, Austria). The 
sections were collected in a filtered drop of ddw on a pre- cleaned slide and kept on the 
hot plate 40
o
C until they dried.  The samples were then stained with   filtered Toluidine 
Blue (Appendix C) for 1-2 minutes on the hot plate 40
o
C, and then were washed with 
distilled water and air dried before viewing with light microscopy.  
F. Ultrathin sectioning:  small plastic boats was glued on the glass knives using melted 
dental wax or nail polish and filled with double distilled water. The blocks, were 
sectioned at 70-80nm. The sections were floated in the water and were collected on 
copper grids (300 meshes) and stained with Uranyl acetate and lead citrate (Agar 
scientific, UK) (Appendix C). Images were viewed using TEM (Leo Libra 120; Carl 
Zeiss SMT AG, Oberkochen Germany). 
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3.3.8 Statistical analysis  
Values for GAG analysis and proliferation test demonstrated as mean± standard 
deviation (SD). The different between experimental groups for proliferation test were 
studied using non-parametric Kruskal-Wallis H test, and for both GAG and proliferation 
tests, the different between two experimental groups using Mann-Whitney U test 
available on the statistical software package SPSS (version 18.0). P≤0.05 was 
considered significant. 
 
3.4  Results  
3.4.1 Gross morphology   
Chondrogenic pellet and alginate beads increased in size by day 21 (Fig. 3-1 A&B). 
Alginate beads on day 21 looks white in texture, it was firm and easily handled 
compared to an earlier time point on day 3 with a clear appearance (Fig. 3-1B).  
 
  
Figure  3-2 Gross morphology of chondrogenic pellet and alginate beads 
A. Gross morphology of pellet cultured in chondrogenic medium, left to right: day21, day3. 
B. Chondrogenic MSC loaded in alginate bead, left to right:  day21, day 3.   
 
  
3.4.2 Chondrogenic differentiation  
Chondrogenic differentiation was verified through histology, immunocytochemisty and 
biochemical study with GAG analysis. Alizarin Red staining ruled out mineral 
deposition during chondrogenic differentiation in 3D culture of alginate and pellet on 
day 21 (Fig. 3-5 B&D), while in monolayer the expression of  chondrogenic markers 
A B 
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was very low (Fig. 3-2F, 3-4 C&I) and collagen type I was the prominent protein 
expressed in chondrogenic monolayer compared to collagen type II (Fig. 3-6, 3-4 C).   
 
3.4.2.1 Histology  
Morphological studies of chondrogenic differentiation of MSC in different experimental 
groups are shown at (Fig. 3-2) Safranin O Fast Green staining of pellet culture on day 
21 showed positive GAG stained in red and some green area indicated non-GAG 
depositions (Fig. 3-2 A). In chondrogenic alginate on day 21 Safranin O Fast green 
showed mainly red colour an indication of high GAGs production in this group when it 
compared with control group (Fig. 3-2 B&E).  
Safranin O Fast Green staining for GAG detection in monolayer cultured with 
chondrogenic medium was negative when compared to the control group. Scant staining 
of cells in the test and control groups mainly indicated the background staining (Fig. 3-2 
C&F). 
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Figure  3-3 Safranin O Fast Green staining of different experimental groups 
Upper panel:  Chondrogenic groups: A. Pellet culture B.  CMSCs in Alginate bead 4X, C. chondrogenic 
monolayer, day 21, 10X.  
Lower panel: Control group:  D. pellet culture X10, E. MSCs in alginate bead 4X, F. Monolayer culture, 
day 21, 10X. 
 
Safranin O Fast Green staining of 3D chondrogenic groups of pellet and alginate culture 
in different time points was positive from day 12 onward. The intensity of red colour 
(an indication of abundance of GAG) was increased in alginate group overtime as it was 
shown in (Fig.3-3), CMSC in alginate group showed similarity with native human 
cartilage on day 30. The expression of GAG from day 12 onward was more prominent 
in alginate group compared to pellet culture (Fig. 3-3). 
 
 
 
A B C 
D E F 
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Figure  3-4 Safranin O Fast Green staining of CMSC in alginate and pellet culture over time 
Safranin O Fast Green staining of Alginate group (upper panel) and pellet culture (lower panel) on 
different time points, compared with human articular cartilage (HCH). The intensity of the staining in 
CMSC alginate D30 was more similar to that of HCH 20X. 
 
The expression of  collagen type II  in chondrogenic groups of Pellet, monolayer, and 
alginate showed positive for collagen type II stained with immunohistochemistry 
method on day 21 (Fig. 3-4 A-C), compared with the negative controls that  stained only  
with secondary antibody (Fig. 3-4 D-F). 
Immunohistochemistry study of Aggrecan showed positive staining for chondrogenic 
pellet and alginate; however the staining had no positive result in immunocytochemistry 
of chondrogenic monolayer when compared with the negative control (Fig. 3-4 I&L). 
 
 
 
 
 
D3 D 12 D21 D30 
D3 D12 D21 HCH 
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Figure  3-5 Immunochemistry staining of  chondrogenic groups on day 21   
   Collagen type II 
+
 (A-C).  ACAN
+
 (G-I). Negative control Collagen II
-
 (D-F), ACAN
- 
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Figure  3-6 Mineral deposition and expression of collagen type I in 3D cultures of pellet and alginate 
during chondrogenic differentiation 
Upper panel: Alizarin Red staining A. Human bone (Red) and cartilage purple (arrow) as positive control 
4X, B. chondrogenic pellet day 21, C. CMSC in alginate bead  day 21, 4X, D. CMSC in alginate bead day 
30, 4X.  
Lower panel collagen type I, immunohistochemistry E. Chondrogenic pellet culture day 21 4X F. Pellet 
negative control, G. CMSC in alginate bead day 21, 4X, H. CMSC in alginate bead negative control 4X.      
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Figure  3-7 Expression of collagen type I in 2D monolayer during chondrogenic differentiation using 
immunocytochemistry 
Premature hypertrophy and increase in collagen type I in chondrogenic group can be seen on day 12 and 
day 21 (B &C) compared with control group (E & F).   G-I negative control for chondrogneic group. J-L 
negative control for control group, 10X. (+) indicates staining with primary and secondary antibodies, 
negative control samples stained only with secondary antibody. 
 
3.4.2.2 GAG analysis  
Biochemical test for GAG content of supernatant in different experimental  groups 
showed no GAG in the medium of monolayer cultured in chondrogenic medium as well 
as all control groups of alginate bead, pellet culture and monolayer.  
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In the chondrogenic groups, there was no significant difference between GAG content 
of chondrogenic alginate beads and pellet culture on day 3 as it was shown by Mann-
Whitney test (p>0.05). However at the other time points, day 12 and day 21 alginate 
beads showed significantly higher amount of cumulative GAG than pellet culture    
(Fig. 3-7; p<0.01).  
In the alginate group, GAG content (GAG per cell number) significantly increased 
overtime from day 3 to day 12 (p=0.01), but in pellet culture there was no significant 
different between day 3 and day 12 GAG (p>0.05).  GAG content in both group 
significantly increased from day 12 to day 21 (Fig. 3-7). 
               
 
Figure  3-8 Biochemical analysis of sulphated GAGs content 
Cumulative GAG content of supernatant (µg/ml) in alginate and pellet culture after reduction of 
background GAG, Mean ± SD. * p<0.05, ** p<0.01  
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3.4.3 Proliferation assay   
Comparison between proliferation of chondrogenic experimental groups showed that  
only in  alginate beads cell proliferation was increased overtime at day 21 as compared 
to day 3 (p=0.05), while in  pellet culture cell proliferation  remained the same at all 
time-points (p>0.05). In monolayer cell number significantly reduced   overtime      
(Fig. 3-8 B; p<0.05). 
In 3D cultures of pellet and alginate control (non-induced) groups, cell proliferation 
decreased overtime on day 21 compared to day 3, but increased in 2D monolayer     
(Fig. 3-8 A; p=0.05). 
In all experimental groups, there was no significant increase in the percentage reduction 
of AlamarBlue between day 0 and day 3, in monolayer group the values were higher but 
not significant (p>0.05). From day 3 to day 12 only monolayer control cultures showed 
higher cell proliferation (p=0.05) and in pellet control there was a significant decrease 
in the value (Fig. 3-8 A; p=0.05). In chondrogenic groups there was no significant 
increase in the percentage of reduction of AlamarBlue (Fig. 3-8 B; p>0.05).  
Comparison between day 12 and day 21 in chondrogenic groups showed significant 
increase in cell proliferation in alginate group and decrease in monolayer (p=0.05). 
There was no significant increase in chondrogenic pellet culture (p>0.05). In control 
groups, cell proliferation in alginate group decreased significantly (p=0.05) but there 
was no significant different in monolayer and pellet culture groups (p>0.05). 
Comparison between groups using Kruskal Wallis test showed no significant difference 
between cell proliferation in all chondrogneic groups except for day 21 that alginate 
group was significantly higher than pellet and monolayer (Fig. 3-8 B; p<0.05). 
Comparison between groups showed no significant different in cell proliferation on   
day 0 (p>0.05).  
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Figure  3-9 Percentage reduction of AlamarBlue in experimental groups in different time points 
  Percentage reduction of AlamarBlue A. Control groups B. Chondrogenic groups. Mean ±SD, *p≤0.05. 
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3.4.4 Live/Dead cell assay  
Qualitative test of cell viability using Calcein/EthD-1 is shown in (Fig. 3-9) for different 
experimental groups on day 3 and day 21. In chondrogenic alginate group cell viability 
was higher on day 21 when it compared with day 21 control.  
Chondrogenic pellet culture showed a solid spherical shape on day 21 using normal 
fluorescent microscopy, cell viability was inconclusive in a packed texture (Fig. 3-9 F), 
but in control group cells were dispersed and cell death visibly increased on day 21 
when it compared with day 3 (Fig. 3-9 G&H). In chondrogenic monolayer detached 
patches of cells in each medium change was an indication of high cell death in this 
group. Although staining with EthD did not show any red spots due to the removal of 
dead cells during media change and washing with PBS before staining, empty spaces  
between cells on day 21 implied cell death (Fig. 3-9 J) when it compared with the 
control group (Fig. 3-9 L).  
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Figure  3-10 Live/Dead cell staining using Calcein/EthD-1 
Green colour indicates live cells, red spots show dead cells, Alginate 10X, pellet chondrogenic 4X, 
control 10X,  Monolayer 10X. Arrows indicate empty spaces resulted from detached cells. 
 
3.4.5 Scanning Electron Microscopy (SEM)  
MSCs surface was studied using SEM before and after chondrogenic differentiation. In 
an undifferentiated MSCs (day 0) cell surface covered with protrusions, filopodia or 
blebs (Fig. 3-10 A&B).  
 
A B C D 
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Figure  3-11 SEM image of MSCs day 0 
A. Human MSC day 0 2000X.  
B. Higher magnification of the inset at A. 5000X the surface is covered with protrusions 
(filopodia/blebs) (open arrow). 
 
 
Cell surface in chondrogenic differentiated MSCs in alginate were covered in 
extracellular matrix (ECM), while layers of ECM were deposited between the cells    
(Fig. 3-11). 
  
Figure  3-12 SEM image of chondrogenic alginate group day 21 
A. Chondrogenic MSC in alginate beads day 21 2000X.  
B. Higher magnification of the inset 5000X shows cell surfaces covered with ECM. ECM deposited 
between the cells (arrow). 
  
 
3.4.6 Transmission Electron Microscopy (TEM) 
Resin embedded samples of chondrogenic pellet and alginate on day 21 as well as 
MSCs on day 0, were cut into 1µm semi thin sections, stained with Toluidine Blue and 
A B 
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studied under light microscopy (Fig. 3-12). Ultrathin sections of 70nm thickness on 
copper grids, stained with uranyl acetate and lead citrate studied with electron 
microscopy (Fig. 3-13 to 3-20).  
 
3.4.6.1 Semi-thin sections 
The prominent feature of semi-thin sections of alginate beads compared to pellet 
cultures was a lower cellularity, and increased inter-cellular spaces (Fig. 3-12 B double 
head arrow). In alginate cells arranged in small groups of two or three cells and the 
matrix between them stained purple using toluidine blue (Fig. 3-12 B arrow). While in 
pellet culture cells were in closer contact with each other and less purple colour 
indicated lower extra cellular deposition (Fig. 3-12 C).  
The presence of abundance poly anions in the extracellular matrix of cartilage gives a 
purple colour to the metachromatic dyes such as Toluidine Blue (Sridharan G. et al. 
2012). Samples of MSC day 0 as a control group stained blue, samples of CMSC in 
alginate and pellet culture showed positive metachromatic areas (purple colour), 
especially in alginate group in the matrix surrounding the cells (Fig. 3-12 B arrow) an 
indication of GAG deposition.  
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Figure  3-13 Semi-thin sections of chondrogenic alginate and pellet day 21 
A. MSC day 0. 
B. CMSC in alginate bead day 21. 
C. CMSC in pellet culture day 21 Semi-thin section 1µm 20X Toluidine Blue staining. 
 
 
          
3.4.6.2 Ultrathin Sections  
MSCs: Cell surface of MSCs formed filopodia or blebs (Charras G. et al. 2008) 
associated with dens bodies (Fig. 3-13 B&C). Cytoplasm occupied with rER, free 
B 
C 
A 
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ribosomes, mitochondria (M), and vacuoles (Fig. 3-13). Nuclei were euchromatin, 
usually with a distinct nucleolus, demonstrating an active protein synthesizing cell, in 
some cells the nucleus was convoluted (Fricker M. et al. 1997, Fig. 3-13A). 
  
  
Figure  3-14 TEM images of MSCs day 0 
A. MSC with a convoluted nucleus and prominent nucleoli (arrow) 1151X.  
B. Blebs in the cell surface (arrow) 1600X N=Nucleus.   
C. MSC with a round nucleus and uneven cell surface 1233X. 
D. Higher magnification of MSCs shows mitochondria (M) and rough endoplasmic reticulum (rER) 
4000X. 
                                     
In chondrogenic groups of alginate  and pellet the cells actively produced extracellular 
matrices, as it was evidenced with a highly developed rER full of secretions, fibrils and 
fibres in the cytoplasm and in the ECM (Fig. 3-14, 3-15, 3-16, 3-17, 3-19).  
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Alginate: Ultrastructure of nucleus in CMSC showed euchromatin with variety of 
phenotype, round, oval or slightly indented (Fig.3-14 & 3-17). 
  
  
Figure  3-15 TEM images of chondrogenic alginate group day 21 
Different cell morphology in CMSC-alginate, N=Nucleus, RER=Rough endoplasmic reticulum.  
A. The cytoplasm is filled with distended RER, Golgi apparatus in the supra-nuclear region (G) 
2000X. 
B. Three cells similar to isogenic groups in cartilage deposit their products in the 
ECM=Extracellular matrix 2520X.  
C. A cell undergoing cell death with no clear nucleus and abundant cytoplasmic vesicles (V) and 
cytoplasmic inclusions or multilayer whorled membrane (MW) 1575X. 
D. A cell with a euchormatic nucleus, rER and mitochondria (M) 1575X.  
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Figure  3-16 TEM images of ECM in alginate group 
A. Territorial matrix surrounding CMSC.  ECM=Extracellular matrix, Ce=cell 6300X.  
B. Higher magnification shows striation of collagen fibers (arrow) and branched molecules 
probably aggrecan (asterisk) 10000X. 
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Figure  3-17 TEM image of perinuclear cytosol in chondrogenic alginate group 
A. A part of nucleus (N) and cytoplasm containing rough endoplasmic reticulum (rER) and 
Mitochondria (M) 6300X.  
B. High magnification of cytoplasm. G= Golgi, black arrow indicates ribosomes, Red arrow shows 
microtubules, rER= Rough endoplasmic cytoplasm 10000X. 
  
 
Chondrogenic MSCs in  alginate showed characteristic features of cells that are actively 
involved in  protein synthesizing (Pavelka M., et al. 2010), with  euchromatic nuclei, 
prominent nucleoli, abundant rER filled with electron lucent materials,  producing 
abundant ECM, containing collagen fibres (Fig. 3-14, 3-15, 3-17) and  molecules with 
side branches similar to  proteoglycan aggregates among the fibres (Fig. 3-15B).  
Chondrogenic differentiated cells usually arranged in small groups as it was seen in 
lower magnification in semi thin (Fig. 3-12B) and ultrathin sections       (Fig. 3-14B & 
3-17A). Higher magnification of adjacent cells did not show any junctional complexes 
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between the cells.  Smaller vesicles contained electron lucent material near cell 
membrane (Fig. 3-17 A) might originate from rER releasing their content to ECM, 
causing the cells grow apart from each other, similar to that seen during the interstitial 
growth in cartilage.  
In highly active protein synthesizing, chondrogenic cell in  alginate in which the 
cytoplasm was packed with rER, it was difficult to distinguish between distended rER 
and Golgi apparatus (Fig. 3-14 A), however in higher magnification the rER can be 
easily recognized with studded ribosomes (Fig. 3-16 B) (Pavelka M., et al. 2010) 
 
  
Figure  3-18 TEM image of divided cells in chondrogenic alginate group 
A. Two daughter cells resulted of cell division 1260X.  
B. Higher magnification of the inset shows ECM (asterisk) in the inter- cellular space. Note small 
vesicles near cytoplasmic membrane (arrows), rER=rough endoplasmic reticulum 6300X. 
  
 
Pellet culture: In general, two subpopulation of cells could be distinguished in ultrathin 
sections of pellet culture: In one group the signs of cell death appeared (Kumar V., et al. 
2013) with abundant cytoplasmic vesicles, lipid droplets, free ribosomes, swelled or 
fused mitochondria  (Fig. 3-18 A), vacuoles, expelling of cytoplasmic organelles to 
ECM (Fig. 3-18 B), indented nucleus (Fig. 3-18 A&D) or cells without a prominent 
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nucleus (Fig. 3-18 C). The second population consisted of active protein synthesizing 
cells with a euchromatin and round nucleus, abundance of collagen fibres secreted in the 
ECM (Fig. 3-19 & 3-20). Golgi apparatus can be observed in both groups (Fig. 3-18 D 
& Fig. 3-19 A) as machinery for synthesis of carbohydrate (Alberts B. et al.  2002) or 
GAG in chondrogenic induced MSCs. 
  
  
Figure  3-19 TEM images of cell death in chondrogenic pellet culture 
A. Increase of lipid droplet, N=nucleus MW= Multivesicular membrane, L=lipid droplet, 
M=mitochondria, Fi=cytoplasmic fibrils, 1600X. 
B. Fused mitochondria (M), expelled cell organelles including mitochondria (arrow) 2520X.  
C. No clear nucleus 1000X.  
D.  Cell with U-shape nucleus, free ribosomes (FR) in cytoplasm, Golgi apparatus (G), and lipid 
droplets (L) 1984X. 
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Figure  3-20 TEM image of chondrogenic pellet day 21 
A. Well-defined Golgi apparatus and Centriole (arrow) in the perinuclear cytosol 4000X. 
B. Collagen fibers (F) secreted to the ECM directly from the cytoplasm (white arrow) 3969X. 
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Figure  3-21 TEM image of ECM in chondrogenic pellet day 21          
A. Collagen fibers (F) in the ECM 2500X. 
B. Higher magnification 10000X shows striation (arrow) on fibers. Small molecules (black dots) 
and branched molecules between the fibers (asterisk). 
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3.5 Discussion  
In this study, superior production of GAGs demonstrated in CMSC alginate group 
during  chondrogenic differentiation compared to chondrogenic pellet culture and 
monolayer and control groups, using  Safranin O Fast green staining (Fig. 3-2 &  3-3) 
and quantitative GAGs analysis (Fig. 3-7).  It was shown that (Derfoul A. 2007) 
glucosamine (GlcN), a chemical constitute of GAGs, promotes chondrogenesis in 
human MSCs and chondrocytes phenotype while inhibiting the expression of MMP-13. 
Alginate with a structure simulating GAGs may have such an effect on MSCs 
chondrogenesis, in addition to providing a spherical morphology and isotropic 
cytoskeletal tension to MSCs (Nava M.M. et al 2012) a prerequisite for chondrogenic 
differentiation (Guilak F. et al. 2009). 
 Moreover, higher expression of GAGs during chondrogenic differentiation of MSCs 
was shown to be associated with increase in shear moduli of the constructs (Awad H.A. 
et al. 2004). In this study, although the mechanical properties of alginate constructs 
were not tested, higher expression of GAGs may be an indirect indication of higher 
biomechanical moduli of alginate constructs after chondrogenic differentiation. This 
property may make CMSC alginate constructs a superior candidate for cartilage repair 
application compared to  undifferentiated MSCs in alginate.  
Immunohistochemistry for chondrogenic markers collagen II and aggrecan were 
consistent with GAG result. However the positive results of immunohistochemistry for 
collagen I can be an indication of undifferentiated or fibroblastic like cells among the 
chondrogneic differentiated groups. In fact, among the chondrogenic groups, collagen 
type I was the highest expressed protein in 2D monolayer accompanied with a 
hypertrophic morphology (Fig. 3-6).  This may indicate a premature hypertrophy of the 
chondrogenic induced MSCs in monolayer. It also showed that in 2D chondrogneic 
monolayer, although Col II expressed weakly on day 21 (Fig. 3-4C), GAG and ACAN, 
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the important ECM compartments of cartilage, were only expressed in a 3D 
environment of pellet and alginate cultures.    
Alizarin Red staining showed no deposition of minerals during chondrogneic 
differentiation of MSCs in 3D cultures of pellet and alginate, while in another study 
(Ichinose S. et al. 2005), Alizarin Red positive calcification was reported during 
chondrogenic differentiation of MSC in alginate beads in a defined medium containing 
TGFβ3. During endochondral ossification of large bones, the primary cartilage template 
replaces with bone, which is as a result of removing the hypertrophic chondrocytes by 
osteoclasts and  mineral deposition by osteoblasts brought  to the ossification centres by 
blood vessels under regulation of endothelial growth factor (VEGF) isoforms (Yang 
Y.Q. et al. 2012 ). In previous literature, the possibility of transdifferentiation of 
hypertrophic chondrocyte to osteoblast remained to be proved in subsequent studies, 
however based on the study on hypertrophic chondrocytes in epiphyseal plate it 
suggested that the local environment may have a role in determining cell fate during 
endochondral ossification (Adams C. S. et al. 2002). 
Among the chondrogenic groups, alginate showed the highest cell proliferation and 
monolayer showed the lowest proliferation rate. Pellet culture did not show any 
significant changes in cell number during chondrogenic differentiation. These results 
were consistent with viability tests using Calcein/EthD. In lung bud organ culture and 
prostate epithelium it was shown that TGFβ had an inhibitory effect on cell 
proliferation, but in mammary epithelia it had a bi-functional role in carcinogenesis, as 
during neoplastic transformation the growth inhibitory role changed to stimulatory 
effect (Moses H.L. et al. 1994). TGFβ was shown to increase cell proliferation and 
invasiveness of rat placental cell line as well (Lafontaine L. et al. 2010).  In our study 
chondrogenic MSCs in alginate beads under defined medium containing TGFβ3 
exhibited a higher proliferation rate compared to the same cells in pellet and monolayer 
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cultures. It seems that the inhibitory or stimulatory effect of TGFβ3 on MSCs 
proliferation depends on the 3D structure and biochemical properties of the 
microenvironment.  
 MSCs loaded in alginate beads in growth medium, did not show any cellular 
proliferation during the experiment. In such condition, adhesive dependent MSCs 
remain in a quiescent phase, since they do not receive any signals through adhesion 
molecules in a suspension-like alginate. Although adherent cells undergo apoptosis or 
Anoikis if they do not have correct cell/ECM attachment in suspension (Gilmore A.P. et 
al. 2005), in a viscous medium such as synovial fluid of rheumatoid arthritis patient, 
MSCs survived (Swart J. et al. 2008). It is possible that with a similar mechanism, 
MSCs may be able to survive in a viscous alginate culture system. In a chondrogenic 
medium, MSCs produce chondrogenic ECM and have an interaction with the newly 
formed ECM probably via integrins and CD44 (Lee G.M. et al. 1998). They later 
proliferate through the downstream signalling pathways (Schwartz M.A. et al.  2001; 
Walker J.L et al. 2005). In our experiment cell proliferation in chondrogenic alginate 
group only was observed on third week following chondrogenic differentiation and 
expression of chondrogenic protein markers, as it was shown by immunohistochemistry 
or biochemical analysis of collagen type II, ACAN, and GAG. 
Actin remodelling at the MSCs surface produces protrusions or projections surrounding 
the cells or construct (Fig. 3-10). Formation of actin based protrusions including 
filopodia and lamellopodia or blebs has been shown to be linked with the migratory and 
invasiveness potential of the cells (Fackler O.T. et al.  2008). While in chondrogenic 
differentiated MSCs, the alginate at the cell surface were embedded in a thick ECM 
(Fig. 3-11). 
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TEM study revealed an increase in cell death in pellet culture, as compared to alginate 
culture. It can be due to an immature hypertrophy and cell death, as it may happen 
during endochondral ossification (Adams. C. S. et al.  2002; Mackie E.J.et al.  2008). 
The type of cell death can be non-apoptotic or physiologic cell death, since it lacked the 
whole characterization of apoptotic cells such as crescent heterochromatin nucleus 
(Zamli Z.  et al. 2011). However, there is a possibility that distinctive morphology of 
apoptotic nucleus is missing in our experiment due to its occurrence in an earlier time 
point.  
The morphology and abundance of mitochondria in non-induced MSCs and alginate 
culture were similar (Fig. 3-13 & 3-16). Hypoxic microenvironment in cartilage may 
have caused lower number of mitochondria in articular cartilage compared to 
metabolically active cells since chondrocytes rely on glycolytic metabolism rather than 
oxidative phosphorylation (Milner P.I. et al. 2012).  In this study we did not perform 
any quantitative method for comparing mitochondria in MSC and CMSC, however the 
qualitative pictures did not show any  differences in the mitochondrial density between 
non-induced MSCs and chondrogenic MSCs, it might be the culture condition with 
ambient oxygen 21% that do not similar to normal habitat of chondrocyte in cartilage 
with low oxygen concentration 2-10% (Zhou S. et al. 2004)  it has been shown 
chondrocytes isolated from the joint and cultured in vitro expressed mitochondrial 
biosynthesis (Milner P.I. et al. 2012). Further studies using immunofluorescent for 
detecting mitochondria can verify mitochondrial quantities during in vitro chondrogneic 
differentiation of MSC.  
In pellet culture, swollen and fused mitochondria may be due to hypertrophy and cell 
death. Mitochondrial fusion was shown in cells undergoing cell death. Fusion of 
mitochondria is described as a reaction of the cells to damaged mitochondria to repair 
by inter-mixing DNA and protein between mitochondria during damage or senescence 
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(Chan D.C. et al. 2006). Swollen mitochondria was also reported in fibrillated cartilage 
in OA patients (Roy S. et al.  1968).  
The morphology of the nuclei in the chondrogenic groups of alginate and pellet were 
varied. These appeared more elongated and indented in pellet, whilst in alginate it 
appeared mostly oval and spherical. Although a typical chondrocyte is observed with a 
spherical nucleus, previous ultrastructureal studies have shown variations in shapes 
including oval, spherical, elongated or indented in human articular cartilage, which 
appears to be acceptable for chondrocyte morhpology (Roy S. et al. 1968).   
3.6  Conclusion   
 The results demonstrated superior chondrogenesis in 3D cultures compared to 2D 
monolayer and superior chondrogenesis in alginate compared to pellet cultures in 
chondrogenic medium. MSCs in different experimental groups cultured in growth 
medium did not demonstrate chondrogenic activities, therefore suggesting that alginate 
alone in vitro, cannot induce chondrogenesis of MSCs without the presence of 
chondrogenic stimulating factors such as TGFβ. Detailed ultrastructural observations 
using TEM supported histological and biochemical quantitative results.  Although 
‘live/dead’ staining was inconclusive in pellet cultures, TEM images revealed cell death 
prevalence in pellet culture compared to alginate culture.  
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4 CHAPTER4 
Study 2: Chondrogenic, hypertrophic and adhesion molecule gene 
expression during chondrogenic differentiation of human bone 
marrow-derived mesenchymal stromal cells in alginate beads, pellet 
culture, and monolayer 
 
4.1 Study design 
In this part of the study human bone marrow derived mesenchymal stromal cells 
(MSCs), were isolated, expanded until passage 3 and characterized with criteria 
(Dominici M. et al. 2006) such as tri- lineage differentiation  and expression  or lack of 
expression of  specific CD markers using immunocytochemistry and flow cytometry.  
The cells were then divided and cultured into two groups: one group with chondrogenic 
medium and the other group with growth medium. Each group contains cultures of 
monolayer, alginate beads and pellet culture. In different time points (day 3, day 12 and 
day 21) RNA was extracted from different groups and converted to cDNA. Gene 
expression was studied using Real Time Polymerase Chain Reaction (RT-PCR) for 
chondrogenic markers such as Sox9, Collagen type II, aggrecan; hypertrophic markers 
included RunX2 and Collagen type X. Adhesion molecules such as NCAM1 and N-
Cadherin and collagen type I as a non-chondrogenic gene. 
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Figure  4-1 Flowchart shows the study design for chapter 4.  
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Sox9, NCAM1, and N-Cad  
Day 3, 12, and 21 
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4.2 Introduction  
Chondrogenic differentiation is a unique process that initiates with cell-cell interactions, 
and requires the influence of specific growth and differentiation factors. During 
embryonic limb formation this process is described as condensation. Based on this 
phenomena different chondrogenic induction techniques have been developed to 
recapitulate the in vivo chondrogenesis. In such methods usually high density of cells in 
shape of pellet or aggregates or a combination of cells with biomaterials are applied to 
provide a three-Dimentional (3D) structure for maximum cell-cell and cell-matrix 
interactions (Penick K.J. et al. 2005). Integrins a heterodimer receptor responsible for 
cell-matrix and cell-cell interactions, have been studied extensively during 
chondrogenesis in vitro and in vivo (Shakibaei M. 1998; Fukumoto T. et al. 2002; 
Goessler U.R. et al. 2006; Lu Z.F. et al. 2008).  
Expression of N-CAM and N-cadherin as two major adhesion molecules has been 
shown   during condensation of MSCs in limb bud formation (Monroy J.C. et al. 1999; 
Woodward W.A. et al. 1999; Hall B.K. et al. 2000). These molecules were later down-
regulated after chondrogenic differentiation  and only  expressed in periphery of the  
limb anlagen  in vivo or chondrogenic  aggregate in vitro (Widelitz R.B. et al. 1993)  
(Tavella S et al. 1994 ). In articular cartilage, each chondrocytes individually is 
responsible for production of extracellular matrix (ECM) as functional unit of cartilage 
or chondron, (Poole C.A. et al. 1997) and there is  no direct cell-cell contact between 
chondrocytes (Mobasheri A. et al. 2009 ).  In this study gene expression of N-CAM1 
and N-Cadherin was explored in different chondrogenic models of Alginate bead, 
Pellet, and monolayer cultures. We assumed that a chondrogenic differentiation model 
that has the least expression of cell-cell adhesion molecules along with the high 
expression of chondrogenic markers was more similar to articular cartilage.  
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The comparison of 2D and 3D culture systems conventionally has been used to study 
chondrocyte dedifferentiation in vitro ( Domm C. et al. 2002, Caron M.M. et al. 2012). 
However, a systematic investigation into the role of 2D and 3D cultures with or without 
alginate as a scaffold to demonstrate the potential for chondrogenic differentiation of 
MSCs had not been performed at the time this study was conducted. In this study, 2D 
monolayers were used as the control group to support the rationale of using 3D cultures 
(Pellet and alginate) for chondrogenic differentiation of MSCs; while pellet culture was 
used as a known hypertrophic model to be compared with an alginate chondrogenic 
model of MSCs.  
 
4.3 Methods and Materials  
4.3.1 Isolation of human bone marrow stromal cells 
Healthy human bone marrow samples (male, age=21+2.6 years) from patients 
undergoing long bone fixation, were used for gene expression. This study was approved 
by the University of Malaya Medical Centre Ethics Committee (Reference no. 472.95). 
Human bone marrow was collected in sterile 3ml BD Vacutainer blood   tubes (K2 
EDTA, BD franklin Lakes NJ USA) by orthopaedic surgeons and was kept at 4°C until 
isolation. The mononuclear cells were isolated using Ficoll density gradient method as 
described in chapter 2, cultured and expanded until P3 in 75ml culture flasks. The cells 
were confirmed as MSCs by characterization through flow cytometry using cell surface 
markers (positive and negative markers) and their ability to undergo tri-lineage 
differentiation (adipogenic, chondrogenic and osteogenic differentiation) as described in 
chapter 2.  
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4.3.2 Chondrogenic differentiation and experimental groups  
4.3.2.1 Pellet culture 
 MSCs were harvested at P3, 250X 10
3
 cells were pelleted in a 15ml propylene 
centrifuge tube, at 1100 rpm for 5 minutes. After removal of the supernatant, the pellet 
cultured either with 2ml of basal growth medium containing 10% FBS or chondrogenic 
medium containing:  DMEM high glucose (4.5mg/ml D-Glucose) with sodium pyruvate 
(110 µg/ml) (invitrogen). ITS Sigma 50mg/ml(1X) (invitrogen), L Ascorbate 2 
phosphate (50µg/ml) Sigma, TGFβ3 10ng/ml (invitrogen), Dexamethason 100nM 
(1x10
-7
M) (Sigma), Penicillin/Streptomycin 100µg/ml (invitrogen), L Proline 40µg/ml 
(Sigma), or growth medium containing high glucose DMEM supplemented with 10% 
FBS and 1% pencillin/Streptomycin.  The media were changed every 3 days. 
 4.3.2.2 Cell-alginate constructs  
1.2% alginate prepared from alginic acid powder, low viscosity (Sigma-Aldrich) in 
0.9% sodium chloride (NaCl) and filtered sterile by a 0.2µm filter. 
MSCs at P3 were harvested and a concentration of 4X10
6
 cell per ml of alginate were 
obtained before dropping into sterile, calcium chloride solution (CaCl2) using a pipette. 
Alginate bead constructs cross linked in this solution for 10 minutes in 37ᵒC incubator 
and then were rinsed in 0.9% normal saline 2-3 times, and transferred to the culture 
dishes (ultra-low attachment 12 well plates, Corning). Three beads per well (about      
80 000 cells per bead) and supplemented with 2ml of chondrogenic or growth media. 
The medium changed each 3 days.  
Alginate cells constructs were dissociated in a buffer solution contained 0.015M sodium 
citrate and 0.15M sodium chloride (Na3C6H5O7 dehydrate 2H2O, MW=294.10) pH 7.2, 
centrifuged at 1100 rpm for 5 minutes before gene expression studies were conducted. 
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4.3.2.3 Monolayer culture 
 In two groups P3 cells were cultured in chondrogenic or growth media at density of 
4000 cells/cm
2
 in 6 well plates.  
 
4.3.3 Gene expression studies (real time PCR)  
4.3.3.1 Primers 
Human gene sequences were obtained from NCBI gene bank the primers were designed 
using Primer 3 software and NCBI primer designing tool (Table 4-1). Annealing 
temperature of 58.6 was chosen for primers after being tested by gradient PCR using 
RT-PCR CSFXTM 96. 
 
4.3.3.2 Positive control 
 Human normal chondrocyte (Clonetics
TM
 normal human articular chondrocytes 
(NHAC-kn) Lonza, Walkersville. Inc. U.S.), embedded in alginate beads for 21 day was 
used as a positive control for gene expression. The data were normalized to βactin 
expression while MSCs day 0 considered as a calibrator in ΔΔCt formula. 
 
4.3.3.3 RNA isolation 
 RNA was isolated from cell pellets using SV total RNA isolation system, Promega 
(USA) according to the manufacturer instructions.  Chondrogenic groups of pellet and 
alginate bead after dissociation with sodium citrate buffer, on day 12 and day 21were 
digested with  300-500µl of 0.1% solution of collagenase type II (Worthington, 
Lakewood NJ.) in PBS ( 1.5 hours  in 5% CO2, 37ᵒC incubator) before RNA isolation, 
then centrifuged at 200g for 5 minutes after adding 1X PBS to make pellets.  
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The quality and purity of RNA was measured using a NanoDrop 2000 
(ThermoScientific, UK) spectrophotometer. The integrity of RNA was determined using 
gel electrophoresis for 28S and 18S ribosomal RNA. The ratio of 2/1 for 28S/18S and 
the sharpness of the bands (without smears) were considered intact RNA. The RNA was 
kept in -80°C until further processing to cDNA.  
 
4.3.3.4 cDNA synthesis 
 In each reaction 100ng RNA were converted to first strand cDNA in 20µl final volume 
using iScript
TM
 Reversed Transcription Supermix for RT-qPCR (BioRad) according to 
the manufactures’ protocol.  No template controls (NTC) were used in each reaction as 
negative control.  
 
4.3.3.5 Quantitative Polymerase Chain Reaction  
PCR reactions were carried out in duplicate for each biological samples (N=3) in a final 
volume of 20µl containing SYBR Green mastermix (BioRad) with 160nM 
concentration of each primers and 200ng cDNA in 96-well plates (Bio-Rad) using 
CSFX96
TM
 Real Time System, Bio-Rad under the following conditions: 3.1 minutes at 
95ᵒC followed by 40 cyles of 58.6ᵒC for 0.20 minutes as annealing temperature and    
72ᵒC for 0.30 minutes as extension. The reactions were ended with 0.1 minutes of      
95ᵒC and a melt curve by increasing temperature from 65ᵒC, 0.05 minutes to 95ᵒC, 0.5 
minutes stepwise.  
The data were presented as a time fold change relative to the internal control gene 
expression. The data then normalized to transcription levels of day 0 culture using ΔCT 
and ΔΔCT methods (Livak K.J. et al. 2001).  Values below 1 were considered down 
regulated. The following primer sets were applied in this experiment:  
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Table 4-1 Primer sequence 
Gene Access no. 
 
Primer pairs  5'-3' 
Amplicon 
Size 
Aggecan NM_001135.3 F CTACGACGCCATCTGCTACA          141 
  
R TCAGTGATGTTTCGAGGCAG 
 
Beta-actin NM_001101.3 F CTCTTCCAGCCTTCCTTCCT 116 
  
R AGCACTGTGTTGGCGTACAG 
 
Collagen I NM_000088.3 F ACCTGGTCAAACTGGTCCTG 122 
  
R CCTGTGGTCCAACAACTCCT 
 
Collagen II  NM_033150.2 F GAAAGCCTGGTGATGATGGT 138 
  
R GGCCTGGATAACCTCTGTGA 
 
Collagen X NG_008032.1  F CACCTGTGGTCCTGAATGTG 163 
  
R TCTGAGTGCCTGGATGTCTG 
 
N-Cadherin        NM_001792.3 F GGAAAAGTGGCAAGTGGCAG 159 
  
R GGAGGGATGACCCAGTCTCT 
 
NCAM1   NM_000615.6 F AGGAGACAGAAACGAAGCCA 161 
  
R GGTGTTGGAAATGCTCTGGT 
 
Run X2  NM_001015051.3 F TTACTTACACCCCGCCAGTC 139 
  
R CACTCTGGCTTTGGGAAGAG 
 
SOX9 NM_000346.3  F AGACAGCCCCCTATCGACTT 108 
  
R CGGCAGGTACTGGTCAAACT 
 GAPDH (Bian L. et al., 2011) F AGGGCTGCTTTTAACTCTGGTAAA NA 
  
R GAATTTGCCATGGGTGGAAT 
 
 
 
4.3.4 Statistical analysis  
The different between experimental groups was calculated using non-parametric 
Kruskal-Wallis H test, and the different between two independent experimental groups 
using Mann-Whitney U test, available on the statistical software package SPSS (version 
18.0) with p≤0.05 was being considered significant. 
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4.4 Results                   
4.4.1  Gene expression in human chondrocyte  
The prominent genes expressed in human chondrocytes were collagen type II, type X, 
and aggrecan (ACAN). Collagen type I, cell adhesion molecules  NCAM1 and N-
Cadherin were down-regulated. Sox9,   slightly up regulated and the expression of 
RunX2 gene was not significant (Fig. 4.1). 
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Figure  4-2    Gene expression in human chondrocytes as positive control            
  
                      
4.4.2 Gene expression in experimental groups  
4.4.2.1 Collagen type II  
 Comparison of chondrogenic samples using Mann-Whitney test showed significantly 
higher expression of Col II in alginate group compared to pellet and monolayer culture 
(p=0.05). comparison between pellet and monolayer showed no difference in Col II 
expression on day 3 ,but over time,  pellet culture showed a higher expression of col II 
on day 12 and  21 compared to monolayer culture (p=0.05). 
Expression of collagen II in all experimental groups were significantly increased 
between day 3 and day 12 (p≤0.05), but from day 12 to day 21 the increase was not 
significant in alginate group (P>0.05) and in monolayer it decreased non-significantly 
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(p>0.05). However in pellet culture the increasing trend from day 12 to day 21 was 
significant (p<0.05). In general in all experimental groups expression of collagen II 
increased significantly from day 3 to day 21 (P≤0.05) (Fig. 4-2).   
 
Figure  4-3 Gene expression of Collagen II 
A. Chondrogenic groups B. Control groups * p≤0.05. 
 
 
4.4.2.2 Sox9  
Comparison between group in chondrogenic groups showed significant differences 
between Sox9 expression in alginate group with pellet and monolayer cultures on day 
12 and day 21 (p=0.05), while there was no difference between groups on day 3 
(p>0.05). Sox9 expression significantly increased from day 3 to day 12 (p=0.05) in 
alginate group but the increase from day 12 to day 21 was insignificant (p>0.05). These 
comparisons were insignificant in monolayer culture for all time points. In pellet culture 
the different of Sox9 expression between day 3 and day12 was insignificant (p>0.05) 
but between day 3 and day 21 was significant (p=0.05) (Fig. 4-3). 
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Figure  4-4 Gene expression of Sox9 
A. chondrogenic groups B. Control groups *p≤0.05. 
 
 
4.4.2.3 Aggrecan (ACAN)  
ACAN gene expression in alginate group was significantly higher than pellet culture in 
all time points (P<0.05), whereas in monolayer group no ACAN expression was 
observed. In alginate group the expression of ACAN increased significantly from day 3 
to day 12 (p=0.05) but in another two groups there were no significant increase in these 
time points (p>0.05). In alginate, ACAN expression did not increased from day 12 to 21 
(p>0.05), but in pellet culture it significantly increased (p<0.05). In both groups of 
alginate bead and pellet cultures ACAN gene expression increased from day 3 to day 21 
significantly (p=0.05) (Fig. 4-4). 
 
Figure  4-5 Gene expression of ACAN 
A.  Chondrogenic groups B. Control groups *p≤0.05. 
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4.4.2.4 Collagen type I  
Gene expression of Col I were significantly different among the chondrogenic 
experimental groups on different time points using Kruskal-Wallis test (P<0.05). 
The different was especially significant between time points in pellet culture group in 
which it significantly increased on day 21 (P<0.05). Comparison between two groups 
using Mann-Whitney test showed that expression of Collagen I was higher in alginate 
bead compared to pellet and monolayer culture at all-time points (P=0.05). The 
comparison between monolayer and alginate primarily showed higher expression of 
Collagen I in monolayer on day 3 (p=0.05) but there was no significant different 
between two groups on day 12 and day 21 (p>0.05). 
Col I expressed higher on day 12 compared to day 3 in alginate bead but in other two 
groups the increase in col I was not significant (p>0.05). However in pellet culture it 
was significantly higher on day 21 compare to day 12 (p=0.05) while in alginate  and 
monolayer culture groups the differences at this time points were not significant 
(p>0.05). In general in all experimental groups col I significantly increased from day 3 
to day 21 (Fig. 4-5; P=0.05). 
 
Figure  4-6 Gene expression of Collagen I 
A. Chondrogenic groups B. Control groups *p≤0.05. 
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                                 Table 4-2 Ratio of Collagen I to Collagen II gene expression   
Groups Col I Col II Col I/Col II 
Alginate 12.5 116900 0.000107 
pellet 3 2300 0.001304 
Monolayer 7.6 3.8 2 
    
 Data represents fold expression of genes in chondrogenic groups compared to day 0 MSCs 
 
4.4.2.5 Collagen type X  
Comparison between chondrogenic groups using Kruskal-Wallis test showed the 
highest expression of collagen X in monolayer group on day 3 and day 12, while pellet 
culture showed the highest expression of this gene on day 21. The expression of 
Collagen X in alginate group was significant (p<0.05) among different time points with 
the highest on day3 but down regulated on day 12 and day 21. In pellet and monolayer 
the differences were insignificant (p>0.05). Pellet culture expressed the highest level of 
Col X expression on day 21 and monolayer on day12. Mann-Whittny test showed the 
difference in the expression of Col X between alginate group and pellet on day 3 and 
day 21 was significant (p=0.05). On day 3 alginate had higher expression while on    
day 21 on contrary pellet culture showed higher expression than alginate.  The 
differences in the expression of Col X on day 12 was not significant between two 
groups of pellet and alginate cultures (p>0.05). 
Comparison between pellet culture and monolayer showed Col X significantly 
expressed  higher in  monolayer on day 3 and day 12 (p=0.05), however on day 21 the 
different was not significant between two groups (p>0.05).  The expression of Col X in 
alginate group compared to monolayer on day 3 was not significant (p>0.05), but over 
time on day 12 and day 21 monolayer expressed significantly higher amount of Col X 
(Fig. 4-6; p<0.05).  
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Figure  4-7 Gene expression of Collagen X and Run X2 
A & C. Chondrogenic groups. B & D. Control groups *p≤0.05. 
 
4.4.2.6  Run X2  
Gene expression differences of RunX2 on day 3 and day 21 was significant between 
alginate and pellet culture (p=0.05), on day 3 alginate group had a higher expression but 
on day 21 RunX2 was more expressed in pellet culture. There was no statistically 
significant different between the two mentioned groups on day 12 (p>0.05). 
Comparison between pellet and monolayer culture using Mann-Whitney test showed 
higher expression of RunX2 on day 3 and day 12 in monolayer than pellet culture. 
However on day 21 expression of RunX2 was more prominent in pellet than monolayer 
culture (p=0.05). Comparison between alginate and monolayer on day 3 showed no 
significant difference between the two groups (p>0.05), but on day 12 and day 21 
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expression of RunX2 was significantly higher in monolayer than alginate culture 
(p=0.05). 
In alginate group, expression of RunX2 decreased significantly from day 3 to day 12 
(p=0.05) but the difference on day 12 compared to day 21 was insignificant (p>0.05). In 
monolayer and pellet culture the difference in the RunX2 gene expression was not 
significant from day 3 to day 12 (p>0.05), but in monolayer it decreased and in pellet 
increased significantly on day 21 (p=0.05).  
In general in alginate and monolayer culture RunX2 expression decreased overtime. The 
difference in alginate group was significant between time points over time (p=0.05) but 
in monolayer was insignificant (p>0.05). In pellet culture expression of RunX2 was 
significantly increased over time (Fig. 4-6; p<0.05). 
 
4.4.2.7  N-CAM1 
N-CAM1 remained down-regulated on day 3 and day 12 during chondrogenic 
differentiation of MSCs in  pellet culture and up regulated on day 21, but in alginate 
group it up-regulated over time from day 3 to day 21. In monolayer culture the 
expression of N-CAM1 in chondrogenic group increased significantly from day 3 to day 
12 (P<0.05) and then   down-regulated from day 12 to day 21 (p<0.05). 
Expression of NCAM1 in CMSC in alginate group increased over time from day 3 to 
day 21 (p=0.05) but the increase in Pellet culture was not significant (Fig. 4-7; p>0.05).  
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4.4.2.8  N-Cadherin (N-Cad) 
N-Cad was down-regulated in pellet culture and alginate group on day 3 and day 12 but 
it was up-regulated on day 21. In CMSC alginate culture N-Cad increased significantly 
from day 3 to day12 (p=0.05) but in another two experimental groups the increase was 
not significant (p>0.05). N-Cad increased in pellet culture from day 12 to day 21 
significantly (p=0.05) but the increase of the gene expression in alginate culture was not 
significant (p>0.05) and it decreased in monolayer culture though not significantly 
(p>0.05).  
Comparison between pellet and monolayer showed N-Cad significantly expressed 
higher in monolayer than pellet culture on day 3 and day 12 (p=0.05). However on day 
21 it was less expressed in monolayer than pellet culture (p=0.05). On day 3 
chondrogenic monolayer showed higher expression of N-Cad compared to alginate 
culture but there was no significant differences on day 12 and day 21 between these two 
groups (Fig. 4-7; p>0.05). 
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Figure  4-8 Gene expression of N-CAM1 and N-Cad. 
A & C: Chondrogenic groups. B. & D. Control groups *p≤0.05. 
 
 
4.5 Discussion  
Gene expression of cartilaginous markers which includes collagen type II and ACAN in 
CMSC alginate culture in this experiment was higher than that of mature normal human 
chondrocytes. This is due to the fact that newly formed chondrogenic construct in 
alginate bead resembles an immature foetal cartilage in which anabolic activity 
surpluses the catabolic activities in chondrocytes and results a higher production of 
ECM compared to an adult cartilage tissue ( Aigner T. et al. 2006). 
Gene expression results showed superior chondrognenic differentiation of MSCs in 3D 
culture of alginate compared to pellet culture and 2D culture of monolayer. These 
results are consistent with previous researches (Yang I.H. et al. 2004) but it is different 
from Ichinose S. et al. 2005 in which during chondrogenic differentiation of MSCs in 
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alginate beads induced with TGFβ3 calcification was reported. In our study 
hypertrophic genes of RunX2 and Col X down regulated/did not expressed in alginate 
group, but they up-regulated in pellet and monolayer culture under similar culture 
medium.  
Expression of transcription factor Sox9 is accompanied by the expression of 
chondrogenic genes, such as Col II, and ACAN (de Crombrugghe B. et al. 2000). In this 
study the increase of gene expression of Sox9 overlaps with the expression of Col II and 
ACAN genes in 3D chondrogenic systems as well, however in chondrogenic monolayer 
it was not accompanied with an increase of ACAN. In this experiment expression of 
Sox9 remained low in monolayer and chondrognic pellet culture model, while the 
expression of Col X and Run X2 were prominent in these groups, considering the fact 
that Sox9 inhibits hypertrophic changes in chondrocytes (Bi W. et al. 1999, Murakami 
S. et al. 2004; Ikegami D. et al. 2011; Dy P. et al. 2012), in this study higher expression 
of Sox9 in alginate culture may have protected the cells from being differentiated to a 
hypertrophic conditions.   
Comparison between chondrogenic and control groups showed an increase in the 
expression of collagen type I in chondrogenic groups. The increase synthesis of 
collagen type I in fibroblasts has been shown by TGFβ3 through Smad3 protein, in vitro 
and in vivo (Verrecchia F. et al. 2007). It might be a possibility that a fraction of cells 
transdifferentiated to fibroblast/myofibroblasts during chondrogenic differentiation and 
produce col I under the influence of TGFβ3.  
Expression of collagen type I was also shown in other researches during chondrogenic 
differentiation of bone marrow derived MSC in pellet or alginate culture (Kosher R.A. 
et al.1986; Barry F. et al. 2001; Endres M. 2009; Jang M.Y. et al. 2013, Fernandes 
A.M.,. et al. 2013).  It seems that current static chondrogenic induction conditions have 
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yet to be optimized, and by applying mechanical loading in a bioreactor, culture 
condition may be improved and enhances chondrogenesis by reducing collagen type I 
formation (O’Conor C.J. et al. 2013). In our study although expression of Collagen I in 
alginate beads was higher than pellet and monolayer culture. The ratio of Collagen I to 
Collagen II in alginate group was lowest among the groups, while in chondrogenic 
monolayer culture the expression of Col type I dominated the expression of collagen 
type II (Table 4-2).  
In our study, cell adhesion molecules of N-CAM1 and N-Cad were down regulated in 
3D cultures of alginate beads and pellet cultures on day 3. These results are consistent 
with down regulation of these genes during embryonic  chondrogenesis  (Widelitz R.B. 
et al. 1993; Tavella S. et al. 1994 ), in which N-CAM1 and N-Cad down regulated after 
expression of chondrocyte specific genes. On the other hand during chondrogenic 
differentiation of MSCs in periosteal of membranous bone in craniofacial skeleton such 
as avian quadratojugal joint (an equivalent to mammalian mandibular condylar 
cartilage), it was shown that N-CAM was not necessary before chondrogenesis (Fang J. 
et al. 1999). MSCs in gel-like biomaterials such as Col I, fibrin glue, Matrigel and 
PuraMatrix peptide hydrogel underwent proper chondrogeneis without a direct cell-cell 
communication (Dickhut A. et al. 2008) as well. Therefore, it seems that direct cell-cell 
interactions both in vitro and in vivo, are not always necessary for chondrogenic 
differentiation (Boeuf S. et al. 2010). However indirect paracrine communication 
between the cells in the gel-like material might play a role as it has shown that MSCs 
express different cytokine and growth factors (Liu C.H. et al. 2005; Kim D.H. et al. 
2005).  
In our study N-Cad remained down regulated in both groups of pellet and alginate bead 
until third week of differentiation and then it expressed in pellet and alginate culture on 
day 21. In limb bud experiment it was shown N-Cad expressed prior condrogensis in 
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condensed MSC and then it disappear from the centre of condensation while the cells 
continue their differentiation and then re-expressed in perichondrium, an indication of 
appositional growth (Oberlender S et al. 1994). As a comparison the expression of N-
Cad in our experiment on day 21 can be justified with appositional growth of  
chondrogenic model of pellet in which the peripheral undifferentiated layer of cells 
behave as perichondrium (Hillel A.T. et al. 2010) or fibroblast (Alberts B. et al. 2002).  
As limitation of this study is the limited time points up to three weeks, it has been 
reported that in 3-Dimentional woven scaffold hypertrophy depended to the duration of 
chondrogenesis (Dickhut A. et al. 2008) up to day 45, although in our study the gel like 
nature of alginate is different from the porous scaffold in the mentioned study, more 
investigation in longer time points in future studies is recommended.  
4.6 Conclusion  
 Chondrogenic differentiated MSCs showed different characteristics in pellet and 
alginate cultures. Pellet culture showed a hypertrophic model, whilst in alginate there 
appears to be higher quality of chondrogenic differentiation process occurring with 
higher expression of chondrogenic genes and down-regulation of hypertrophic genes. 
The expression of adhesion molecules was not consistent with that of a normal 
chondrocytes. Since chondrocytes are solitary cells surrounded with ECM and are not in 
direct contact with each other, the expression of N-CAM1 and N-Cad may indicate the 
immature nature of chondrogneic differentiated MSCs in alginate culture. MSCs 
cultured in different experimental groups of alginate, pellet and monolayer, did not 
show the expression of chondrogenic or hypertrophic genes in control groups cultured 
in growth medium. These findings are consistent with morphological studies described 
in the previous chapter.   
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5 CHAPTER 5 
Study 3: Treatment of full thickness articular cartilage defects in 
rabbit model with chondrogenic and undifferentiated bone marrow 
derived mesenchymal stromal cells loaded in alginate and alginate 
bead alone
1
 
 
5.1 Study design  
In this part of the study, rabbit mesenchymal stromal cells (MSCs) were isolated, 
expanded until passage 3 (P3) and characterized. The cells were transplanted into the 
rabbit (N=12) knee defects in two groups of chondrogenic group which were cultured in 
alginate beads for 21 days in chondrogenic medium, and non-chondrogenic group 
included undifferentiated MSCs (d0) loaded in alginate beads. In another group of 
rabbits (N=6), alginate beads transplanted without cells were performed in the knee 
defects. The rabbits were sacrificed after 3 and 6 months and the defects area of the 
knees were studied with gross morphological scoring (Brittberg scoring system), 
Histology (H&E, Safranin O Fast Green staining, O'Driscoll scoring), 
Immunohistochemistry for collagen type II, and biochemical analysis (GAG and 
protein). 
 
 
                                                          
1
 Parts of this project have been published at 1. J.  Ortho. Res.  2011; 29(9):1336-42 2.  2. Am J Sports Med. 2012 Jan;40(1):83-90  
and 3.  Knee Surg Sports Traumatol Arthrosc. 2013 Oct 22.  
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Figure  5-1  Flowchart shows the study design for chapter 5 in vitro and in vivo studies. 
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Figure  5-2  Flowchart shows the study design for chapter 5 in vivo study. 
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5.2 Introduction 
Damage to cartilage tissue as the result of trauma or disease conditions are becoming 
increasingly common. The poor vascular properties of cartilage tissue make healing 
extremely difficult especially in the presence of full thickness articular cartilage defects. 
Cellular therapy has been considered a successful treatment option and has 
demonstrated to produce superior tissue repair quality as compared to conventional 
surgery in many studies (Wakitani S. et al. 1994; Brittberg M. et al. 1994; Fragonas E. 
et al. 2000; Wakitani S. et al. 2002; Brittberg M. 2010).  Autologous chondrocyte 
implantation (ACI) has been used in many clinical trials and has been reported to 
produce good outcomes in previous literatures (Grande D.A. et al. 1989). However, the 
use of ACI has several limitations. These include donor site morbidity, cellular 
dedifferentiation when cultured in vitro and the reduced ability to maintain good long-
term tissue repair (Temenoff J.S. et al. 2000). To overcome these issues, mesenchymal 
stem cells (MSCs) have emerged as an alternative cell source. One of the main 
characteristics of MSCs is its multipotency in which MSCs will continue to be a 
progenitor for other cell types despite being removed from its original environment 
(Pittenger M.F. et al.  1999). From previous studies, allogeneic or autologous bone 
marrow (BM) derived MSCs have been encapsulated into different scaffolds with or 
without the addition of growth factors to treat cartilage defects in various animal 
models. It has been reported that the transplantation of BM-derived MSCs in cartilage 
defects provide good repair outcomes (Colemana R.M et al. 2007, Guo X. et al. 2010). 
However, in vivo assessments of chondrogenic pre-differentiated MSCs (CSMC) in 
alginate to repair full thickness cartilage defect have not been previously demonstrated 
and therefore warrants further investigations. In previous chapters (3& 4), when 
chondrogenic induced MSCs using defined chondrogenic medium (hereto referred to as 
induced-MSCs) were compared to the MSCs that were cultured using growth medium 
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without the addition of any factors (hereto referred as non-induced MSCs), it became 
apparent that superior chondrogenesis using gene expression, biochemical, histological 
and immunohistochemical analysis, as well as ultra- structural studies can be observed. 
In this study, CMSC i.e. MSCs encapsulated in alginate gel cultured in chondrogenic 
medium, were implanted in cartilage defects and compared to MSCs loaded in alginate 
beads and transplanted without chondrogenic differentiation. The objective of this study 
was to compare the effectiveness of using non-induced MSCs and CMSC (or the 
terminologically similar induced-MSC) in alginate beads in order to evaluate the repair 
outcomes of full thickness cartilage defect in rabbit’s knee at 3 and 6 months after 
injury. Moreover in order to investigate the role of alginate alone in the repaired tissue, 
in a separated group of rabbits (N=6) the defective knees were transplanted with 
alginate beads alone. 
 
5.3 Methods and Materials  
5.3.1 Experimental animals 
Twenty  New Zealand White male rabbits ( N=20; 15- 16-week old, 2–3 kg) that were 
used in this study was in accordance with the guidelines of the Animal Care and Use 
Committee and, institutional review board in University of Malaya (Reference number: 
OS/10/11/2008/HD (R)). Two rabbits were sacriﬁced for bone marrow (BM) harvesting 
while the rest were used for the main experiment. BM was harvested in sterile 
conditions and the mononuclear layer (Fig. 5-1) was isolated as described earlier in 
chapter 2. The mononuclear cells was suspended in growth medium DMEM-LG 
supplemented with 10% foetal bovine serum (FBS) and cultured in 75cm
2
 tissue culture 
ﬂasks (Nunc, Rockside, Denmark). Cell culture medium was changed every 3 days and 
the cells were cultured and expanded until P3 in a humidiﬁed incubator at 37°C, 5% 
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CO2. Cell viability was veriﬁed at each passage using TrypanBlue exclusion dye 
method prior to cell counting.  
 
 
 
Figure  5-3 MSCs isolation, expansion, culture in alginate beads, and transplantation in rabbit knee 
 
5.3.2 Preparation of alginate beads loaded with MSCs  
MSC alginate constructs in growth medium were prepared just before being 
transplanted into the knee defects (Group 1; Fig. 5-1). Alginate bead loaded with cells, 
and cultured in chondrogenic medium (Group 2) as described earlier (3.3.2), Group3: 
alginate bead alone was dropped into CaCl2 solution, and washed with PBS after 10 
minutes and transferred to sterile medium for transplantation.     
 
5.3.3 Creation of cartilage defects 
Eighteen rabbits were equally divided into three groups. Each animal underwent surgery 
to create full thickness cartilage defects on the articular surface of the weight-bearing 
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medial femoral condyle of both knees (hind legs). The defects were created using a 
custom-made cylindrical chondrotome (Fig. 5-2), and standardized according to the 
following dimensions: 5 mm diameter and approximately 1 mm depth (or until cartilage 
tissue was completely removed, as observed under 5X magniﬁcation). Care was taken 
to not violate the subchondral bone. Total removal of cartilage tissue was conﬁrmed 
using observations made under the aid of a microsurgical microscope. 
 
5.3.4  Transplantation of alginate constructs and alginate beads alone  
 Transplantations of the MSCs (group 1) and CMSC (group 2) constructs or alginate 
bead alone (group 3) into the defective areas (i.e., right knee in each respective group) 
were conducted approximately 3–4 weeks following the initial defect creation 
procedure. The transplanted cells were obtained only from rabbits of the same litter. The 
left knee was left untreated as a control until the end of the experiment, representing the 
control group of the study. A periosteal ﬂap was used to hold the alginate beads at the 
defect area using microsurgical sutures (Nylon 9-0) and ﬁbrin glue (Fig. 5-2). Post-
operatively, antibiotics and analgesia were administered for 3 consecutive days. No 
wound infection was observed in any of the rabbits. The rabbits moved freely within 
their cages and were sacriﬁced at 3 and 6 months after transplantation. 
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Figure  5-4 Surgical procedures 
               Upper panel: knee exposure 
A. The knees were shaved and draped with sterile draping towel, and wiped with povidone- iodine. 
B. Lignocaine 1% was injected subcutaneously as an anesthesia supplement.  
C. Medial skin incision. 
D. A  parapatellar arthrotomy exposed the knee cartilage. 
Middle panel: Creation of the defect in the femoral medial condyle of both knees. 
E. Creation of the defect with a custom made chondrotome. 
F. Removal of cartilage using a scalpel. 
G. The soft tissue sutured back. 
H. Skin was closed. 
Lower panel: Transplantation 3-4 weeks after creation of defects in the right knee. 
I. A periosteal flap was marked and separated from the upper medial side of tibia (arrow). 
J. The periosteal flap with cambium layer faced down was sutured to the defect area of the right 
knee. 
K. The constructs or alginate bead alone were placed under the periosteal flap. 
L. The borders were sealed using fibrin glue. 
 
 
 
  
A 
B
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5.3.5 Morphological Analysis 
The quality of cartilage tissues in both knees were compared by two independent 
observers, in accordance to the Brittberg morphological score (Appendix G) (Brittberg 
M. 2000) and general histological evaluation. 
 
5.3.6 Histology and Immunohistology 
The distal femur was cut and the medial condyle was divided into two equal parts using 
a saw. Half of the samples used for histology. These samples were ﬁxed in 10% 
buffered formalin for 48–72 hours, and decalciﬁed in 10% formic acid. The specimens 
were processed for histological slides, embedded in paraffin, and cut into 5µm sections 
using a microtome. The slides were stained using haematoxylin and eosin (H&E), 
Safranin O Fast Green and immunohistochemical staining for collagen type II 
(Appendix B). 
 Immunohistochemistry for collagen type II was performed using primary antibody anti 
collagen type II (mouse-anti-rabbit; Merck, Darmstadt, Germany) in 1:100 dilution and 
according to the company protocol (DakoCytomation, Glostrup, Denmark). The 
histology images were analysed using O’Driscoll histological scoring as previously 
described (O’Driscoll S.W. 1988) (Appendix H).  
 
5.3.7 Biochemical Analysis 
Protein and glycosaminoglycan (GAG) were determined using Bio-Rad DC protein 
assay kit (Bio-Rad Laboratories, Richmond, CA) and Blyscan sulphated 
Glycosaminoglycan assay kit (Biocolor Ltd., Country Antrim, UK) according to the 
manufacturer’s protocols. Spectrophotometer absorbance measurements were 
performed using a microplate reader (Epoch Bio-Tek) at 750 and 656nm for protein and 
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GAG assays, respectively. GAG content was normalized according to the protein 
contents (µg GAG/mg protein). 
 
5.3.8 Statistical Analysis 
Grading scores obtained from the Brittberg, O’Driscoll measures and GAG contents 
were statistically analysed using Wilcoxon signed-rank test available on the statistical 
software package SPSS (version 18). To compare the signiﬁcant differences of values 
between the two experimental groups and, between treatment and control groups, 
Mann–Whitney tests were conducted accordingly. P value ≤0.05 was considered 
significant. 
 
5.4 Results  
5.4.1 Macroscopic Observation 
The gross morphological appearances of the regenerated cartilage tissues filling in the 
defects at 3 and 6 months post-transplantation are shown (Fig.5- 3 B & D). The 
Brittberg’s scores for the MSCs and CMSC groups were higher than their respective 
controls (8.17 ±1.83 and 7.00 ± 2.28 for MSC and CMSC, respectively). However these 
differences were not statistically significant (Fig. 5-7) at third month, but there were 
significant differences in the Brittberg score of transplanted knees in both groups treated 
with MSCs at 6 months (7.50 ±1.38 points) to that of the untreated knees (4.50 ± 1.38 
points). CMSC-treated knees demonstrated better result as compared to MSC group 
(9.00 ± 2.00 vs. 7.33 ± 1.53). In group 3, i.e.: transplanted with alginate bead alone, the  
difference of Britterg’s scores of right knees vs. left knees  after 3 and 6 months 
(5.6±1.36 vs.  4.8 ± 1.437) was not statistically significant p>0.05 (Fig. 5-7). 
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Fig 5-3 D, illustrates the gross appearance of the regenerated tissue from CMSC treated 
and the untreated defect at 6 months post-transplantation. In the MSCs/CMSC treated 
knee, the regenerated cartilage tissues exhibited smooth glistening surface with less 
distinct demarcation of the defect border peripherally. In contrast, the regenerated 
tissues in the untreated knee and knees transplanted with alginate alone (Fig. 5-3 E & F) 
had rough surface and very distinct wound margins. 
 
5.4.2 Sulphated Glycosaminoglycan (GAG) Analysis 
The mean GAG/protein levels were higher in the treated knees, i.e. right knees, as 
compared to the control (left) knees at 3 and 6 months in MSCs group (Fig. 5-8). 
However, there was no significant difference between the mean GAG/protein levels of 
transplanted and control knee at 3 months in both groups of MSCs and CMSC. In 
comparison, the group of MSCs showed an increase in the GAG/protein content when 
compared to group CMSC at 3 months. At  6 months there was no  significant 
differences between two groups of MSCs and CMSC, but the mean GAG level of the 
right knees were measured to be higher than the control, p<0.05 (Fig. 5-8). The 
GAG/protein content of group 3, showed no significant different in the right or left 
knees (0.968±0.09 vs. 0.9±0.08) P>0.05. 
 
5.4.3 Histological and immunohistochemical analysis of specimens 
The histology of the repaired tissue obtained from group MSCs and CMSC after 3 
months showed a neocartilage contained immature tissue with clustered cells           
(Fig. 5-4 A, 5-4 E, 5-5 C&D, 5-6 A). The repaired tissue from CMSC at 6 months 
contained of both fibrocartilage and hyaline cartilage (Fig. 5-4 A). In the control left 
knees or alginate bead transplanted groups (both knees) the defect either were 
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unrepaired (Fig. 5-4 H, 5-5 G) or filled with fibrous tissue (Fig. 5-4 G), or incomplete 
repaired with a hyaline like cartilage, but it had not vertical integration with subchondral 
bone (Fig. 5-5 D) or included deep vertical fissures in the repaired tissue                   
(Fig. 5-5 B, 5-6 G). This repaired tissue at 6 months was shown the primary sign of 
degeneration by deep surface fissures (Pearle A.D. et al. 2005; Koelling S. et al.  2009) 
in the neocartilage (Fig. 5-5 B). In some parts the defect was filled with bone            
(Fig. 5-5 B). Immunohsitochemical staining showed more concentration of type II 
collagen in transplanted tissues of both MSC and CMS (Fig. 5-6 A&C). 
The GAG content of the repaired tissue was verified qualitatively by Safranin O Fast 
Green staining. In transplanted groups of MSCs and CMSC the repaired tissue stained 
with more intensity of maroon colour in comparison with that of the control in the 
intermediate and deep zones (Fig. 5-6).   
O’Driscoll histological scores of the repair tissue was higher in the transplanted groups 
when compared to the untreated knees and alginate bead alone (10.5 ± 1.38 vs 7.67 ± 
0.82 and   6.83±0.6) at 3 month, and (11.8 ± 1.47 vs. 8.67 ± 1.86 and 6.4±1.3) at 6 
months post transplantation respectively, p<0.05. However, significant differences in 
scores were not apparent between the MSCs and CMSC group at 3 and 6 months       
(Fig. 5-9). 
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Figure  5-5 Gross morphology of rabbit knee in treated and control groups 
A. Defect was created in the medial chondyle of the knee. 
B. Right knee 3 months after MSC transplantation.   
C. Left knee (control) defect with an irregular surface. 
D. Right and Left knees of CMSC treated rabbits 6 months after transplantation. On the right knee repair tissue 
is more smooth and homogenous than the left knee (control) which was not treated. 
E. Alginate beads alone transplanted at the right knee 6 months after transplantation.  
F. Left knee control. 
. 
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Figure  5-6 Histology of the defect site of the rabbit H& E staining 
A. CMSC group 3months after transplantation, right knee 
B. Left control arrow indicates fibrous tissue.  
C. CMSC group right knee 6months after transplantation .Arrow shows the repaired tissue in the 
right knee composed of immature cartilage with clustered chondrocytes (arrow). 
D. Normal articular cartilage of the rabbit knee. 
E. MSC 3 months after transplantation in right knee. Arrow shows the repaired tissue. 
A B 
C D 
E F 
G H 
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F. Left knee control after 3 months. 
G. Alginate alone transplanted group after 3 months. Arrow indicates fibrous tissue 10X. 
H. Alginate alone transplanted group after 6 months. Arrow shows the fibrous tissue partially 
covered the defect site 10X.   
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Figure  5-7 Immunohistochemistry for collagen type II in defect site of the rabbit knee 
 (A& B) CMSC 6months:  
A. The repaired tissue of the right knee after 6 months contains a great amount of collagen type II 
especially at superficial layer (arrow).  
B. Repaired tissue of the left knee shows an irregular immature cartilage mass with clustered cells and 
low amount of collagen type II (open arrow), a part of the defect has been replaced by bone (astriks) 
, vertical fisure at the repaired cartilage (thick arrow). 
A B 
C 
D 
E F 
G H 
* 
* 
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(C&D) MSC 3months  treated group:  
C. Collagen type II is deposited  (stained brown) in the repaired cartilage in MSC treated site  after 3 
months. 
D. The defect of the left knee after 3 months, the repaired cartilage has no vertical integration with 
subchondral bone, it contains scarce ammount of collagen type II (arrow). 
 (E & F) normal cartilage: 
E. Normal cartilage as  positive control type II collagen is more aboundant in superficial zone (arrow).  
F. Normal cartilage negative control (stained without collagen type II antibody). 
(G& H) alginate alone: 
G. Alginate bead alone transplanted knee after 6 months, stained for collagen type II with 
immunohistochemistry; arrow indicates the edge of the defect. The brown color indicates collagen 
type II, at the defect area it shows the remaining of  calcified layer. A  small inhomogeneous patch 
of neocartilage is seen at the defect site, astriks 10X. 
H. Negative control 10X. 
  
 115 
 
  
  
  
  
Figure  5-8 Safranin O Fast Green staining of  the repaired tissue in  rabbit knee 
(A&B)  CMSC group:  
A. 3 months after transplantation. 
B. 6 months after transplantation.  
(C & D) MSCs group right knee:  
C. 3 months after transplantation. 
D. 6 months after transplantation. 
E. Left control, the defect site shows no or scarce amount of repaired tissue (arrow). 
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C D 
E F 
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F. Normal cartilage, intermediate and deep layers stains purple an indication of higher 
glycosaminoglycan, superficial layer and bone stains green. 
G. Right knee 6 months after transplantation of alginate bead alone, the right side of the picture shows 
native cartilage (maroon colour), and the repaired tissue is discontinues with vertical fissures 
(arrow). 
H. Left knee control shows no healing at the defect site (arrow). 
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Figure  5-9 Brittberg's scoring 
Brittberg score comparing MSCs and CMSC treated knees (Right) to non-treated knees (Left) in (A) 3 
and (B) 6 months *p≤0.05. 
 
 
Figure  5-10 Biochemical analysis of sulphated GAGs content in experimental groups of rabbit knee 
GAG/total protein levels comparing MSC and CMSC treated knees (Right) to non-treated knees (Left) at 
(A) 3 and (B) 6 months (error bars= SD) *p≤0.05.  
 
 
Figure  5-11 Histological scoring (O'Driscoll scoring) 
O’Driscoll score comparing MSCs and CMSC treated knees to non-treated knees (left) (A) 3 and (B) 6 
months (Error bars=SD) *p≤0.05. 
 
L e ft  k n e e R ig h t  k n e e
0 .0
0 .5
1 .0
1 .5
2 .0
G A G  3 m o n th s
T re a te d  v s . c o n tro l k n e e s

g
G
A
G
/m
g
 p
r
o
t
e
in
A lg in a te
A lg in a te  M S C
A lg in a te  C M S C
 
 * 
 
 
* 
* 
* 
A B 
A B 
A B 
* 
 118 
 
5.5 Discussion  
Mesenchymal stem cells exhibit a stable phenotype in vitro and have multilineage 
potential of differentiating into the adipocytes, chondrocytes, or osteocytes (Pittenger 
M.F. et al. 1999). In vitro studies have suggested that the induction of adult stem cells 
into chondrogenic lineage could be achieved via the introduction of soluble, 
biophysical, and 3D culturing environment factors (Guilak F. et al. 2009). In this study 
both cell types i.e. MSCs vs. CMSC were encapsulated in alginate gel, the 3D 
environment provided by the alginate gel may have maintained the spherical cell shape, 
thereby promoting chonrogenesis. It has been shown that the differentiation of MSCs 
into a chondrogenic phenotype requires the cells to maintain a rounded shape (Guilak F. 
et al. 2009), which can be achieved through encapsulation within a semi-solid material, 
such as that provided by the alginate gel. Moreover compression shear loading in a 
bioreactor was shown to induce MSCs seeded in a Fibrin-polyurethane composite,  
production of  endogenous TGFβ3 and subsequently upregulation of the cartilage 
specific genes including  Collagen type II (Li Z. et al. 2010; Schätti O. et al. 2011).  
Henrionnet C. et al. (2012) reported expression of chondrogenic markers under 
mechanical agitation in human bone MSCs cultured on alginate beads without TGF-β 
treatment. There is a possibility that MSCs loaded in alginate bead after transplantation 
in the knee defect site sustained the same mechanical loading and as a consequence 
differentiated to chondrocyte without being induced to chondrogenic differentiation in 
advance. Therefore after 6 months there was no significant difference between 
GAG/protein quantity of the repaired tissue in both MSC and CMSC treated knees, yet 
significantly higher than empty defects and defects transplanted with alginate beads 
alone.   
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In the present study, the gross morphological appearances of smoother and more 
homogenous regenerated cartilage tissues in the MSCs-treated knee indicated a superior 
tissue repair following MSCs treatment compared those left untreated. This finding 
was consistent with previous reports demonstrating satisfactory repair of damaged 
cartilage with the use of MSCs, even in conditions involving osteochondral defects 
(Wakitani S. et al. 1994; Wakitani S. et al. 2002). The question however remains as to 
whether the observed enhanced cartilage repair was a direct result of the transplanted 
MSCs or merely a consequence of augmented expansion of the surrounding cells, for 
example, chondrocytes/progenitor cells or extracellular matrix, contributing to the 
healing process (pelttari K. et al. 2008). To the best of our knowledge, this issue has not 
been specifically addressed in any previous publications. However the possibility of 
eliciting cartilage repair using alginate itself was   ruled out as in alginate bead alone 
transplanted in the defect knees there was no superior repaired tissue when it compared 
with controls in 3 and 6 months after transplantation .This result is similar to (Fragonas 
E. et al. 2000) study in which the defect filled with alginate alone were produced a 
fibrous tissue, similar to the defect without any treatment. 
The histological analyses of the present study identified clear differences between the 
MSCs-treated and untreated knees. The MSCs treatment appeared to induce a greater 
amount of type II collagen formation. In contrast, the repaired tissue of the untreated 
knee showed an irregular immature cartilage mass with clustered cells and low amount 
of collagen type II. In addition, the repaired tissue treated with MSCs contained a vast 
amount of GAG in the intermediate and deep zones, whereas the untreated regenerated 
tissue showed only scarce amount of GAG. Similar observation was reported in a 
previous study (Diduch D.R. et al. 2000), demonstrating that cartilage treated with 
MSCs had extracellular matrix that primarily consisted of a hyaline and fibro-cartilage 
mixture, while the untreated cartilage defects were composed of merely a thin layer of 
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fibrous tissue. There are a number of limitations in the study that are worth highlighting. 
The present study utilized only a limited numbers of animals as a consequence of 
financial constraints. This prohibits the use of parametric statistical analyses, which 
would in effect, produce more convincing results, and thereby strengthen the 
conclusions derived from the analyses. In addition, the constraints related to the 
availability of resources allowed assessment of cartilage repair only at 2 time points, 
that is, 3 months and 6 months post-surgery. A larger number of observational time 
points that should ideally be performed would provide further information regarding the 
temporal evolution of the repair process, providing a better insight into the actual effect 
of MSCs on the long-term outcome of cartilage repair.  
It was not possible to identify the percentage of MSCs that underwent chondrogenic 
transformation due to the technical complexities involved. In addition this meant that 
the homogeneity of the CMSC used in the present study was also not verified. However, 
the characterization of CMSC has provided strong evidences to support that 
chondrogenic transformation in vitro has occurred to a large degree as demonstrated by 
the strong positive staining of GAG and collagen type II. Lastly, the present study only 
investigated the anatomical profiles of the regenerated cartilage as well as its 
extracellular matrix biochemical profiles. The introduction of more sophisticated 
investigative modalities such as proteomic and gene expression analyses would provide 
more precise molecular markers of the regenerate cartilage tissue, thus providing a 
global depiction of the healing process with and without MSCs treatment. 
 
5.6 Conclusion  
 In conclusion, this study demonstrates that the transplantation of MSCs loaded in 
alginate as a carrier for repair of full thickness articular cartilage defects produced 
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superior healing compared to the intrinsic repair of the untreated cartilage defects, 
irrespective of their state of differentiation. This has a clinical implication on wider use 
of the undifferentiated MSCs for cell-based transplantation therapy for articular 
cartilage repair, as this option is associated with more simplified laboratory processing 
that would not impose on additional resources and financial burden. It also proved the 
safety and effectiveness of alginate as a cell carrier for cartilage damage treatment.  
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6  CHAPTER 6 
 General discussion and future work 
Alginate is an inert biomaterial with poor cell attachment quality. Although this trait can 
be a disadvantage for the differentiation of some adherent dependent cells such as 
osteoblast during osteogenic differentiation (Alsberg E. et al. 2001), its benefit for 
chondrogenic differentiation of MSCs appears to be quite relevant. It is apparent that 
MSCs loaded in alginate system maintain a spherical phenotype that is a pre-requisite 
for chondrogenic differentiation to occur. Moreover the cells surrounded with a 
hydrated microenvironment provide a similar cellular milieu to that of articular cartilage 
ECM. When stimulated with chondrogenic inducing factors such as TGFβ3, cells 
produce a high amount of cartilage matrix including collagen type II and   interact with 
through integrin molecules. These events consequently are involved in complex 
signalling pathways which include establishing cell polarity and maintaining cell 
growth and survival (Ramage L. et al. 2012). 
Cell proliferation studies of chondrogenic groups showed cell number in alginate   
significantly increased over time, while pellet culture remained unchanged and in 
monolayer decreases significantly. These differences in cell proliferation in different 
systems can be explained with hypertrophy in pellet and monolayer, as it was shown by 
higher expression of hypertrophic genes in these groups. It has been shown that 
hypertrophic chondrocytes withdraw from the cell cycle and stop proliferation after 
certain period of time (Hunziker E.B. et al. 1987). 
.    
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In this study MSCs loaded in alginate beads and cultured in chondrogenic medium, as 
determined in previous studies, showed a non-hypertrophic articular cartilage-like 
morphology. This finding is contentious since there are those who have similar findings 
(Yang I.H. et al. 2004, Andriamanalijaona R. et al. 2008) whilst others, whom reported 
the expression of hypertrophic factors during chondrogenic differentiation of MSCs in 
alginate beads, would disagree (Steinert A. et al. 2003, Ichinose S. et al. 2005, Xu J. et 
al. 2008, Bian L. et al. 2011, Fernandes A.M., et al.2013). Further studies would 
therefore be required to further elucidate the process with more encompassing analyses 
of the events occurring to elucidate the reasons for these varying observations. 
Nevertheless, this study at present does provide a valuable opportunity for us and many 
others to explore more about the underlying factors that resulted in different outcomes 
in each of these experiment; i.e. to optimize a truly non-hypertrophic model for cartilage 
tissue engineering application. 
To further investigate the underlying mechanisms of the different chondrogenic 
differentiation systems, i.e.:  alginate bead, pellet culture and monolayer, a study of 
TGFβ receptors activity during such chondrogenic differentiation of MSCs is 
recommended. A recent study using ectopic expression of TGFβ receptor type II 
(TβRII) has shown that this receptor has an important role in the maintenance of the 
chondrocyte phenotype during successive passages in monolayer (Baugé C. et al.2013).   
It is worth noting that the expression of collagen type I and adhesion molecules reduces 
the optimum quality of the engineered cartilage. A low oxygen tension environment is 
recommended to test chondrogenic differentiation of MSCs cultured in alginate. It has 
been shown that the expression of Col I was reduced (Meyer E.G. et al. 2010; Sheehy 
E.J. et al. 2012)  during chondrogneic differentiation of MSCs in low oxygen culture 
environment. Chondrogenic differentiation of MSCs under a low oxygen tension can be 
further investigated for the abundance and morphology of mitochondria following 
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chondrogenic differentiation. It is our suggestion that the use of immunofluorescent and 
transmission electron microscopies be employed to demonstrate these and other 
changes.  
 Our in vivo study showed that a full thickness cartilage defect which had not penetrated 
to the subchondral bone may benefit for the transplant for cells or cell-scaffold 
construct. The use of alginate with cells (undifferentiated or chondrogenic 
differentiated) resulted in a superior repair outcome compared with non-treated knee 
cartilage defects.  The important findings in this thesis were that transplantation of 
alginate alone had no modulatory effect on cartilage repair. This suggests that for 
cartilage repair to take place, cells play a vital role in the remodelling process and thus 
is the main factor that provides superior cartilage repair outcomes in cell therapy. 
However, the issue as to whether it is the cells themselves, the factors they secrete or the 
immunomodulatory effect that results in this positive outcome remains a hotly debated 
issue with no clear consensus at the moment (Caplan A. I. et al. 2006; Iyer S.S. et al. 
2008, Anderson J.A. et al. 2013). Our study lacks this component that explains the 
positive outcome observed as it was not part of the original study design nor of the main 
research question. If we were to attribute the outcome to the cells themselves, cell 
tracking experiment could be employed. Incorporating this in future studies to address 
the cell fate following transplantation of cell alginate constructs between the two 
treatment groups would be a prudent move and may provide the answers for these 
questions. Improvement could also be made to the in vivo study by using autologous 
MSCs instead of allogeneic sources, as it has been shown that in vitro or in vivo 
chondrogenic differentiation of MSCs with or without an alginate matrix increased 
immunogenicity and anti-donor immune response in MSCs (Ryan A.E. et al. 2014). 
This, however, can only be performed in larger animal models, given that extracting 
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MSCs from rabbit marrow may prove to be too challenging. In addition, higher number 
of animals will allow using parametric test with a higher degree of reliability obtained.  
Collagen based cell free scaffold combined with microfracture showed good results of 
cartilage repair in clinical studies (Freymann U. et al. 2013), but in our experiment 
alginate alone did not elicit any chondral repair. This can be due to firstly: the defect 
was not penetrated to the subchondral bone therefore MSCs had no access from bone 
marrow to the repair site. Secondly, alginate is a negatively charged gel that does not 
attract any cells to be incorporated into the repair tissue. Perhaps an active cell free 
alginate scaffold, a modified shape of alginate covalently bonded with adhesive peptides 
such as RGD in an osteochondral defect, or a chondral defect coupled with 
microfractue, would have more satisfactory results.  
Although the repair tissue resulted from transplantation of chondrogenic alginate group 
in rabbit was similar to the outcome of non-induced group, it would not decrease the 
importance of chondrogenic differentiation studies of MSCs in alginate beads in vitro. 
In another study using direct parallel comparison between allogeneic MSCs and 
autologous chondrocyte for repair of focal cartilage defects of rabbit knee, we observed 
similar outcome of morphology and biochemical profiles (Tay L.X. et al, 2012). The 
results indicate the feasibility of using undifferentiated MSCs loaded in alginate  for 
treatment of cartilage injuries, while a chondrogenic differentiated model in alginate 
beads can be a suitable in vitro model for studying  the underlying mechanism of 
hypertrophy  during  in vitro chondrogenic differentiation.  
In addition to the limitations that mentioned earlier, there are several others worth 
mentioning in order to not overstate the finding of the present thesis. This study would 
be more convincing if proteins were studied using immunochemistry, western blotting, 
or protein profile of the constructs. This is especially true for hypertrophic markers such 
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as collagen type X and RunX2 and adhesion molecules of NCAM1 and N-Cadherin. In 
the in vivo study, although Safranin O Fast Green specifically stained proteoglycans 
also showed the non-chondrogenic area of the repaired tissue, most probably contained 
collagen type I. However, Col I could have been studied in the repaired tissue using 
more specific staining such as immunohistochemistry. There were limitations with time 
and finance that prevented us for further studies such as protein expression. Therefore 
more protein expression studies are recommended, for which it is hoped that such 
undertaking may be conducted in the near future.  
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7 CHAPTER 7 
 Conclusions  
To summarize the conclusions of the in vitro and in vivo investigations using alginate as 
a scaffold or cell carrier for cartilage repair as described in the present thesis:  
1. Chondrogenic differentiated MSCs in alginate beads were more similar to cells 
in a healthy articular cartilage like model, than that of a hypertrophic model. 
2. MSCs in pellet culture and monolayer culture represented a hypertrophic model 
of chondrogenesis when subjected to chondrogenic differentiation processes.  
3. Pellet cultures resulted in significant cell death and therefore the use of 
scaffolds/carriers like alginate is preferred since it allows cells to be viable 
whilst supporting chondrogenesis. 
4.  Expression of adhesion molecules N-CAM1 and N-Cad may indicate the 
immature nature of chondrogneic differentiated MSCs in alginate hydrogels. 
5. Superior chondrogenic expression is observed in alginate culture and therefore is 
preferable to pellet culture. 
6. Transplantation of MSCs in cartilage defects showed similar results as 
transplantation of CMSC. 
7. Cell loaded alginate produced superior repair tissue, especially 6 months after 
the transplantation in the cartilage defects. 
8. Alginate bead alone did not support or induce any repair tissue after being 
transplanted in the defected knee cartilage.  
9. In the overall, alginate beads offer great potential as a cell carrier that provides 
the ideal environment for chondrogenic differentiation of MSCs in vitro and in 
vivo, and with further improvement on the chondrogenic conditions, may prove 
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itself as the most potential candidate as a promising scaffold for clinical 
application to be used for repairing damaged cartilage. 
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Use 
 
 
  
  
Translation of the letter 
10 June 2011 
 
Havva Dashtdar 
Department of Orthopaedic Surgery 
Faculty of Medicine 
University of Malaya 
 
 
 
MS,  
Extension of Ethics Number: PVA/NOCC Compostite Hydrogel as a Scaffold for 
Tissue Engineering Application in Orthopaedic Knee Surgery 
With regards to above matter Animal Care and Use Ethics Committee, Faculty of 
Medicine, University of Malaya has extended the application for the above research.  
Ethics approval reference number: OS/10/11/2008/0611/HD(R) 
Please be advised that the above ethics approval reference number is valid for two 
years. 
 
 
Thank you 
Yours Sincerely 
Dr. Haji Azizuddin Bin Haji Kamaruddin 
Head 
Animal Research Centre 
Faculty of Medicine 
Secretary of the Ethics Committee of Animal Care and Use 
 
CC:                  MS Zura Syazleena Hamizan  
                        Secretary MCRC 
                        Dean office 
                        Faculty of Medicine 
  
  
 
APPENDIX: A (b) Approval letter from Medical Ethics Committee, University 
Malaya Medical Centre 
 
 
 
 
 
  
  
 
APPENDIX B: Histological staining protocol 
A. Hematoxylin and Eosin staining (H&E) 
In order to study the general morphology of tissues, cells, or constructs H&E 
staining was performed according to the following protocol:  
Reagents:  
1. Hematoxylin and Eosin (Sigma-Aldrich) were filtered before use.  
2. Acid alcohol 0.25ml of HCl in 100ml of 70% alcohol 
3. Bluing reagent: 0.037 mol/L of Amonium persulphate in distilled water 
Protocol:  
1. Deparafinized the paraffin sections in 3 changes of Xylene each 2 minutes. 
2. Rehydrate the sections through ascending series of ethanol (100, 95, 70 each 
2minutes, water up to 5minutes).  
3. Stain in Harris Hematoxylin 2 minutes. 
4. Rinse slides in running tap water. 
5. Plunge in acid alcohol 1-2 dips as a differentiation reagent. 
6. Rinse with tap water. 
7. Dip in bluing reagent for 5-60 seconds. 
8. Rinse in water or alcohol (if using the aqueous based Eosin, rinse the slides 
with water. For alcoholic based Eosin rinse slides in 95% ethanol). 
9. Place the slides in Eosin for 30-60 seconds. 
10. Wash in distilled water. 
11. Dehydrate in an ascending series of ethanol (70, 95, and 100 each 2 
minutes). 
12. Clear in two changes of Xylene each 2 minutes. 
13. Mount with DPX and Cover Slides. 
  
 
B. Safranin O staining for micromass culture:  
1. Fix the cells with 10% formalin for 20 minutes. 
2. Rinse with PBS 3 times. 
3. Rinse with 1% acetic acid 10 seconds.  
4. Stain in 0.1% Safranin O solution for 5 minutes.   
5. Rinse twice with PBS.  
6. Keep in ddH2O or PBS (or glycerin).  
7. Record pictures. 
C. AlcianBlue staining for micromass culture:  
Reagents: AlcianBlue (Sigma-Aldrich) 1g per 100ml of 3% acetic acid PH=2.5 
1. Fix the cells with 10% formalin for 20minutes.  
2. Rinse the cells 3 times with PBS. 
3. Stain with AlcianBlue for 1-2hrs. 
4. Rinse with 3% acetic acid.  
5. Rinse with PBS twice.  
6. Keep in ddH2O or PBS (or glycerin). 
D. Safranin O Fast green staining for tissue paraffin sections. 
Reagents: 
1. 1.5% aqueous safranin O in distilled water. 
2. 0.02% alcohol Fast green: (0.02 g fast green in 100ml 95% ethanol). 
3. 1% acetic acid (always use fresh). 
Procedure:  
1. Deparafinized sections in 3 changes of Xylene 5 minutes each. 
2. Rinse in 2 changes of 100% ethanol 1minute each to remove Xylene. 
3. Hydrate sections in 2 changes of 95% ethanol 1minute each. 
  
4. Finish hydration with 3 changes of distilled water, 1 minute each. 
5. Put slides in 1. 5% Safranin O for 40 minutes.  
6. Rinse in 3 changes of distilled water 6 dip each.  
7. Dip slides in 0.02% alcoholic Fast Green for 30 seconds.  
8. Dip slides in fresh 1% acetic acid solution 8 dips. 
9. Rinse quickly in distilled water 6 dips. 
10. Quickly dip slides in 95% ethanol 6 dips. 
11. Dehydrate in 2 changes of 100% ethanol 8 dips each.  
12. Clear in two or three changes of Xylene for 2minute each. 
13. Mount with DPX and Cover Slides.  
 
Results: Articular cartilage is stained red because of its proteoglycan content. 
Subchondral bone stained green and calcified cartilage in between stained 
light pink 
 
E. Alizarin Red staining solution:  
Alizarin Red S (Sigma-Aldrich) 2g in 100 deionized water mixed well and 
PH was set to 4.2 by a pH meter using 0.1N NaOH and 10% Acetic acid. 
The dye was filtered before use. 
Protocol:  
1. Washing the cells with warm 1XPBS. 
2. Fix the cells with formalin 10% at room temperature. 
3. Remove the fixative and wash the cells with PBS. 
4. Add filtered AlizarinRed (2-5 minutes at room temperature). 
5. Rinse the cells with PBS one to two times follow with 4 times dw. 
6. Counterstain the nucleus with Hematoxylin.  
  
7. Dehydrate and clear with Acetone 100%, Acetone/Xylene 50/50 Xylene 
100% 1min each  
8. Mount the slides with DPX and Cover Slides. 
9. Capture images.  
F. Oil Red staining for cell culture:  
Oil Red stock solution: Sigma (Cat# 0-0625)  
0.35g Oil Red in 100ml Isopropanol, Stir, Filter store at RT up to one year 
Oil Red working solution: Mix 3 parts of Oil Red O stock with two parts of dw (stable 
for 2 hours) 
Procedure:  
1. Wash the cells with warm 1XPBS.  
2. Fix the cells with 10% formalin (20 minutes RT).  
3. Wash with dw twice.  
4. Rinse with 60% Isopropanol.  
5. Stain with fresh Oil Red working solution (15 minutes). 
6. Rinse with dw. 
7. Stain with Hematoxylin 1 minute.  
8. Rinse with dw (4 times). 
9. Capture images.  
 
 
 
  
  
APPENDIX C: Reagents preparation and protocol for TEM 
A. Toluidine Blue staining (Alkaline Toluidine Blue) for semi thin sections:  
Solution A: Toluidine Blue   1g, 1% Borax Solution in distilled water 100ml  
Solution B: Pyronin G (EM Grade) 1g, 1% Borax solution in distilled water 
100ml 
Mix 4 parts of Solution A to one part of solution B. Keep in amber bottles at 
room temperature. Filter before use.  
B. Uranyl acetate Lead citrate staining:  
Semi thin sections collected on copper grids, and stained with Uranyl 
Acetate &  Lead Citrate.  
1. Centrifuge the stain solutions of Uranyl Acetate and Lead Citrate at 3000 
rpm for 10 minutes to sediment the possible crystals in the stains. Then 
filter (0.22 µm) the solutions prior use. 
2. Put drops of Uranyl acetate solution  on top of a dental wax in a Petri 
dish and float the grids upside down (the sample faced the stain) for 10 
minutes.  
3. Wash in filtered ddw three times each time 10 dips and dry with a small 
piece of a filter paper. (Care must be taken not to damage the sample 
when handling with fine forceps). 
4. Stain with lead citrate and wash with filtered ddw  the same way as 
described for Uranyl Acetate ( put some pellets of NaOH in the Petri dish  
to absorb the humidity). 
5. Place the grids in a clean Petri dish on a piece of filter paper in 
desiccators until viewing with TEM. 
 
 
  
APPENDIX D: AlamarBlue Standard Curve and formula 
 
 
 
 
A-F Human MSCs in ascending densities of 10000,20000, 30000, 35000, 
50000 , 48 hours after seeding in 6 well plate,  growth medium,  Phase 
contrast microscopy 4X. 
             
 
AlamarBlue standard curve after 3 hour incubation of AlamarBlue 10% with MSCs. 
 
 
0
5
10
15
20
25
30
35
40
45
50
0 20000 40000 60000
%
 R
ed
u
ct
io
n
 o
f 
a
la
m
a
rB
lu
e
 
Cell number 
 
Y=0.0002x+23.101 
      R²=0.8973 
 
  
AlamarBlue equation  
                     
               
                
     
O1 = molar extinction coefficient (E) of oxidized AlamarBlue (Blue) at 570nm 
O2 = E of oxidized AlamarBlue at 600nm 
R1 = E of reduced AlamarBlue (Red) at 570nm 
R2 = E of reduced AlamarBlue at 600nm 
A1 = absorbance of test wells at 570nm 
A2 = absorbance of test wells at 600nm 
N1 = absorbance of negative control well (media plus AlamarBlue but no cells) at 
570nm 
N2 = absorbance of negative control well (media plus AlamarBlue but no cells) at 
600nm 
  
  
APENDIX E: GAG and Protein assay standard curve 
 
          
 
A.  Sample standard curve for GAG analysis. 
 
 
 
 
B. Sample standard curve for protein analysis. 
  
y = 0.2319x + 0.0785 
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APPENDIX F: Statistical analysis for gene expression  
Kruskal-Wallis test  
 
 
Ranks  
 Ser N Mean Rank P-Value 
D3 Aggrecan 
expression 
Alginate  3 8.00 0.027 
Pellet 3 5.00  
Monolayer 3 2.00  
Total 9   
D12 Aggrecan 
expression 
Alginate  3 8.00 0.039 
Pellet 3 4.67  
Monolayer 3 2.33  
Total 9   
D21 Aggrecan 
expression 
Alginate  3 8.00 0.027 
Pellet 3 5.00  
Monolayer 3 2.00  
Total 9   
 
 
Ranks  
 Time points N Mean Rank P-Value 
Alginate  
Aggrecan 
dimension1 
D3 3 2.00  
D12 3 5.33 0.039 
D21 3 7.67  
Total 9   
Pellet 
Aggrecan 
dimension1 
D3 3 3.83  
D12 3 3.17 0.063 
D21 3 8.00  
Total 9   
Monolayer
Aggrecan  
Dimensi on 
n1 
D3 3 2.83 0.172 
D12 3 5.17  
D21 3 7.00  
Total 9   
 
 
 
 
 
 
 
 
  
Ranks  
 Ser N Mean Rank P-Value 
D3 Sox9 
expression 
Alginate  3 6.00  
Pellet 3 3.33 0.427 
Monolayer 3 5.67  
Total 9   
D12 Sox9 
expression 
Alginate  3 8.00 0.05 
Pellet 3 3.00  
Monolayer 3 4.00  
Total 9   
D21 Sox9 
expression 
Alginate  3 8.00 0.05 
Pellet 3 3.67  
Monolayer 3 3.33  
Total 9   
 
 
Ranks  
 Time points N Mean Rank P-Value 
Alginate  
Sox9 
dimension1 
D3 3 2.00  
D12 3 5.67 0.05 
D21 3 7.33  
Total 9   
Pellet Sox9 
dimension1 
D3 3 3.67 0.288 
D12 3 4.33  
D21 3 7.00  
Total 9   
Monolayer 
Sox9 
dimension1 
D3 3 3.00 0.276 
D12 3 6.33  
D21 3 5.67  
Total 9   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Ranks  
 Ser N Mean Rank P-Value 
D3 Col X 
expression  
Algiante  3 5.33  
Pellet 3 2.00 0.039 
Monolayer 3 7.67  
Total 9   
D12 Col X 
expression  
Algiante  3 4.00  
Pellet 3 3.00  
Monolayer 3 8.00 0.061 
Total 9   
D21 Col X 
expression 
Algiante  3 2.00  
Pellet 3 7.00 0.059 
Monolayer 3 6.00  
Total 9   
 
 
Ranks  
 Time points 
N Mean Rank 
p-Value  
 
Col X expression in 
Alginate  
dimension1 
Day 3 3 8.00  
Day 12 3 2.33  
Day 21 3 4.67 0.039 
Total 9   
Col X expression in 
Pellet  
dimension1 
Day 3 3 3.67 0.066 
Day 12 3 3.33  
Day 21 3 8.00  
Total 9   
Col X expression in 
Monolayer 
dimension1 
Day 3 3 3.83 0.084 
Day 12 3 7.83  
Day 21 3 3.33  
Total 9   
 
 
 
 
 
 
 
 
 
  
Ranks  
 Ser N Mean Rank P-Value 
Day 3 Col I 
expression 
Alginate  3 5.00  
Pellet 3 2.00 0.027 
Monolayer 3 8.00  
Total 9   
Day 12 Col I 
expression  
Alginate  3 7.67  
Pellet 3 2.00  
Monolayer 3 5.33 0.039 
Total 9   
Day 21 Col I 
expression 
Alginate  3 7.83  
Pellet 3 2.00  
Monolayer 3 5.17 0.032 
Total 9   
 
 
Ranks  
 Time points N Mean Rank P-Value 
Alginate  
 Col I 
dimension1 
D3 3 2.00  
D12 3 7.00 0.061 
D21 3 6.00  
Total 9   
Pellet Col I  
dimension1 
D3 3 2.33  
D12 3 4.67 0.039 
D21 3 8.00  
Total 9   
Monolayer 
Col I  
dimension1 
D3 3 2.17  
D12 3 6.17  
D21 3 6.67 0.086 
Total 9   
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Ranks  
 Ser N Mean Rank P-Value 
Day 3 Col II gene 
expression  
Alginate  3 8.00  
Pellet 3 3.00  
Monolayer 3 4.00 0.05 
Total 9   
Day 12 Col II gene 
expression 
Alginate  3 8.00  
Pellet 3 5.00  
Monolayer 3 2.00 0.027 
Total 9   
Day 21 Col II gene 
expression  
Alginate  3 8.00  
Pellet 3 5.00 0.027 
Monolayer 3 2.00  
Total 9   
 
 
Ranks  
 Time point  N Mean Rank P-Value 
Alginate  
 Col II  
dimension1 
Day 3 3 2.00  
Day 12 3 5.33  
Day 21 3 7.67 0.039 
Total 9   
Pellet Col II  
dimension1 
Day 3 3 2.00  
Day 12 3 5.00 0.027 
Day 21 3 8.00  
Total 9   
Monolayer 
Col II 
dimension1 
Day 3 3 2.00  
Day 12 3 7.00 0.059 
Day 21 3 6.00  
Total 9   
 
 
 
 
 
 
 
 
 
 
  
Ranks  
 Ser N Mean Rank P-Value 
Day 3 RunX2  Alginate  3 6.00  
Pellet 3 2.00 0.061 
Monolayer 3 7.00  
Total 9   
Day 12 RunX2  Alginate  3 4.00  
Pellet 3 3.00  
Monolayer 3 8.00 0.061 
Total 9   
Day 21 RunX2  Alginate  3 2.00  
Pellet 3 8.00 0.027 
Monolayer 3 5.00  
Total 9   
 
 
 
 
Ranks  
 Time point N Mean Rank P-Value 
Alginat
e  
RunX2 dimension1 
Day 3 3 8.00  
Day 12 3 4.00 0.061 
Day 21 3 3.00  
Total 9   
Pellet 
RunX2 
dimension1 
Day 3 3 4.00 0.061 
Day 12 3 3.00  
Day 21 3 8.00  
Total 9   
Monola
yer 
RunX2 dimension1 
Day 3 3 4.50  
Day 12 3 7.50 0.120 
Day 21 3 3.00  
Total 9   
 
 
 
 
 
 
 
 
 
  
Ranks  
 ser N Mean Rank P-Value 
Day3 
NCAM1expression 
Alginate  3 4.33  
Pellet 3 2.67 0.05 
Monolayer 3 8.00  
Total 9   
Day 12 NCAM1 
expression 
Alginate  3 5.00 0.027 
Pellet 3 2.00  
Monolayer 3 8.00  
Total 9   
Day 21 NCAM1 
expression  
Alginate  3 8.00 0.055 
Pellet 3 4.17  
Monolayer 3 2.83  
Total 9   
 
 
 
Ranks  
 Time point N Mean Rank P-Vallue 
Alginate  
NCAM1 
dimension1 
Day3 3 2.00 0.05 
Day 12 3 5.67  
Day 21 3 7.33  
Total 9   
Pellet NCAM1 
dimension1 
Day3 3 3.67 0.193 
Day 12 3 4.00  
Day 21 3 7.33  
Total 9   
Monolayer 
NCAM1 
 
dimension1 
Day3 3 5.50 0.027 
Day 12 3 7.50  
Day 21 3 2.00  
Total 9   
 
 
 
 
 
 
 
 
 
  
 
Ranks  
 Ser N Mean Rank P-Value 
Day3 NCad  Alginate  3 3.67  
Pellet 3 3.33  
Monolayer 3 8.00 0.066 
Total 9   
Day 12 NCad  Alginate 3 4.67  
Pellet 3 2.67  
Monolayer 3 7.67 0.079 
Total 9   
Day 21 NCad  Alginate  3 5.83  
Pellet 3 6.17  
Monolayer 3 3.00 0.295 
Total 9   
 
 
 
Ranks  
 Time point N Mean Rank P-Value 
Alginate  
NCad 
dimension1 
Day 3 3 2.00  
Day 12 3 6.00  
Day 21 3 7.00 0.061 
Total 9   
Pellet 
NCad 
dimension1 
Day 3 3 2.67  
Day 12 3 4.33 0.051 
Day 21 3 8.00  
Total 9   
Monolayer 
NCad 
dimension1 
Day 3 3 3.50  
Day 12 3 6.50  
Day 21 3 5.00 0.404 
Total 9   
 
 
 
 
 
 
 
 
  
            Mann-Whitney U test:   
 
 
Ranks  
 Ser 
N Mean Rank Sum of Ranks 
p-
Value 
Day3 NCad  Alginate  3 3.67 11.00  
Pellet 3 3.33 10.00 0.827 
Total 6    
Day 12 NCad  Alginate  3 4.33 13.00 0.275 
Pellet 3 2.67 8.00  
Total 6    
Day 21 NCad  Alginate  3 3.83 11.50 0.658 
Pellet 3 3.17 9.50  
Total 6    
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks P-Value 
Day3 NCad 
expression 
Pellet 3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
Day 12 NCad 
expression  
Pellet 3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
Day 21 NCad 
expression  
Pellet 3 5.00 15.00 0.05 
Monolayer 3 2.00 6.00  
Total 6    
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks p-Value 
Day3 NCad Alginate  3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
Day 12 NCad  Alginate  3 2.33 7.00 0.127 
Monolayer 3 4.67 14.00  
Total 6    
Day 21 NCad  Alginate  3 4.00 12.00 0.513 
Monolayer 3 3.00 9.00  
Total 6    
  
 
Ranks  
 Time point N Mean Rank Sum of Ranks P-Value 
Alginate  NCad 
dimension1 
Day 3 3 2.00 6.00 0.05 
Day 12 3 5.00 15.00  
Total 6    
Pellet NCad 
dimension1 
Day 3 3 2.67 8.00 0.275 
Day 12 3 4.33 13.00  
Total 6    
Monolayer 
NCad 
dimension1 
Day 3 3 2.50 7.50 0.184 
Day 12 3 4.50 13.50  
Total 6    
 
Ranks  
 Time point N Mean Rank Sum of Ranks P-Value 
Alginate NCad 
dimension1 
Day 12 3 3.00 9.00 0.513 
Day 21 3 4.00 12.00  
Total 6    
Pellet NCad 
dimension1 
Day 12 3 2.00 6.00 0.05 
Day 21 3 5.00 15.00  
Total 6    
Monolayer 
NCad 
dimension1 
Day 12 3 4.00 12.00 0.513 
Day 21 3 3.00 9.00  
Total 6    
 
  
 
  
anks  
 Time point N Mean Rank Sum of Ranks P-Value 
Alginate NCad 
dimension1 
Day 3 3 2.00 6.00 0.05 
Day 21 3 5.00 15.00  
Total 6    
Pellet NCad 
dimension1 
Day 3 3 2.00 6.00 0.05 
Day 21 3 5.00 15.00  
Total 6    
Monolayer 
NCad 
dimenson1 
Day 3 3 3.00 9.00 0.513 
Day 21 3 4.00 12.00  
Total 6    
 
 
  
 
Ranks  
 ser N Mean Rank Sum of Ranks P-Value 
Day 3 NCAM1 Alginate  3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
Day 12 NCAM1  Alginate  3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
Day 21 NCAM1  Alginate  3 5.00 15.00 0.05 
Monolayer 3 2.00 6.00  
Total 6    
 
 
Ranks  
 ser N Mean Rank Sum of Ranks P-Value 
Day 3 NCAM1 Alginate 3 4.33 13.00 0.275 
Pellet 3 2.67 8.00  
Total 6    
Day 12 NCAM1  Alginate  3 5.00 15.00 0.05 
Pellet 3 2.00 6.00  
Total 6    
Day 21 NCAM1 
expression  
Alginate  3 5.00 15.00 0.05 
Pellet 3 2.00 6.00  
Total 6    
 
 
 
Ranks  
 ser N Mean Rank Sum of Ranks P-Value 
Day 3 NCAM1 Pellet 3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
Day 12 NCAM1 Pellet 3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
Day 21 NCAM1  Pellet 3 4.17 12.50 0.376 
Monolayer 3 2.83 8.50  
Total 6    
 
 
 
  
 
  
 
Ranks  
 Time point N Mean Rank Sum of Ranks P-Value 
Alginate NCAM1 
dimension1 
Day3 3 2.00 6.00 0.05 
Day 12 3 5.00 15.00  
Total 6    
Pellet NCAM1 
dimension1 
Day3 3 3.33 10.00 0.827 
Day 12 3 3.67 11.00  
Total 6    
Monolayer NCAM1 
dimension1 
Day3 3 2.00 6.00 0.05 
Day 12 3 5.00 15.00  
Total 6    
 
Ranks  
 Time point N Mean Rank Sum of Ranks P-Value 
Alginate NCAM1 
dimension1 
Day 12 3 2.67 8.00 0.275 
Day 21 3 4.33 13.00  
Total 6    
Pellet NCAM1 
dimension1 
Day 12 3 2.33 7.00 0.127 
Day 21 3 4.67 14.00  
Total 6    
Monolayer NCAM1 
dimension1 
Day 12 3 5.00 15.00 0.05 
Day 21 3 2.00 6.00  
Total 6    
 
Ranks  
 Time point N Mean Rank Sum of Ranks P-Value 
Alginate NCAM1 
dimension1 
Day3 3 2.00 6.00 0.05 
Day 21 3 5.00 15.00  
Total 6    
Pellet NCAM1 
dimension1 
Day3 3 2.33 7.00 0.127 
Day 21 3 4.67 14.00  
Total 6    
Monolayer NCAM1 
dimension1 
Day3 3 5.00 15.00 0.05 
Day 21 3 2.00 6.00  
Total 6    
 
 
  
 
Ranks Aggrecan Mann-Whittny 
 
Sig.(2-tailed) 
 
Ranks  
 Time points N Mean Rank Sum of Ranks P-Value 
Alginate  
Aggrecan 
dimension1 
D3 3 2.00 6.00  
D21 3 5.00 15.00 0.05 
Total 6    
Pellet 
Aggrecan 
dimension1 
D3 3 2.00 6.00  
D21 3 5.00 15.00 0.05 
Total 6    
Monolayer 
Aggrecan 
dimension1 
D3 3 2.00 6.00 0.05 
D21 3 5.00 15.00  
Total 6    
 
anks  
 Time points N Mean Rank Sum of Ranks P-Value 
Alginate 
Aggrecan 
dimension1 
D3 3 2.00 6.00  
D12 3 5.00 15.00 0.05 
Total 6    
Pellet  
Aggrecan 
dimension1 
D3 3 3.83 11.50 0.658 
D12 3 3.17 9.50  
Total 6    
Monolayer 
Aggrecan 
dimension1 
D3 3 2.83 8.50 0.376 
D12 3 4.17 12.50  
Total 6    
 
 
Ranks  
 Time points N Mean Rank Sum of Ranks P-Value 
Alginate 
Aggrecan 
dimension1 
D12 3 2.33 7.00 0.127 
D21 3 4.67 14.00  
Total 6    
Pellet  
Aggrecan 
dimension1 
D12 3 2.00 6.00 0.05 
D21 3 5.00 15.00  
Total 6    
Monolayer 
Aggrecan 
 
dimension1 
D12 3 3.00 9.00 0.513 
D21 3 4.00 12.00  
Total 6    
 
  
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks p-Value 
D3 Aggrecan  Alginate  3 5.00 15.00  
Pellet 3 2.00 6.00 0.05 
Total 6    
D12 Aggrecan Alginate  3 5.00 15.00 0.05 
Pellet 3 2.00 6.00  
Total 6    
D21 Aggrecan  Alginate  3 5.00 15.00  
Pellet 3 2.00 6.00 0.05 
Total 6    
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks p-Value 
D3 Aggrecan Pellet 3 5.00 15.00  
Monolayer 3 2.00 6.00 0.05 
Total 6    
D12 Aggrecan Pellet 3 4.67 14.00  
Monolayer 3 2.33 7.00 0.127 
Total 6    
D21 Aggrecan  Pellet 3 5.00 15.00 0.05 
Monolayer 3 2.00 6.00  
Total 6    
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks P-Value 
D3 Aggrecan  Alginate  3 5.00 15.00  
Monolayer 3 2.00 6.00 0.05 
Total 6    
D12 Aggrecan  Alginate  3 5.00 15.00  
Monolayer 3 2.00 6.00 0.05 
Total 6    
D21 Aggrecan  Alginate  3 5.00 15.00 0.05 
Monolayer 3 2.00 6.00  
Total 6    
 
  
Sig.(2-tailed) 
  
 
Ranks  
 Time points N Mean Rank Sum of Ranks P-Value 
Alginate Sox9 
dimension1 
D3 3 2.00 6.00 0.05 
D12 3 5.00 15.00  
Total 6    
Pellet Sox9 
dimension1 
D3 3 3.67 11.00 0.827 
D12 3 3.33 10.00  
Total 6    
Monolayer 
Sox9 
dimension1 
D3 3 2.67 8.00 0.246 
D12 3 4.33 13.00  
Total 6    
 
 
Ranks  
 Time points 
N Mean Rank Sum of Ranks 
P-Value 
Alginate 
Sox9 
dimension1 
D12 3 2.67 8.00  
D21 3 4.33 13.00 0.275 
Total 6    
Pellet Sox9 
dimension1 
D12 3 3.00 9.00  
D21 3 4.00 12.00 0.513 
Total 6    
Monolayer 
Sox 
dimension1 
D12 3 4.00 12.00 0.513 
D21 3 3.00 9.00  
Total 6    
 
Ranks  
 Time points N Mean Rank Sum of Ranks P-Value 
Alginate  
Sox9 
dimension1 
D3 3 2.00 6.00 0.05 
D21 3 5.00 15.00  
Total 6    
Pellet Sox9 
dimension1 
D3 3 2.00 6.00 0.05 
D21 3 5.00 15.00  
Total 6    
Monolayer 
Sox9 
dimension1 
D3 3 2.33 7.00 0.121 
D21 3 4.67 14.00  
Total 6    
 
  
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks p-Value 
D3 Sox9 expression Alginate  3 4.33 13.00 0.275 
Pellet 3 2.67 8.00  
Total 6    
D12 Sox9 expression Alginate  3 5.00 15.00 0.05 
Pellet 3 2.00 6.00  
Total 6    
D21 Sox9 expression Alginate  3 5.00 15.00 0.05 
Pellet 3 2.00 6.00  
Total 6    
 
Ranks  
 Ser N Mean Rank Sum of Ranks p-Value 
D3 Sox9 expression Alginate  3 3.67 11.00 0.825 
Monolayer 3 3.33 10.00  
Total 6    
D12 Sox9 expression Alginate  3 5.00 15.00  
Monolayer 3 2.00 6.00 0.05 
Total 6    
D21 Sox9 expression Alginate  3 5.00 15.00 0.05 
Monolayer 3 2.00 6.00  
Total 6    
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks p-Value 
D3 Sox9 expression Pellet 3 2.67 8.00  
Monolayer 3 4.33 13.00 0.268 
Total 6    
D12 Sox9 expression Pellet 3 3.00 9.00 0.513 
Monolayer 3 4.00 12.00  
Total 6    
D21 Sox9 expression Pellet 3 3.67 11.00 0.827 
Monolayer 3 3.33 10.00  
Total 6    
 
 
  
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks P-Value 
Day 3 Col I expression Alginate 3 5.00 15.00 0.05 
Pellet 3 2.00 6.00  
Total 6    
Day 12 Col I expression  Alginate  3 5.00 15.00 0.05 
Pellet 3 2.00 6.00  
Total 6    
Day 21 Col I expression Alginate  3 5.00 15.00 0.05 
Pellet 3 2.00 6.00  
Total 6    
 
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks P-Value 
Day 3 Col I expression Pellet 3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
Day 12 Col I expression  Pellet 3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
Day 21 Col I expression Pellet 3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks P-Value 
Day 3 Col I expression Alginate  3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
Day 12 Col I expression  Alginate  3 4.67 14.00 0.127 
Monolayer 3 2.33 7.00  
Total 6    
Day 21 Col I expression Alginate  3 4.83 14.50 0.077 
Monolayer 3 2.17 6.50  
Total 6    
 
 
  
 
 
 
 
Ranks  
 Time points N Mean Rank Sum of Ranks P-Value 
Alginate Col I 
dimension1 
D3 3 2.00 6.00 0.05 
D12 3 5.00 15.00  
Total 6    
Pellet Col I  
dimension1 
D3 3 2.33 7.00 0.127 
D12 3 4.67 14.00  
Total 6    
Monolayer Col I  
dimension1 
D3 3 2.17 6.50 0.077 
D12 3 4.83 14.50  
Total 6    
 
 
Ranks  
 Time points N Mean Rank Sum of Ranks P-Value 
Alginate Col I 
dimension1 
D12 3 4.00 12.00 0.513 
D21 3 3.00 9.00  
Total 6    
Pellet Col I  
dimension1 
D12 3 2.00 6.00 0.05 
D21 3 5.00 15.00  
Total 6    
Monolayer Col I  
dimension1 
D12 3 3.33 10.00 0.827 
D21 3 3.67 11.00  
Total 6    
 
 
Ranks  
 Time points N Mean Rank Sum of Ranks P-Value 
Alginate Col I 
dimension1 
D3 3 2.00 6.00 0.05 
D21 3 5.00 15.00  
Total 6    
Pellet Col I  
dimension1 
D3 3 2.00 6.00 0.05 
D21 3 5.00 15.00  
Total 6    
Monolayer Col I  
dimension1 
D3 3 2.00 6.00 0.05 
D21 3 5.00 15.00  
Total 6    
  
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks P-Value 
Day 3 Col II gene 
expression  
Alginate  3 5.00 15.00 0.05 
Pellet 3 2.00 6.00  
Total 6    
Day 12 Col II gene 
expression 
Alginate  3 5.00 15.00 0.05 
Pellet 3 2.00 6.00  
Total 6    
Day 21 Col II gene 
expression  
Alginate  3 5.00 15.00 0.05 
Pellet 3 2.00 6.00  
Total 6    
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks P-Value 
Day 3 Col II gene 
expression  
Alginate  3 5.00 15.00  
Monolayer 3 2.00 6.00 0.046 
Total 6    
Day 12 Col II gene 
expression 
Alginate  3 5.00 15.00 0.05 
Monolayer 3 2.00 6.00  
Total 6    
Day 21 Col II gene 
expression  
Alginate  3 5.00 15.00 0.05 
Monolayer 3 2.00 6.00  
Total 6    
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks P-Value 
Day 3 Col II gene 
expression  
Pellet 3 3.00 9.00  
Monolayer 3 4.00 12.00 0.507 
Total 6    
Day 12 Col II gene 
expression 
Pellet 3 5.00 15.00 0.05 
Monolayer 3 2.00 6.00  
Total 6    
Day 21 Col II gene 
expression  
Pellet 3 5.00 15.00 0.05 
Monolayer 3 2.00 6.00  
Total 6    
 
 
  
 
 
Ranks  
 Time point  N Mean Rank Sum of Ranks p-Value 
Alginate Col II  
dimension1 
Day 3 3 2.00 6.00  
Day 12 3 5.00 15.00 0.05 
Total 6    
Pellet Col II  
dimension1 
Day 3 3 2.00 6.00  
Day 12 3 5.00 15.00 0.05 
Total 6    
Monolayer Col II 
dimension1 
Day 3 3 2.00 6.00 0.046 
Day 12 3 5.00 15.00  
Total 6    
 
 
 
Ranks  
 Time point  N Mean Rank Sum of Ranks p-Value 
Alginate Bead Col II  
dimension1 
Day 12 3 2.33 7.00 0.125 
Day 21 3 4.67 14.00  
Total 6    
Pellet Col II  
dimension1 
Day 12 3 2.00 6.00 0.05 
Day 21 3 5.00 15.00  
Total 6    
Monolaye colll  
dimension1 
Day 12 3 4.00 12.00 0.513 
Day 21 3 3.00 9.00  
Total 6    
 
 
Ranks  
 Time point  N Mean Rank Sum of Ranks P-Value 
Alginate  Col II  
dimension1 
Day 3 3 2.00 6.00 0.05 
Day 21 3 5.00 15.00  
Total 6    
Pellet Col II  
dimension1 
Day 3 3 2.00 6.00 0.05 
Day 21 3 5.00 15.00  
Total 6    
Monolayer Col II 
Di 
mensi on1 
Day 3 3 2.00 6.00 0.046 
Day 21 3 5.00 15.00  
Total 6    
  
 
 
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks P-Value 
Day 3 RunX2 expression  Alginate  3 5.00 15.00 0.05 
Pellet 3 2.00 6.00  
Total 6    
Day 12 RunX2 expression  Alginate  3 4.00 12.00 0.513 
Pellet 3 3.00 9.00  
Total 6    
Day 21 RunX2 expression  Alginate  3 2.00 6.00 0.05 
Pellet 3 5.00 15.00  
Total 6    
 
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks P-Value 
Day 3 RunX2 expression  Pellet 3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
Day 12 RunX2 expression  Pellet 3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
Day 21 RunX2 expression  Pellet 3 5.00 15.00 0.05 
Monolayer 3 2.00 6.00  
Total 6    
 
nks  
 Ser N Mean Rank Sum of Ranks P-Value 
Day 3 RunX2 expression  Alginate  3 3.00 9.00 0.513 
Monolayer 3 4.00 12.00  
Total 6    
Day 12 RunX2 expression  Alginate  3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
Day 21 RunX2 expression  Alginate  3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
  
 
 
 
Ranks  
 Time point N Mean Rank Sum of Ranks P-Value 
Alginate RunX2 
dimension1 
Day 3 3 5.00 15.00 0.05 
Day 12 3 2.00 6.00  
Total 6    
Monolayer 
dimension1 
Day 3 3 2.50 7.50 0.184 
Day 12 3 4.50 13.50  
Total 6    
Pellet 
dimension1 
Day 3 3 4.00 12.00 0.513 
Day 12 3 3.00 9.00  
Total 6    
 
 
Ranks  
 Time point N Mean Rank Sum of Ranks P-Value 
Alginate  
Runx2 
dimension1 
Day 12 3 4.00 12.00 0.513 
Day 21 3 3.00 9.00  
Total 6    
Monolayer 
dimension1 
Day 12 3 5.00 15.00 0.05 
Day 21 3 2.00 6.00  
Total 6    
Pellet 
 
Densi  
on1 
Day 12 3 2.00 6.00 0.05 
Day 21 3 5.00 15.00  
Total 6    
 
 
Ranks  
 Time point N Mean Rank Sum of Ranks P-Value 
Alginate Run X2 
dimension1 
Day 3 3 5.00 15.00 0.05 
Day 21 3 2.00 6.00  
Total 6    
Monolayer 
dimension1 
Day 3 3 4.00 12.00 0.513 
Day 21 3 3.00 9.00  
Total 6    
Pellet 
dimension1 
Day 3 3 2.00 6.00 0.05 
Day 21 3 5.00 15.00  
Total 6    
  
 
 
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks P-Value 
D3 Col X expression  Algiante  3 5.00 15.00 0.05 
Pellet 3 2.00 6.00  
Total 6    
D12 Col X expression  Algiante  3 4.00 12.00 0.513 
Pellet 3 3.00 9.00  
Total 6    
D21 Col X expression Algiante  3 2.00 6.00 0.05 
Pellet 3 5.00 15.00  
Total 6    
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks P-Value 
D3 Col X expression  Pellet 3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
D12 Col X expression  Pellet 3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
D21 Col X expression Pellet 3 4.67 14.00 0.121 
Monolayer 3 2.33 7.00  
Total 6    
 
 
Ranks  
 Ser N Mean Rank Sum of Ranks p-Value 
D3 Col X expression  Algiante  3 2.33 7.00 0.127 
Monolayer 3 4.67 14.00  
Total 6    
D12 Col X expression  Algiante  3 2.00 6.00 0.05 
Monolayer 3 5.00 15.00  
Total 6    
D21 Col X expression Algiante  3 2.00 6.00 0.046 
Monolayer 3 5.00 15.00  
Total 6    
  
 
 
 
Ranks  
 Time points N Mean Rank Sum of Ranks P-Value 
Col X expression in Alginate  
dimension1 
Day 3 3 5.00 15.00 0.05 
Day 12 3 2.00 6.00  
Total 6    
Col X expression in Pellet  
dimension1 
Day 3 3 3.67 11.00 0.827 
Day 12 3 3.33 10.00  
Total 6    
Col X expression in 
Monolayer 
dimension1 
Day 3 3 2.17 6.50 0.077 
Day 12 3 4.83 14.50  
Total 6    
 
 
Ranks  
 Time points N Mean Rank Sum of Ranks P-Value 
Col X expression in Alginate  
dimension1 
Day 12 3 2.33 7.00 0.127 
Day 21 3 4.67 14.00  
Total 6    
Col X expression in Pellet  
dimension1 
Day 12 3 2.00 6.00 0.05 
Day 21 3 5.00 15.00  
Total 6    
Col X expression in 
Monolayer 
 
dimension1 
Day 12 3 5.00 15.00 0.046 
Day 21 3 2.00 6.00  
Total 6    
 
anks  
 Time points N Mean Rank Sum of Ranks P-Value 
Col X expression in Alginate  
dimension1 
Day 3 3 5.00 15.00 0.05 
Day 21 3 2.00 6.00  
Total 6    
Col X expression in Pellet  
dimension1 
Day 3 3 2.00 6.00 0.05 
Day 21 3 5.00 15.00  
Total 6    
Col X expression in 
Monolayer 
dimension1 
Day 3 3 3.67 11.00 0.827 
Day 21 3 3.33 10.00  
Total 6    
 
 
  
APPENDIX G: Macroscopic Evaluation of the repaired cartilage  
 Brittberg Scoring System 
Graft Assesment Maximal 
Score=12* 
Criteria Points 
Degree of defect repair               
in level with surrounding cartilage 
75% repair of defect depth 
50% repair of defect depth 
25% repair of defect depth 
0% repair of defect depth 
4 
3 
2 
1 
0 
Integration to border zone           Complete integration with surrounding 
cartilage           
Demarcating border <1mm ¾ of graft 
integrated, ¼ with a notable border>1mm 
width      
½ of graft integrated with surrounding 
cartilage, ½               
With a notable border>1mm 
Form no contact to ¼ of graft integrated 
with  
    surrounding cartilage 
 
4 
 
3 
 
2 
1 
0 
Macroscopic appearance Intact smooth surface                                                                  
   Fibrillated surface   
Small scattered fissures or cracks 
Several small or few but large fissures                                            
Total degeneration of grafted area                                                  
4
3 
2 
1 
0 
*For a classification as a biologically acceptable appearance a minimal score of 7 points 
with at least 3 in Group 1(degree of defect repair) and 2 in the other groups are 
necessary.  
 
  
APPENDICX H:  Microscopic evaluation of repaired cartilage 
 O’Driscoll scoring system  
O’Driscoll Histological Scoring System 
  Characteristics         Score 
Nature of predominant tissue   
Cellular morphology                                 
  Hyaline articular cartilage 
    
4 
Incompletely differentiated mesenchyme   2 
Fibrous tissue or bone 
    
0 
Safranin O staining of the matrix    
 Normal or nearly normal 
    
3 
Moderate       2 
Slight             1 
None 
      
0 
Structural characteristics    
 Surface regularity 
      Smooth and intact      3 
Superficial horizontal lamination 
   
2 
Fissures 25 to 100 percent of thickness    1 
Severe disrupting including fibrillation 
   
0 
Structural integrity      
 Normal 
      
2 
Slight disruption including cysts    1 
Severe disintegration 
    
0 
Thickness       
 100 percent of normal adjacent cartilage 
  
2 
50 to 100 percent of normal cartilage     1 
  
 
0 to 50 percent of normal cartilage                                     
 
0 
Bonding to the adjacent cartilage      
 Bonded at both ends of graft 
    
2 
Bonded at one end and partially at both ends   1 
Not bonded 
     
0 
Freedom from cellular changes of degeneration  
 Hypocellularity 
      Normal cellularity      3 
Slight hypocellularity 
    
2 
Moderate hypocellulartiy     1 
Severe hypocellularity 
    
0 
Chondrocyte clustering     
 No clusters 
     
2 
<25 percent of the cells     1 
25 to 100 percent of the cells 
    
0 
Freedom from degenerative changes in adjacent cartilage 
 Normal cellularity, no clusters, normal staining 
  
3 
Normal cellularity, mild clusters, moderate staining  2 
Mild or moderate hypocellularity, slight staining     1 
Severe hypocellularity, poor or no staining 
  
0 
Total Score         
  
  
  
Appendix I : Raw data for Brittberg and O’Driscoll scoring 
N=6 in each group 
O’Driscoll scores 
Left knee Right knee 
Alginate 7 6.4 
Alginate-MSC 8.166666667 11.66666667 
Alginat-CMSC 6.7 11 
 
 
N=6 in 
each group 
Brittberg Score  
Left knee Right knee 
Alginate 4.8 5.6 
Alginate-
MSC 5.5 7.9 
Alginat-
CMSC 6 9.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
APPENDIX J: Flow cytometry analysis of  MSCs CD markers 
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